Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3028192	s-igg2	g/l (g/l)	3061	4147	0.00%
3028192	s-igg2	— (—)	1414	1879	100.00%	Distribution not available
3028192	s-immunoglobuliinig,alaluokka2	g/l (g/l)	24	26	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma/COPD (KELA code 203)

1274

2557

3.47

319.13

1.5

1.3

2.80

3.01

g/l

3.32

946

1710

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

310

117

19.78

313.42

1.5

1.2

2.96

3.22

g/l

0.64

214

Second line medication for Crohn's disease

923

2392

3.94

310.20

1.6

1.3

2.84

2.93

g/l

0.71

651

1675

Asthma, including avohilmo

1524

2749

3.15

309.14

1.5

1.3

2.88

2.99

g/l

1.32

1112

1851

Chronic sinusitis

775

1495

5.32

307.65

1.5

1.3

2.89

3.01

g/l

0.97

589

999

ILD medications

1932

1786

5.99

307.65

1.5

1.2

2.85

3.12

g/l

5.64

1378

1188

Inflammatory bowel disease treatment related agents

2012

1987

5.79

307.65

1.5

1.2

2.87

3.10

g/l

4.25

1435

1334

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1046

2107

4.54

307.65

1.4

2.93

2.95

g/l

0.08

737

1459

Asthma, excluding more controls

1229

895

7.31

307.65

1.5

1.3

2.85

3.23

g/l

5.69

896

558

Asthma, unspecified (mode)

789

863

7.03

307.65

1.4

1.3

2.87

3.19

g/l

3.57

546

544

Asthma (diagnoses ohter than nonallergic)

1378

2886

4.04

307.65

1.5

1.3

2.83

2.98

g/l

2.17

1007

1979

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1438

2722

3.71

307.65

1.5

1.3

2.67

3.08

g/l

11.05

1019

1897

Asthma, hospital admissions , main diagnosis only

1308

2924

4.02

307.65

1.5

1.3

2.81

2.99

g/l

2.83

961

1994

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1377

2783

3.43

307.65

1.4

2.68

3.07

g/l

10.53

999

1893

Oral corticosteroids

1993

1897

6.39

307.65

1.5

1.2

2.83

3.13

g/l

6.64

1422

1266

Chronic lower respiratory diseases

1621

2568

3.41

307.65

1.4

1.3

2.89

3.00

g/l

1.35

1188

1716

ILD medications: prednisolone, methylprednisolone, prednisone

1915

1743

6.28

307.65

1.5

1.2

2.84

3.14

g/l

6.48

1370

1158

Asthma, hospital admission 2, infections

1136

2106

5.43

307.65

1.5

1.3

2.78

2.95

g/l

2.34

852

1448

Immunodeficiencies

362

146

30.46

307.65

2.0

1.3

2.05

2.84

g/l

5.16

287

103

Immunodeficiency with predominantly antibody defects

286

53.03

307.65

2.1

1.3

1.89

2.63

g/l

3.23

234

Asthma, unspecified (mode), excluding more controls

780

820

7.27

307.65

1.4

1.3

2.88

3.19

g/l

3.33

539

518

First line medication for Crohn's disease

1793

1768

5.59

307.65

1.5

1.2

2.86

3.12

g/l

5.12

1272

1188

Pneumonia, organism unspecified

1307

2520

3.70

307.65

1.4

2.66

3.09

g/l

11.86

944

1704

Undetermined asthma, excluding more controls

304

202

15.74

307.65

1.7

1.2

2.88

3.17

g/l

1.23

219

130

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1311

1790

4.51

307.65

1.4

1.3

2.69

3.16

g/l

11.92

954

1181

Influenza and pneumonia

1477

2723

3.50

307.65

1.4

1.3

2.69

3.10

g/l

12.40

1071

1847

ILD medications: immunosuppressive drugs

1122

1616

6.62

307.65

1.5

1.2

2.83

3.12

g/l

3.88

797

1079

Asthma-related infections

1136

2106

5.43

307.65

1.5

1.3

2.78

2.95

g/l

2.34

852

1448

Bronchiectasis

288

156

20.20

307.65

1.4

2.87

2.79

g/l

0.18

213

109

All pneumoniae

1425

2778

3.48

307.65

1.4

2.68

3.09

g/l

11.81

1030

1889

1311

1790

4.51

307.65

1.4

1.3

2.69

3.16

g/l

11.92

954

1181

Asthma, hospital admissions 3, pneumonia

720

1135

6.54

307.65

1.5

1.3

2.68

2.94

g/l

2.88

541

781

Fever of other and unknown origin

941

1724

4.97

307.65

1.4

1.3

2.69

3.08

g/l

7.27

675

1214

Certain disorders involving the immune mechanism

599

699

9.14

307.65

1.9

1.3

2.45

2.93

g/l

5.86

438

482

Asthma-related pneumonia or sepsis

720

1135

6.54

307.65

1.5

1.3

2.68

2.94

g/l

2.88

541

781

Abnormal findings on diagnostic imaging of lung

811

1475

5.41

307.65

1.4

2.87

2.96

g/l

0.59

592

1012

Asthma (only as main-diagnosis), excluding more controls

1242

895

8.13

307.65

1.5

1.3

2.83

3.23

g/l

6.40

909

558

Acute pancreatitis

504

583

9.09

307.65

1.6

1.3

2.87

2.93

g/l

0.24

225

427

Asthma (mode)

1211

951

6.96

307.65

1.5

1.3

2.88

3.22

g/l

4.86

886

592

Systemic connective tissue disorders

704

1244

5.86

307.65

1.7

1.3

2.79

2.94

g/l

1.17

510

861

Asthma-related pneumonia

719

1133

6.54

307.65

1.5

1.3

2.69

2.94

g/l

2.87

540

780

Asthma (only as main-diagnosis)

1262

946

7.90

307.65

1.5

1.3

2.82

3.22

g/l

6.74

921

589

Undetermined asthma

304

208

15.28

307.65

1.7

1.2

2.88

3.20

g/l

1.36

219

137

938

1609

5.97

307.65

1.5

1.3

2.77

2.92

g/l

1.69

708

1113

Acute pancreatitis (for exclusion)

504

686

7.71

307.65

1.6

1.3

2.87

2.92

g/l

0.18

225

502

Pneumonias (Asthma/COPD co-morbidities)

1418

2770

3.49

307.65

1.4

2.69

3.08

g/l

11.04

1026

1887

Asthma

1257

946

7.11

307.65

1.5

1.3

2.86

3.22

g/l

5.37

916

589

L04AX Other immunosuppressants

899

2319

3.96

304.16

1.6

1.3

2.85

2.93

g/l

0.58

639

1626

Other systemic involvement of connective tissue (FG)

495

790

6.39

290.66

1.8

1.3

2.87

2.93

g/l

0.25

361

538

Other pulmonary diagnosis

866

954

4.60

275.38

1.3

2.86

3.23

g/l

4.72

609

595

Autoimmune diseases related-to ILD

1115

2950

3.28

274.32

1.4

2.95

g/l

0.02

767

2052

Other systemic involvement of connective tissue

511

914

5.77

271.88

1.8

1.3

2.84

2.91

g/l

0.28

371

632

Excluding asthma or asthma-COPD overlap

857

954

4.55

269.44

1.3

2.87

3.23

g/l

4.37

601

595

ILD differential diagnosis

851

951

4.54

266.41

1.3

2.88

3.22

g/l

4.03

597

592

COPD differential diagnosis

850

952

4.53

265.46

1.3

2.88

3.22

g/l

4.03

597

592

Asthma and opportunity respiratory infection

202

105

21.63

263.73

1.5

1.3

2.81

2.73

g/l

0.14

145

COPD/asthma/ILD related infections

1189

1791

3.36

255.17

1.4

1.3

2.78

3.16

g/l

7.82

858

1181

COPD/asthma related infections

1189

1791

3.36

255.17

1.4

1.3

2.78

3.16

g/l

7.82

858

1181

Abnormalities of breathing

1115

1942

3.38

254.54

1.4

1.3

2.85

3.05

g/l

2.61

796

1296

Cough

608

1249

4.70

253.57

1.4

1.3

2.88

2.96

g/l

0.46

456

845

Other respiratory diseases principally affecting the interstitium

367

516

7.41

247.87

1.4

1.3

2.96

2.90

g/l

0.21

254

360

Other and unspecified immunodeficiencies with predominantly antibody defects

146

54.60

245.81

2.2

1.4

1.74

2.70

g/l

2.24

119

ILD, hospital admission 2, with pulmonary infections

232

178

13.73

245.50

1.4

1.3

2.85

3.10

g/l

0.82

161

124

Acute sinusitis

771

1892

3.84

245.50

1.5

1.3

2.90

3.03

g/l

1.16

581

1279

Disorders of gallbladder, biliary tract and pancreas

1228

2573

3.05

245.37

1.5

1.3

3.00

2.97

g/l

0.23

727

1923

Allergic asthma (mode), excluding more controls

346

447

7.74

243.69

1.5

1.3

2.85

3.12

g/l

1.75

284

285

Allergic asthma (mode)

346

455

7.61

240.02

1.5

1.3

2.85

3.15

g/l

2.05

284

292

Other interstitial pulmonary diseases

328

422

8.13

239.69

1.4

1.3

2.99

2.88

g/l

0.38

227

293

Non-allergic asthma (mode), excluding more controls

295

327

9.17

239.23

1.6

1.2

2.74

3.08

g/l

1.97

222

217

Interstitial lung disease endpoints

328

424

8.09

238.73

1.4

1.3

2.99

2.88

g/l

0.39

227

294

Interstitial lung disease

328

424

8.09

238.73

1.4

1.3

2.99

2.88

g/l

0.39

227

294

ILD medications: azathioprine

305

365

8.68

236.30

1.7

1.2

2.89

3.01

g/l

0.42

219

258

ILD, hospital admissions

324

418

8.11

236.24

1.4

1.3

2.99

2.88

g/l

0.38

223

288

Non-allergic asthma (mode)

295

338

8.87

233.13

1.6

1.2

2.74

3.10

g/l

2.12

222

224

GASTRO-related operations

890

1169

3.86

230.74

1.4

1.2

2.89

2.97

g/l

0.49

589

937

Any gastric operation

890

1169

3.86

230.74

1.4

1.2

2.89

2.97

g/l

0.49

589

937

1292

2279

2.96

230.38

1.4

1.3

2.80

3.09

g/l

5.69

942

1520

Reimbursement for rheumatic diseases

809

2349

3.49

228.11

1.5

1.4

2.84

2.95

g/l

0.82

583

1635

Autoimmune diseases excluding thyroid diseases

1256

2362

2.94

224.87

1.4

1.3

2.92

2.96

g/l

0.29

884

1641

Azathioprine

305

388

8.17

224.69

1.7

1.2

2.89

2.97

g/l

0.24

219

276

Bacterial pneumonia (organism specified)

612

1362

4.15

215.45

1.4

2.56

3.07

g/l

8.64

444

932

Autoimmune diseases excluding thyroid diseases, strict definition

1207

2285

2.93

215.26

1.4

1.3

2.92

2.96

g/l

0.36

855

1597

Bacterial pneumoniae

559

1122

4.48

214.85

1.4

2.61

3.15

g/l

8.36

409

755

ILD, hospital admissions 1, main diag only

292

373

8.20

214.80

1.4

1.3

3.04

2.92

g/l

0.41

204

259

Obesity related asthma

519

1163

4.57

212.26

1.4

1.3

2.76

3.00

g/l

2.13

369

786

General symptoms and signs

1219

2113

2.92

210.29

1.5

1.3

2.84

3.08

g/l

3.69

862

1450

ILD, hospital admissions 3, with pneumonia sepsis

206

171

12.72

207.91

1.2

1.4

2.85

3.18

g/l

1.10

143

119

Chronic rhinitis, nasopharyngitis and pharyngitis

493

1088

4.64

205.45

1.4

2.86

2.98

g/l

0.84

399

741

Bacterial pneumonia, not elsewhere classified

522

1041

4.50

201.92

1.3

1.4

2.63

3.15

g/l

7.41

382

703

Bronchitis

1230

2968

2.64

190.23

1.4

1.3

2.72

3.08

g/l

9.11

897

2017

Other acute lower respiratory infections

722

2086

3.35

189.22

1.5

1.4

2.60

2.97

g/l

6.64

530

1444

Nonhereditary hypogammaglobulinemia

108

52.76

182.08

2.3

1.4

1.60

2.93

g/l

2.14

Chronic pancreatitis

253

336

7.86

179.94

1.9

1.2

3.21

3.07

g/l

0.40

131

248

Bacterial infection, other or unspecified

658

1660

3.50

179.54

1.3

1.4

2.56

3.08

g/l

8.90

473

1139

Dyspnoea

1046

2883

2.71

178.29

1.4

2.84

2.99

g/l

1.83

744

2013

Symptoms and signs involving the circulatory and respiratory systems

1085

1949

2.82

176.14

1.4

1.3

2.90

3.05

g/l

1.54

768

1297

Bacterial infection, other or unspecified

700

1808

3.32

175.51

1.3

1.4

2.60

3.06

g/l

7.39

506

1247

Acute upper respiratory infections

1145

2712

2.63

174.78

1.4

1.3

2.83

3.03

g/l

2.71

840

1833

Other bacterial diseases

1074

2768

2.64

169.16

1.4

2.69

3.04

g/l

6.47

761

1915

Other diseases of pleura

556

1323

3.75

168.62

1.5

1.4

2.59

2.99

g/l

4.75

385

905

Cholangitis (primary sclerosing, PSC)

163

137

12.63

163.39

1.8

1.2

3.47

2.80

g/l

2.44

102

Other diseases of biliary tract

186

190

10.26

163.03

2.1

1.3

3.26

2.90

g/l

0.99

101

139

Examination and observation for other reasons

692

1177

3.44

162.68

1.5

1.3

2.96

3.03

g/l

0.42

580

690

Acute bronchitis

549

1517

3.61

162.57

1.4

2.57

2.97

g/l

5.90

403

1056

Kela reimbursement Agammaglobulinemia (D80-84)

64.82

161.90

2.2

1.5

1.89

3.08

g/l

0.97

Other bacterial diseases

1127

2850

2.54

161.66

1.4

2.71

3.04

g/l

6.41

808

1962

Selective deficiency of immunoglobulin G [IgG] subclasses

67.68

161.33

2.5

1.2

2.15

3.16

g/l

1.11

Autoimmune diseases

1176

2374

2.54

158.88

1.4

1.3

2.99

2.96

g/l

0.21

822

1649

Used for control exclusion in common control thyroid runs

1108

2157

2.62

158.21

1.4

1.3

3.02

2.97

g/l

0.31

754

1518

Asthma and allergy, excluding more controls

209

257

8.23

155.42

1.5

1.4

2.82

3.04

g/l

0.88

174

171

Pain in joint

658

1265

3.36

154.24

1.4

2.95

2.98

g/l

0.15

482

855

Asthma and allergy

209

260

8.14

153.92

1.5

1.4

2.82

3.04

g/l

0.87

174

169

Anaemias

350

417

5.59

153.29

1.4

1.3

2.97

3.09

g/l

0.43

248

301

Diseases of the respiratory system

597

795

3.80

152.04

1.4

1.3

2.83

3.22

g/l

4.04

420

492

Enlarged lymph nodes

276

486

5.85

149.44

1.5

1.2

2.86

3.05

g/l

0.84

197

347

Tramadol

861

1915

2.79

147.26

1.4

2.78

3.18

g/l

6.81

612

1314

Acute upper respiratory infections of multiple and unspecified sites

841

2298

2.74

146.78

1.4

1.3

2.75

3.04

g/l

4.40

619

1558

Suggestive for eosinophilic asthma

198

252

8.23

146.21

1.8

1.3

3.02

2.96

g/l

0.15

153

169

Early onset COPD, excluding more controls

223

328

6.92

143.82

1.6

1.2

2.53

3.26

g/l

5.58

157

216

Other specified/unspecified systemic involvement of connective tissue

160

161

10.60

142.27

2.4

1.4

2.85

2.91

g/l

0.11

129

111

Other necrotizing vasculopathies

168

182

9.75

141.27

1.4

2.48

2.89

g/l

1.46

123

135

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

172

192

9.40

141.20

1.6

1.4

3.31

2.96

g/l

0.93

111

132

Septicaemia

492

1323

3.53

139.61

1.4

2.60

3.00

g/l

4.22

342

918

Abnormal findings on examination of blood, without diagnosis

565

1624

3.25

139.46

1.6

1.4

3.10

2.95

g/l

0.93

386

1122

Diseases of oesophagus, stomach and duodenum

1121

2858

2.37

137.25

1.3

1.4

2.98

2.97

g/l

0.10

792

1982

Bacterial Sepsis

535

1387

3.35

136.22

1.4

2.60

3.04

g/l

5.10

377

953

Any reimbursement code in KELA

609

895

3.45

135.95

1.4

1.3

2.87

3.14

g/l

2.64

427

621

Ethmoidectomy

262

486

5.60

134.60

1.7

1.3

3.04

2.92

g/l

0.49

189

340

FESS (DNB20)

257

473

5.65

133.21

1.7

1.4

3.02

2.93

g/l

0.34

185

329

Diseases of liver

454

1299

3.56

132.39

1.3

1.4

3.10

2.90

g/l

1.26

294

919

Other diseases of upper respiratory tract

1081

2359

2.41

132.05

1.4

1.3

2.85

3.02

g/l

1.95

785

1566

Pain in throat and chest

828

1870

2.68

131.01

1.4

1.3

2.90

3.05

g/l

1.51

606

1238

Other necrotizing vasculopathies (FG)

144

140

10.87

130.98

1.4

1.3

2.57

2.81

g/l

0.57

104

101

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

574

1856

3.04

129.38

1.4

1.3

2.88

3.03

g/l

1.09

394

1236

Finngen Rheumatological endpoints

1002

2365

2.43

128.20

1.4

1.3

2.88

3.02

g/l

1.57

712

1608

Headache

681

1952

2.82

127.53

1.5

1.3

2.85

3.07

g/l

2.48

502

1355

Explicit Sepsis

514

1502

3.24

127.48

1.4

1.3

2.63

2.98

g/l

3.49

360

1042

Gastrointestinal diseases

579

873

3.35

124.52

1.4

1.3

2.92

3.04

g/l

0.73

397

655

Other septicaemia

428

1178

3.55

123.28

1.4

1.3

2.62

2.99

g/l

3.23

301

813

Vasomotor and allergic rhinitis

447

1333

3.34

117.87

1.4

1.3

2.92

2.97

g/l

0.24

353

886

Implicit bacterial Sepsis

449

1196

3.38

117.29

1.4

2.59

3.02

g/l

4.44

317

823

Other diseases of pancreas

153

190

8.39

115.28

1.6

1.2

3.04

2.96

g/l

0.14

139

Infections, IBD-co-morbidities

207

218

6.91

114.98

1.6

1.2

2.69

3.21

g/l

2.38

143

151

Polyarthropathies

725

1815

2.64

113.66

1.4

2.81

3.00

g/l

1.85

528

1255

Medical observation and evaluation for suspected diseases and conditions

660

1179

2.89

113.21

1.5

1.3

2.85

3.04

g/l

1.41

499

692

Certain infectious and parasitic diseases

945

1999

2.39

112.02

1.4

1.3

2.80

3.08

g/l

4.25

658

1357

Opioids

964

2148

2.35

111.80

1.4

2.83

3.16

g/l

5.50

667

1480

Other immunodeficiencies

28.07

110.46

2.3

1.3

2.75

2.73

g/l

0.01

Symptoms and signs involving the digestive system and abdomen

962

2072

2.34

109.84

1.4

1.3

2.87

2.97

g/l

0.86

650

1464

Implicit bacterial Sepsis

471

1306

3.16

109.76

1.4

2.60

3.04

g/l

4.94

334

896

L04AA Selective immunosuppressants

344

929

3.79

109.73

1.5

1.3

2.68

2.90

g/l

1.57

250

644

Mixed connective tissue disease

150

195

8.11

109.06

1.9

1.5

2.79

2.89

g/l

0.25

119

132

Other soft tissue disorders, not elsewhere classified

948

2443

2.29

107.91

1.4

1.3

2.90

2.97

g/l

0.52

688

1674

Codeine

905

2105

2.36

106.94

1.4

2.76

3.16

g/l

8.44

621

1450

Other specific joint derangements/joint disorders

777

2052

2.47

106.68

1.4

2.98

2.99

g/l

0.06

558

1413

Dermatitis

661

2632

2.53

105.49

1.5

1.3

2.91

2.95

g/l

0.21

472

1848

Other and unspecified dermatitis

577

2164

2.70

105.03

1.5

1.4

2.89

2.95

g/l

0.29

413

1526

Gastro-oesophageal reflux disease

700

2460

2.48

103.99

1.4

2.89

2.94

g/l

0.32

480

1712

Implicit viral Sepsis

350

990

3.60

103.87

1.4

2.58

2.99

g/l

3.45

252

697

Malaise and fatigue

497

1364

2.96

102.47

1.4

1.3

2.72

3.05

g/l

3.36

349

958

Abdominal and pelvic pain

939

2072

2.29

102.32

1.4

1.3

2.90

2.97

g/l

0.56

629

1464

Primary_lymphoid and hematopoietic malignant neoplasms

310

819

3.87

101.95

1.4

2.21

3.00

g/l

8.01

222

569

Implicit Sepsis

744

2340

2.42

101.82

1.4

2.74

3.04

g/l

3.75

514

1625

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

313

343

4.62

100.66

1.3

2.95

3.07

g/l

0.45

221

229

Sicca syndrome [Sjögren]

163

254

6.68

100.31

1.5

1.4

2.76

2.79

g/l

0.06

106

184

Idiopathic pulmonary fibrosis

128

156

8.52

97.89

1.4

1.2

3.19

2.93

g/l

0.63

112

Vocal cord dysfunction

176

262

6.15

97.09

1.6

1.2

2.73

3.16

g/l

2.04

116

176

Other diseases of intestines

1045

2835

2.11

96.99

1.4

1.3

2.88

2.98

g/l

0.90

735

1968

Viral Sepsis

270

670

4.12

96.94

1.4

1.3

2.49

2.98

g/l

4.05

193

481

Implicit viral Sepsis

269

667

4.12

96.68

1.4

1.3

2.48

2.99

g/l

4.30

192

479

Haemorrhage from respiratory passages

335

872

3.51

93.64

1.4

1.3

2.89

3.03

g/l

0.59

234

570

Low back pain

745

2314

2.33

92.88

1.4

1.3

2.83

3.03

g/l

2.37

525

1572

Other diseases of blood and blood-forming organs, wide

308

865

3.64

92.75

1.4

2.60

2.92

g/l

1.94

205

608

Noninfective enteritis and colitis

537

2066

2.63

92.73

1.3

1.4

2.88

2.91

g/l

0.09

360

1467

Liquid cancers, helper endpoint

422

1255

2.98

89.14

1.4

2.36

3.00

g/l

7.81

303

877

Adrenocortical insufficiency

104

111

10.04

88.76

1.7

1.4

2.49

2.86

g/l

0.87

Nasal polyp

240

591

4.14

87.11

1.6

1.3

3.00

g/l

0.02

196

397

Parasetamol

697

1459

2.44

87.06

1.4

1.3

2.93

3.08

g/l

1.18

488

975

Other disorders of adrenal gland

116

146

8.42

86.82

1.6

1.3

2.44

2.95

g/l

1.59

104

Other special examinations and investigations of persons without complaint or reported diagnosis

604

1179

2.61

86.57

1.3

2.87

3.04

g/l

1.25

438

692

Oedema, not elsewhere classified

320

946

3.38

86.52

1.6

1.3

2.84

3.02

g/l

0.90

236

667

Budesonide

170

318

5.46

86.27

1.4

1.2

3.23

2.99

g/l

0.68

115

219

All influenza

287

806

3.62

86.19

1.5

1.3

2.70

3.07

g/l

2.66

210

562

Exclusions for E4_PCOS_BROAD

269

727

3.79

85.78

1.5

1.4

2.59

2.83

g/l

1.18

131

535

Codeine or tramadol medication

1056

2890

2.01

85.70

1.4

2.76

3.07

g/l

6.00

728

1993

Diagnoses used for exclusion with ILD

310

923

3.42

85.19

1.4

1.3

3.12

2.92

g/l

0.89

208

665

Cholelithiasis, broad definition with cholecystitis

765

2330

2.23

84.54

1.4

3.01

2.94

g/l

0.37

487

1734

Respiratory disorders in diseases classified elsewhere

20.20

84.14

1.8

1.3

2.31

2.77

g/l

0.77

Other respiratory disorders and diseases

249

646

3.93

84.10

1.5

1.4

2.29

2.96

g/l

7.64

178

458

Other diseases of the respiratory system

249

646

3.93

84.10

1.5

1.4

2.29

2.96

g/l

7.64

178

458

Drug-induced adrenocortical insufficiency

16.62

83.99

1.9

1.4

2.36

2.63

g/l

0.37

Other disorders involving the immune mechanism, not elsewhere classified

11.37

83.80

2.6

1.3

2.71

2.88

g/l

0.29

Implicit Sepsis

769

2587

2.19

83.23

1.4

2.76

3.03

g/l

3.14

525

1810

Other disorders of white blood cells

116

154

7.90

82.82

1.4

2.68

2.77

g/l

0.17

108

General examination and investigation of persons without complaint and reported diagnosis

581

1179

2.59

82.78

1.4

1.3

2.90

3.04

g/l

0.95

478

692

Heart failure, not strict

697

2086

2.29

82.31

1.5

1.4

2.69

3.01

g/l

4.12

493

1435

Unspecified acute lower respiratory infection

217

518

4.29

82.24

1.5

1.3

2.69

3.03

g/l

1.88

161

360

Cardiovascular diseases

638

1411

2.45

82.03

1.4

1.3

2.87

3.01

g/l

1.00

432

1017

Disorders of other endocrine glands

491

1897

2.58

81.31

1.5

1.3

2.59

2.89

g/l

3.02

281

1360

Nausea and vomiting

293

846

3.44

81.26

1.4

1.3

2.83

2.88

g/l

0.15

217

627

Disorders of lacrimal system

462

1761

2.65

81.19

1.5

1.4

2.92

2.91

g/l

0.02

320

1226

Osteoporosis

280

745

3.57

80.99

1.5

1.3

2.50

2.85

g/l

2.04

192

513

Dermatitis and eczema

1035

3297

1.96

80.42

1.4

1.3

2.93

2.96

g/l

0.19

732

2277

Pain in limb

759

2356

2.17

78.89

1.4

1.3

2.82

2.97

g/l

1.53

556

1614

Other disorders of lacrimal gland

392

1402

2.84

78.51

1.6

1.3

2.94

2.91

g/l

0.11

270

974

Provisional assignment of new diseases of uncertain etiology

552

2341

2.38

77.31

1.5

1.3

2.77

2.97

g/l

1.88

411

1615

Cardiovascular diseases (excluding rheumatic etc)

661

1651

2.32

77.21

1.4

1.3

2.85

3.01

g/l

1.32

443

1174

Cholangitis (primary sclerosing, PSC), with reimbursement 202

13.90

77.18

1.9

1.3

3.57

2.47

g/l

2.59

Other heart diseases

503

1275

2.60

77.17

1.5

1.3

2.82

2.98

g/l

1.05

353

907

Codes for special purposes

552

2343

2.38

77.16

1.5

1.3

2.77

2.98

g/l

1.90

411

1617

COPD (mode)

216

398

4.31

77.11

1.3

1.2

2.68

3.20

g/l

3.39

158

254

Wegener granulomatosis

19.20

76.70

1.7

1.3

2.41

2.62

g/l

0.21

Sulfasalazine

255

719

3.59

76.10

1.4

1.2

2.85

3.12

g/l

1.41

177

483

Pneumonia due to other infectious organisms, not elsewhere classified

11.60

76.04

1.4

1.3

2.05

2.82

g/l

1.80

Pain, not elsewhere classified

288

879

3.32

75.97

1.7

1.3

2.72

3.03

g/l

2.54

224

620

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

11.42

75.72

2.7

1.3

2.59

2.94

g/l

0.74

Oxycodone

369

1164

2.90

75.53

1.5

1.4

2.67

3.17

g/l

4.81

254

806

Irritable bowel syndrome

323

1061

3.09

75.45

1.5

1.4

2.91

2.94

g/l

0.10

225

732

Cholelithiasis

715

2280

2.18

75.43

1.4

2.99

2.95

g/l

0.21

450

1697

Other inflammatory liver diseases

121

187

6.73

75.11

1.3

1.5

3.13

2.96

g/l

0.33

129

Dental caries

295

881

3.27

74.96

1.5

1.3

2.68

3.03

g/l

2.35

220

594

Dorsalgia

903

2396

2.03

74.90

1.5

1.3

2.87

3.03

g/l

1.65

631

1627

Covid-19 confirmed case

389

1420

2.78

74.90

1.5

1.3

2.58

2.95

g/l

3.56

263

968

Viral pneumonia

172

369

4.77

74.63

1.3

2.59

3.10

g/l

2.19

123

261

COPD

369

1049

2.91

74.01

1.4

1.3

2.61

2.99

g/l

3.41

263

697

Eosinophilic disease (BM)

21.98

73.95

1.6

1.2

2.97

2.41

g/l

0.95

Biological medicines for asthma

13.42

73.76

1.3

2.79

2.67

g/l

0.19

Other arthritis (FG)

327

1105

3.00

72.65

1.4

1.3

2.84

2.98

g/l

0.64

235

752

Pleural effusion

177

397

4.55

72.65

1.5

1.4

2.93

3.08

g/l

0.38

115

282

Aplastic and other anaemias

426

1530

2.62

72.54

1.4

2.77

2.96

g/l

0.87

265

1081

Diseases of the skin and subcutaneous tissue

898

2243

2.02

72.14

1.4

1.3

2.90

3.01

g/l

0.92

627

1524

Neurological diseases

803

1930

2.10

71.68

1.4

2.91

3.01

g/l

0.82

556

1360

Neurological diseases, wide definition

294

408

3.65

71.60

1.4

1.2

2.95

2.99

g/l

0.11

204

286

15.68

71.38

1.5

1.3

2.70

2.55

g/l

0.18

Pain (limb, back, neck, head abdominally)

618

1327

2.35

71.27

1.4

2.84

2.95

g/l

0.76

435

900

Implicit fungal Sepsis

112

169

6.87

71.08

1.3

1.4

2.39

2.91

g/l

1.86

120

Osteopathies and chondropathies

546

2222

2.31

70.75

1.5

1.4

2.68

2.94

g/l

2.46

375

1567

Other chronic obstructive pulmonary disease

352

1011

2.90

70.50

1.4

1.3

2.60

2.99

g/l

3.58

250

666

Condition for Implicit Sepsis (Organ dysfunction codes)

768

2667

2.05

69.54

1.3

1.4

2.74

3.03

g/l

3.74

524

1871

Caries of dentine

261

769

3.35

69.38

1.5

1.3

2.70

3.03

g/l

1.98

195

518

Disorders of thyroid, IBD co-morbidities

170

242

5.00

69.14

1.4

1.2

2.91

3.24

g/l

1.28

122

165

Certain infectious and parasitic diseases

637

1407

2.28

69.00

1.3

2.82

3.12

g/l

3.44

461

943

Lower back pain or/and sciatica

953

3292

1.90

68.99

1.4

1.3

2.85

3.00

g/l

1.69

674

2262

Hernia of abdominal wall, postoperative

161

349

4.68

68.80

1.5

1.3

2.69

3.00

g/l

1.04

106

292

Simple and mucopurulent chronic bronchitis

10.28

68.77

1.3

2.57

2.53

g/l

0.06

Condition for Implicit Sepsis (Organ dysfunction codes)

807

2801

2.00

68.25

1.3

1.4

2.79

3.02

g/l

2.63

555

1947

Other and unspecified anaemias

390

1419

2.65

68.03

1.4

2.75

2.93

g/l

0.84

244

998

5-aminosalicylic acid

210

563

3.78

67.65

1.4

1.2

3.13

3.07

g/l

0.17

129

378

Other heart diseases, wide

866

2721

1.96

67.28

1.4

2.83

2.98

g/l

1.43

596

1905

Other anaemias

391

1430

2.63

67.12

1.4

2.76

2.94

g/l

0.83

245

1006

Complications of surgical and medical care, not elsewhere classified

894

3213

1.92

67.00

1.4

2.87

2.99

g/l

1.16

641

2218

Intestinal infectious diseases

869

3455

1.92

66.84

1.4

1.3

2.76

2.99

g/l

3.64

612

2396

Allergic rhinitis

371

1399

2.66

65.52

1.4

1.3

2.91

2.92

g/l

0.04

301

961

Respiratory insufficiency

8.95

65.09

1.3

2.13

3.19

g/l

4.59

Disorders of eyelid, lacrimal system and orbit

772

2979

1.98

65.00

1.5

1.3

2.90

2.96

g/l

0.37

543

2085

Symptoms and signs involving the skin and subcutaneous tissue

660

3169

2.05

64.34

1.5

1.3

2.89

2.97

g/l

0.52

506

2198

ILD-related respiratory insufficiency

10.57

64.27

1.2

2.29

2.85

g/l

1.29

Diseases of salivary glands

354

1341

2.68

63.57

1.6

1.3

2.86

2.92

g/l

0.25

246

924

Other specified/unspecified arthritis

288

980

2.98

63.30

1.4

2.87

2.96

g/l

0.34

203

680

Other noninfective gastroenteritis and colitis

287

975

2.99

63.23

1.4

1.3

2.71

2.86

g/l

0.58

202

704

L04AD Calcineurin inhibitors

179

452

4.08

63.20

1.3

1.4

2.64

2.87

g/l

0.77

123

327

Fibrosis and cirrhosis of liver

119

216

5.69

62.74

1.2

1.4

3.37

2.99

g/l

1.13

150

Hypothyroidism, levothyroxine purchases

256

415

3.52

62.27

1.4

1.3

2.92

3.16

g/l

1.09

170

294

Hypothyroidism and >3 levothyroxin purchases

256

415

3.52

62.27

1.4

1.3

2.92

3.16

g/l

1.09

170

294

Rheumatoid arthritis

316

1010

2.84

62.20

1.5

1.4

2.68

2.98

g/l

2.06

234

698

Other headache syndromes

418

1730

2.44

62.08

1.4

3.01

2.97

g/l

0.13

297

1219

Sarcoidosis

181

467

3.97

61.89

1.4

3.29

3.00

g/l

0.98

117

334

Candidiasis

321

1173

2.78

61.89

1.4

1.3

2.79

2.90

g/l

0.53

235

812

Other joint disorders

786

2098

1.99

61.40

1.4

2.96

2.98

g/l

0.15

562

1442

Diarrhoea and gastroenteritis of presumed infectious origin

660

2956

2.03

61.10

1.4

2.78

3.01

g/l

2.73

465

2057

Infection due to other mycobacteria

18.08

60.60

1.5

1.4

2.90

2.85

g/l

0.05

Hypothyroidism (congenital or acquired)

254

417

3.48

60.59

1.4

1.3

2.90

3.15

g/l

1.18

167

296

Spondylopathies

673

1955

2.07

60.55

1.4

1.3

2.83

3.05

g/l

2.23

463

1318

Childhood asthma (age<16), excluding more controls

138

215

5.13

60.39

1.3

1.2

2.82

3.15

g/l

1.09

133

Soft tissue disorders

900

2478

1.88

59.59

1.4

1.3

2.89

2.97

g/l

0.63

632

1698

Diseases of the eye and adnexa

735

1829

2.03

59.56

1.4

1.3

2.88

2.99

g/l

0.83

525

1243

Episodal and paroxysmal disorders

963

2677

1.84

59.54

1.4

2.88

2.98

g/l

0.87

655

1893

Childhood asthma (age<16)

138

219

5.03

59.23

1.3

1.2

2.82

3.16

g/l

1.11

135

All kidney diseases

874

3245

1.85

58.97

1.4

2.70

3.02

g/l

4.88

590

2291

Chronic laryngitis and laryngotracheitis

161

395

4.16

58.91

1.4

1.3

2.83

2.94

g/l

0.29

117

262

Other functional intestinal disorders

420

1649

2.39

58.62

1.5

1.3

2.68

2.93

g/l

1.93

293

1159

Coagulation defects, purpura and other haemorrhagic conditions

237

758

3.18

58.20

1.5

1.3

2.63

2.92

g/l

1.82

177

532

Eosinophilia

13.63

57.99

1.6

1.3

2.97

2.61

g/l

0.51

Other dorsopathies, not elsewhere classified

866

2419

1.88

57.93

1.4

1.3

2.87

3.02

g/l

1.65

606

1646

Colitis, primary sclerosing

12.63

57.85

1.4

1.2

3.48

2.35

g/l

3.26

Methotrexate

140

313

4.55

57.72

1.6

1.2

2.61

2.93

g/l

1.17

100

221

Dorsopathies

892

2445

1.86

57.39

1.4

1.3

2.92

3.02

g/l

0.74

620

1669

Migraine

485

1766

2.25

57.34

1.4

1.3

2.96

2.95

g/l

0.04

348

1271

Diarrhoea and gastroenteritis of presumed infectious origin

891

3236

1.83

57.06

1.4

1.3

2.81

3.00

g/l

2.61

627

2238

Symptoms and signs concerning food and fluid intake

131

281

4.76

56.80

1.5

1.3

3.04

2.97

g/l

0.13

213

Persons encountering health services for examination and investigation

530

1179

2.27

56.79

1.4

1.3

2.90

3.04

g/l

0.86

399

692

Fibromyalgia

130

279

4.78

56.55

1.6

1.4

2.91

2.90

g/l

0.02

196

Diseases of the digestive system

417

1796

2.33

56.10

1.5

1.3

2.99

2.93

g/l

0.23

278

1247

COPD, hospital admission 2, with asthma infections

286

875

2.83

55.60

1.4

2.43

2.98

g/l

6.01

203

600

Other intervertebral disc disorders

702

2158

1.97

55.44

1.4

1.3

2.92

3.06

g/l

1.10

492

1458

Arthropathies

794

2111

1.92

55.43

1.4

2.91

2.97

g/l

0.43

574

1455

Fungal Sepsis

8.15

55.23

1.4

1.3

2.26

2.70

g/l

1.09

Other general symptoms and signs

143

6.52

54.89

1.6

1.3

2.67

2.73

g/l

0.11

108

Sleep disorders (combined)

964

2846

1.79

54.73

1.3

1.4

2.93

2.98

g/l

0.35

646

1997

Intestinal infectious diseases

988

3218

1.76

54.71

1.4

2.78

3.00

g/l

3.50

696

2220

Abnormalities of heart beat

292

1060

2.73

54.53

1.3

1.4

2.83

3.00

g/l

0.86

195

714

Endocrine, nutritional and metabolic diseases

724

1877

1.97

54.27

1.4

1.3

2.87

3.02

g/l

1.39

476

1354

Pneumocystosis

12.15

54.21

1.6

1.4

1.90

2.71

g/l

1.62

All chronic kidney diseases

477

1783

2.21

54.14

1.5

1.4

2.73

3.02

g/l

2.40

324

1246

Purpura and other haemorrhagic conditions

176

490

3.67

53.96

1.5

1.4

2.65

2.91

g/l

1.15

131

349

Complications of medical and surgical care

645

3071

1.94

53.46

1.4

2.85

2.98

g/l

1.03

461

2139

Voice disturbances

281

1035

2.75

53.45

1.4

2.78

2.91

g/l

0.70

203

718

Hypertensive diseases (excluding secondary)

482

1249

2.26

53.40

1.5

1.3

2.85

3.05

g/l

1.42

316

882

Implicit fungal Sepsis

8.34

53.22

1.5

1.3

2.20

2.68

g/l

1.26

Diseases of the musculoskeletal system and connective tissue

465

1009

2.33

52.76

1.4

1.3

2.85

2.99

g/l

0.86

326

694

Inflammatory bowel disease

340

1386

2.48

52.53

1.3

3.12

2.95

g/l

0.81

221

964

Persons encountering health services in other circumstances, wide

992

2931

1.75

52.42

1.4

1.3

2.82

3.01

g/l

2.42

716

2011

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

120

7.01

52.41

1.5

1.4

2.72

3.01

g/l

0.45

Protozoal diseases

8.50

52.12

1.5

1.4

2.07

2.88

g/l

2.43

Other diseases of pericardium

103

7.55

51.94

1.4

1.3

2.82

3.03

g/l

0.31

Mycoses

287

1085

2.68

51.89

1.5

1.3

2.98

2.93

g/l

0.16

192

758

Persons encountering health services for specific procedures and health care

939

3224

1.76

51.86

1.3

1.4

2.76

3.01

g/l

3.99

667

2230

Functional dyspepsia

264

956

2.80

51.85

1.4

3.01

2.87

g/l

0.60

194

656

Sleep apnoea

802

2853

1.83

51.71

1.3

1.4

2.92

2.99

g/l

0.55

522

2002

Other disorders of fluid, electrolyte and acid-base balance

290

1045

2.67

51.70

1.3

2.64

3.01

g/l

2.81

193

716

COPD, hospital admissions 3, with asthma pneumonia sepsis

242

701

2.99

51.61

1.5

1.4

2.36

3.00

g/l

6.67

175

489

Complications of procedures, not elsewhere classified

700

3100

1.88

51.55

1.4

2.88

3.00

g/l

0.95

508

2141

Dysphagia

223

741

3.05

51.21

1.4

1.3

2.94

3.00

g/l

0.16

153

529

Osteoporosis with pathological fracture (FG)

142

6.29

51.14

1.6

1.2

2.09

2.86

g/l

3.68

104

Viral infections characterized by skin and mucous membrane lesions

411

1840

2.26

51.09

1.5

1.4

2.59

2.92

g/l

3.12

303

1282

Primary biliary cholangitis (PBC)

13.29

50.73

1.2

3.45

2.65

g/l

1.47

Viral infections characterized by skin and mucous membrane lesions

757

3577

1.82

50.57

1.4

2.72

2.98

g/l

3.42

546

2479

Renal failure

380

1449

2.34

50.40

1.4

2.67

2.95

g/l

2.06

239

1006

Cardiac arrhythmias

551

1747

2.06

50.32

1.3

1.4

2.89

3.00

g/l

0.70

368

1249

Cholecystectomy

606

2697

1.95

50.25

1.4

3.10

2.93

g/l

1.22

377

1913

Rheumatoid arthritis, including avohilmo

361

1547

2.36

49.90

1.4

2.73

2.92

g/l

1.17

263

1063

Urticaria and erythema

375

1634

2.32

49.86

1.4

2.80

2.90

g/l

0.56

275

1144

Depression medications

266

444

3.04

49.76

1.4

1.3

2.91

3.20

g/l

1.61

183

316

Other diseases of liver

209

684

3.11

49.45

1.3

2.92

2.88

g/l

0.14

133

486

Hypopituitarism

124

287

4.46

49.27

1.5

1.3

2.67

2.83

g/l

0.40

219

Rheumatism, unspecified

157

432

3.70

48.96

1.8

1.4

3.02

2.84

g/l

0.55

116

302

Drug-induced osteoporosis with pathological fracture

14.27

48.17

1.9

1.3

2.23

2.59

g/l

0.48

Other pleural conditions

109

231

4.81

48.12

1.4

2.81

3.13

g/l

0.78

165

Antihypertensive medication - note that there are other indications

572

1499

2.04

47.90

1.4

1.3

2.92

2.99

g/l

0.35

394

1068

Chronic kidney disease

261

961

2.69

47.59

1.4

2.55

2.98

g/l

3.02

168

685

Persons encountering health services in other circumstances

383

1710

2.25

47.41

1.4

1.3

2.80

2.96

g/l

0.87

224

1172

Anxiety disorders, excluding more controls

725

2583

1.84

47.38

1.5

1.4

2.89

3.02

g/l

1.14

529

1777

Intestinal malabsorption

124

6.52

47.20

1.4

1.3

3.22

2.71

g/l

1.18

Sleep apnoea, including avohilmo

834

2945

1.76

47.19

1.4

2.92

2.99

g/l

0.52

546

2061

Symptoms and signs involving speech and voice

319

1328

2.43

47.13

1.4

2.74

2.92

g/l

1.16

230

922

Ulcerative colitis, NAS

178

545

3.33

47.13

1.3

1.4

3.11

2.95

g/l

0.48

120

390

Chronic hepatitis, not elsewhere classified

7.84

47.00

1.4

1.3

3.12

2.53

g/l

1.35

Abnormal findings on diagnostic imaging of other body structures

151

417

3.69

46.87

1.5

1.3

3.26

2.88

g/l

1.21

296

Explicit bacterial Sepsis

125

303

4.21

46.58

1.4

2.68

3.06

g/l

1.00

220

Myalgia

239

872

2.78

46.34

1.5

1.3

2.94

2.96

g/l

0.05

173

596

Ulcerative colitis

264

1016

2.63

46.12

1.3

3.12

2.94

g/l

0.77

171

715

Bleeding

684

2658

1.84

45.92

1.4

2.97

2.95

g/l

0.10

478

1847

Disorders of conjunctiva

728

3278

1.79

45.90

1.5

1.3

2.79

2.95

g/l

1.73

546

2263

Other chronic obstructive pulmonary disease, including avohilmo

427

1653

2.15

45.80

1.4

2.66

2.99

g/l

3.38

303

1138

Renal tubulo-interstitial diseases

728

3031

1.80

45.74

1.4

2.64

3.01

g/l

5.75

487

2134

Pulmonary heart disease, diseases of pulmonary circulation

283

1130

2.53

45.71

1.4

2.72

2.91

g/l

0.96

210

784

Neoplasms

680

1926

1.88

45.65

1.4

2.87

3.04

g/l

1.49

448

1366

Constipation

742

2877

1.80

45.65

1.4

2.75

2.94

g/l

2.04

503

2046

Nutritional anaemias

424

1935

2.13

45.60

1.5

1.4

2.88

2.93

g/l

0.19

310

1349

Erysipelas

556

2184

1.96

45.43

1.5

1.4

2.85

3.09

g/l

2.13

400

1496

Seropositive rheumatoid arthritis

223

789

2.85

45.43

1.5

1.3

2.68

2.95

g/l

1.43

166

537

Polymyalgia rheumatica

126

313

4.09

45.41

1.5

1.3

2.93

2.87

g/l

0.10

222

Other disorders of skin and subcutaneous tissue

576

2700

1.91

45.01

1.4

2.85

2.95

g/l

0.62

416

1879

Early onset COPD

223

798

2.84

44.93

1.6

1.4

2.53

2.96

g/l

3.18

157

542

Biological medication for rheuma

215

759

2.88

44.52

1.3

1.4

3.14

2.90

g/l

0.97

145

522

Sciatica+with lumbago

430

1897

2.10

44.35

1.4

2.86

3.05

g/l

1.38

307

1288

Lumbar disc prolapse

526

2056

1.98

44.28

1.4

2.90

3.05

g/l

0.99

362

1385

Later onset COPD, excluding more controls

122

220

4.32

43.79

1.1

1.2

2.71

3.02

g/l

1.01

143

Streptococcal septicaemia

104

230

4.62

43.66

1.5

1.4

2.56

3.09

g/l

1.39

171

Colitis, primary sclerosing, strict definition

11.94

43.40

1.4

1.2

3.42

2.43

g/l

2.51

Other and unspecified iron deficiency

305

1291

2.39

43.36

1.4

1.3

2.84

2.92

g/l

0.27

219

902

Symptoms and signs involving the nervous and musculoskeletal systems

498

2554

1.96

43.22

1.6

1.4

2.78

2.94

g/l

1.12

360

1798

Benign neoplasm of colon, rectum, anus and anal canal

503

2230

1.97

43.18

1.4

2.80

2.99

g/l

1.51

374

1520

Iron deficiency anaemia

370

1677

2.19

43.07

1.4

2.81

2.93

g/l

0.57

268

1174

Metabolic disorders

787

2768

1.74

42.81

1.5

1.4

2.72

3.04

g/l

5.11

550

1923

Multiple myeloma and malignant plasma cell neoplasms

108

6.60

42.38

1.4

1.3

1.69

2.89

g/l

2.53

Pneumonia due to Streptococcus pneumoniae

6.89

42.20

1.4

1.2

2.14

2.88

g/l

2.54

Nerve, nerve root and plexus disorders

865

3154

1.69

41.94

1.4

2.90

3.00

g/l

0.94

594

2180

Non-Hodgkin lymphoma, all, including Hilmo

147

430

3.48

41.88

1.5

1.4

2.29

2.95

g/l

3.60

105

304

Hypermobility syndrome

172

5.22

41.87

1.6

1.4

2.80

2.91

g/l

0.23

122

Anxiety disorders

776

3152

1.73

41.75

1.5

1.3

2.90

2.95

g/l

0.38

567

2161

COPD, hospital admissions

351

1337

2.24

41.73

1.4

2.59

2.96

g/l

3.53

249

904

Unspecified jaundice

6.88

41.69

1.9

1.2

3.16

2.95

g/l

0.27

Aspergillosis

16.04

41.48

1.4

1.2

2.67

2.65

g/l

0.02

Persons encountering health services for other counselling and medical advice, not elsewhere classified

900

2931

1.68

41.46

1.4

1.3

2.75

3.01

g/l

4.21

682

2011

COPD, early/later onset

352

1342

2.23

41.42

1.4

2.60

2.96

g/l

3.38

250

909

Other symptoms and signs involving the nervous and musculoskeletal systems

384

1824

2.12

41.32

1.6

1.3

2.75

2.95

g/l

1.35

274

1266

Neurotic, stress-related and somatoform disorders

766

3129

1.72

41.02

1.5

1.3

2.89

2.95

g/l

0.39

561

2143

Atrial fibrillation and flutter

268

679

2.58

40.86

1.3

2.75

3.09

g/l

2.19

187

469

Benign neoplasm: Colon

428

2026

2.03

40.68

1.5

1.4

2.85

2.97

g/l

0.71

317

1391

Other antidepressants

843

2548

1.70

40.56

1.4

2.81

3.04

g/l

3.28

571

1770

Acute renal failure

200

715

2.83

40.41

1.4

1.3

2.73

2.97

g/l

0.85

117

507

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

384

1118

2.18

40.36

1.5

1.3

2.98

3.10

g/l

0.51

254

784

Polyarthrosis

185

584

2.98

40.24

1.6

1.5

2.76

2.88

g/l

0.38

122

411

Diverticular disease of intestine

542

1822

1.91

39.94

1.6

1.4

2.89

3.02

g/l

0.88

400

1257

IBD (strict) with PSC

13.48

39.89

1.3

3.51

2.79

g/l

0.82

Pulmonary embolism

255

1036

2.49

39.79

1.4

2.73

2.91

g/l

0.83

184

722

Inflammatory diseases of the central nervous system

111

278

4.09

39.73

1.5

1.4

2.86

2.96

g/l

0.16

194

Abnormal results of function studies

110

274

4.11

39.65

1.4

1.3

3.01

g/l

0.01

195

Abnormal serum enzyme levels

257

1023

2.48

39.47

1.5

1.4

3.09

3.03

g/l

0.16

187

706

Chronic diseases of tonsils and adenoids

596

2052

1.85

39.46

1.3

2.75

2.98

g/l

2.44

444

1360

Multiple myeloma, including Hilmo

110

6.30

39.30

1.4

1.72

2.89

g/l

2.43

Other gastritis (incl. Duodenitis)

200

726

2.79

39.25

1.5

1.4

3.05

2.90

g/l

0.49

148

494

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

805

3131

1.68

39.09

1.4

2.72

3.00

g/l

4.42

552

2235

Pulmonary heart disease

255

1045

2.47

39.07

1.4

2.73

2.90

g/l

0.76

184

730

Ulcerative colitis (strict) with PSC

15.70

38.84

1.3

3.55

2.49

g/l

1.75

Conjunctivitis

651

3112

1.76

38.70

1.5

1.3

2.79

2.93

g/l

1.19

496

2145

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

500

2637

1.88

38.37

1.3

1.4

2.84

2.98

g/l

0.94

358

1830

Giant cell arteritis

7.01

38.35

1.2

1.5

2.69

2.70

g/l

0.02

Drug-induced cataract

8.19

38.22

1.5

1.3

2.59

2.68

g/l

0.11

Other specified/unspecified necrotizing vasculopathies

13.23

37.92

1.4

2.60

2.57

g/l

0.02

Benign neoplasms

800

2633

1.68

37.55

1.4

1.3

2.86

3.03

g/l

1.74

553

1818

Spondyloarthritis

173

595

2.94

37.55

1.4

1.3

3.06

2.97

g/l

0.22

120

423

Mood disorders, excluding more controls

761

2699

1.69

37.07

1.4

2.91

3.02

g/l

0.87

534

1856

Dialysis, with operation codes

144

450

3.26

37.00

1.4

2.31

3.01

g/l

3.95

318

Heart failure,strict

383

1303

2.09

36.99

1.4

2.64

3.06

g/l

3.88

259

879

Syncope and collapse

317

1236

2.21

36.85

1.4

1.3

2.89

3.07

g/l

0.89

218

866

Erysipelas

408

1816

2.00

36.74

1.5

1.4

2.85

3.11

g/l

1.74

294

1237

Pneumonia derived septicemia

6.95

36.70

1.4

2.29

2.83

g/l

1.00

Depression or dysthymia

561

1678

1.86

36.64

1.4

2.96

3.09

g/l

0.83

386

1165

Non-invasive ventilation

194

633

2.76

36.63

1.3

2.42

3.09

g/l

3.65

435

Infections of the skin and subcutaneous tissue

506

2730

1.85

36.59

1.4

1.3

2.79

2.98

g/l

1.51

377

1880

All influenza (not pneumonia)

148

474

3.17

36.41

1.4

2.57

3.13

g/l

3.23

100

328

Nephropathy related operations

140

435

3.28

36.33

1.4

1.3

2.37

2.97

g/l

2.95

308

Collagenous colitis

110

292

3.85

36.33

1.4

2.65

2.87

g/l

0.51

206

Mycoses

700

3626

1.69

36.30

1.4

2.83

2.98

g/l

1.47

487

2515

Diseases of arteries, arterioles and capillaries (FINNGEN)

201

503

2.79

36.27

1.3

1.4

2.84

3.14

g/l

1.36

143

342

IBD patients in KELA-register

237

974

2.46

36.21

1.2

1.3

3.23

2.95

g/l

1.27

143

688

Noninfectious colitis NAS

153

502

3.10

36.19

1.5

1.3

2.80

2.91

g/l

0.27

115

367

Transplanted organ and tissue status

124

358

3.54

36.17

1.5

1.4

2.49

2.98

g/l

1.68

274

Diaphragmatic hernia

299

1358

2.22

36.17

1.4

2.85

2.91

g/l

0.25

224

942

Urticaria

297

1346

2.23

36.16

1.5

1.4

2.82

2.89

g/l

0.32

218

949

Heart failure and antihypertensive medication

219

539

2.69

36.12

1.5

1.3

2.63

2.98

g/l

1.80

152

383

Benign neoplasm of other and ill-defined parts of digestive system

177

632

2.84

35.96

1.5

1.3

2.83

2.82

g/l

0.02

127

435

Migraine with aura

233

954

2.47

35.83

1.4

2.99

2.98

g/l

0.04

171

683

Spondylopathies (FG)

146

469

3.16

35.78

1.5

1.3

3.17

2.97

g/l

0.61

103

315

SLE (Finngen)

7.16

35.78

1.6

1.4

2.69

2.81

g/l

0.15

Hypertensive diseases

659

2143

1.75

35.46

1.4

2.83

2.99

g/l

1.44

442

1503

Candidiasis

150

493

3.09

35.40

1.5

1.3

2.95

2.88

g/l

0.16

103

351

Hypertension, essential

633

2043

1.76

35.31

1.4

2.81

3.01

g/l

1.90

422

1424

Depression

787

3264

1.64

35.18

1.4

2.91

2.97

g/l

0.40

554

2248

Hypertension

657

2140

1.74

35.13

1.4

2.82

2.99

g/l

1.59

440

1501

COPD related to multimorbidity

290

1100

2.24

34.86

1.4

2.55

2.96

g/l

3.50

204

738

Hypothyroidism, strict autoimmune

506

1798

1.86

34.77

1.3

3.04

2.99

g/l

0.19

346

1267

Migraine without aura

201

779

2.61

34.75

1.4

2.99

3.00

g/l

0.04

146

568

Recurrent or chronic depression

358

1212

2.09

34.75

1.3

1.4

2.95

3.07

g/l

0.68

252

847

Care involving use of rehabilitation procedures

532

2742

1.79

34.64

1.4

2.77

3.00

g/l

2.21

368

1914

Other and unspecified disorders of white blood cells

107

5.99

34.62

1.3

2.39

2.69

g/l

0.48

Diseases of middle ear and mastoid

502

2250

1.84

34.52

1.4

2.82

2.95

g/l

0.90

350

1547

Crohn disease

153

517

3.01

34.43

1.2

1.3

3.24

2.97

g/l

0.79

102

371

Disorders of sclera, cornea, iris and ciliary body

461

2490

1.86

34.39

1.4

3.06

2.95

g/l

0.66

319

1744

Diseases of the ear and mastoid process

936

2972

1.59

34.32

1.4

1.3

2.91

2.99

g/l

0.60

658

2077

Other bacterial intestinal infections

173

628

2.79

34.06

1.4

1.3

2.73

2.88

g/l

0.50

124

436

Glomerular diseases

181

673

2.73

34.06

1.6

1.3

2.40

3.00

g/l

4.38

119

475

Temporomandibular joint disorders, including avohilmo

396

2012

1.96

34.03

1.5

1.3

2.98

2.94

g/l

0.17

267

1419

Enterocolitis due to Clostridium difficile

104

278

3.80

33.96

1.5

1.4

2.57

2.86

g/l

0.83

198

Pericarditis

6.96

33.67

1.2

1.3

2.73

3.05

g/l

0.46

Spondylosis

402

1686

1.96

33.51

1.4

1.3

2.70

3.05

g/l

3.47

255

1143

Pulmonary eosinophilia, not elsewhere classified

13.73

33.50

1.8

1.3

3.38

2.86

g/l

0.53

Mood disorders

827

3350

1.60

33.46

1.4

2.92

2.97

g/l

0.31

577

2316

Migraine with aura and triptan purchases

175

648

2.74

33.22

1.4

3.01

2.95

g/l

0.19

130

454

Acute suppurative otitis media

272

1145

2.24

33.11

1.4

1.3

2.62

2.97

g/l

3.12

198

796

Mood [affective] disorders

824

3350

1.60

33.08

1.4

2.93

2.97

g/l

0.28

575

2315

Inflammatory bowel disease, strict (require KELA)

237

1017

2.36

32.94

1.2

1.3

3.23

2.93

g/l

1.40

143

716

Thrombocytopenia, unspecified

214

4.21

32.85

1.6

1.3

2.79

2.90

g/l

0.20

145

Nonsuppurative otitis media

231

838

2.41

32.82

1.5

1.3

2.75

2.91

g/l

0.69

166

592

Unspecified chronic bronchitis

7.74

32.79

1.3

1.4

2.84

2.47

g/l

0.54

Tumor necrosis factor alpha inhibitors

182

693

2.67

32.74

1.3

1.4

3.27

2.89

g/l

1.70

120

474

Bacterial intestinal infections, IBD co-morbidities

172

636

2.74

32.71

1.4

1.3

2.71

2.88

g/l

0.55

124

444

Herpesviral [herpes simplex] infections

133

428

3.16

32.60

1.4

2.90

2.92

g/l

0.05

100

306

Alcohol-induced acute pancreatitis

110

5.76

32.59

1.4

1.3

3.50

3.06

g/l

0.54

DVT of lower extremities and pulmonary embolism

321

1554

2.07

32.59

1.4

2.77

2.95

g/l

0.92

228

1081

Pollen allergy

213

864

2.47

32.56

1.4

1.3

2.96

2.86

g/l

0.41

180

612

Gout

198

683

2.57

32.51

1.4

1.5

2.64

3.06

g/l

2.48

132

470

Venous thromboembolism

409

2089

1.90

32.42

1.5

1.4

2.72

2.97

g/l

1.90

288

1447

Cholecystitis

120

364

3.34

32.32

1.9

1.2

3.23

2.92

g/l

0.83

258

Visual disturbances and blindness

424

2277

1.87

32.21

1.5

1.4

2.97

2.93

g/l

0.19

317

1584

Hypothyroidism, drug reimbursement

124

255

3.47

32.17

1.7

1.3

3.12

3.22

g/l

0.22

185

Polypectomy (DHB20)

207

4.21

31.70

2.0

1.3

3.16

2.95

g/l

0.51

140

Other symptoms and signs involving the digestive system and abdomen

142

482

2.98

31.64

1.4

1.3

2.69

2.90

g/l

0.59

356

Atopic dermatitis, strict definition with reimbursement

282

1275

2.15

31.48

1.4

1.3

2.83

2.90

g/l

0.30

215

893

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

305

1478

2.08

31.35

1.6

1.3

2.76

2.86

g/l

0.41

171

1047

COPD, hospital admissions 1, only main diagnosis

253

963

2.27

31.33

1.3

1.4

2.45

2.99

g/l

5.34

182

656

Other reaction to severe stress, and adjustment disorders

331

1655

2.02

31.19

1.5

1.3

2.84

2.97

g/l

0.70

236

1142

Zoster [herpes zoster]

385

1997

1.91

30.99

1.4

2.64

2.97

g/l

3.03

287

1376

Suppurative and unspecified otitis media

339

1507

2.01

30.98

1.4

1.3

2.76

2.95

g/l

1.30

244

1052

Other disorders of urethra and urinary system

540

2241

1.75

30.92

1.4

1.3

2.78

2.98

g/l

1.88

372

1579

Other ulcerative colitis

194

4.28

30.90

1.3

3.18

3.03

g/l

0.24

133

Hypo-osmolality and hyponatraemia

153

548

2.81

30.58

1.3

2.83

2.90

g/l

0.19

375

Mucosal proctocolitis

143

498

2.92

30.53

1.3

3.02

2.96

g/l

0.14

358

Ischemic heart diseases

637

2288

1.68

30.48

1.5

1.4

2.80

2.96

g/l

1.40

447

1585

Other bacterial intestinal infections

203

842

2.44

30.47

1.3

2.78

2.93

g/l

0.57

148

584

Visual disturbances

398

2136

1.88

30.40

1.6

1.4

3.00

2.91

g/l

0.45

297

1482

Polyarteritis nodosa and related conditions

10.61

30.34

1.6

1.3

2.90

2.51

g/l

0.49

Spinal stenosis

355

1370

1.98

30.29

1.4

2.75

3.05

g/l

2.23

257

921

Disorders of lens

503

1770

1.78

29.94

1.3

1.4

2.79

2.97

g/l

1.26

346

1248

Other specified/unspecified inflammatory spondylopathies

138

4.91

29.81

1.6

1.4

3.00

2.89

g/l

0.20

Congenital malformations of the respiratory system

6.91

29.67

1.5

1.4

2.48

2.36

g/l

0.13

Percutaneous Coronary Intervention

599

2179

1.69

29.65

1.4

2.80

2.94

g/l

1.10

439

1508

Continuous positive airway pressure

154

467

2.80

29.62

1.3

2.49

3.07

g/l

3.24

138

327

Pneumococcal septicemia

5.89

29.60

1.4

1.3

2.27

2.82

g/l

1.02

Corticotropin deficiency

12.70

29.59

2.1

1.3

2.69

2.34

g/l

0.40

Viral pneumonia (unknown virus, not influenza)

209

4.06

29.59

1.2

1.3

2.67

3.05

g/l

0.76

149

Heart failure, strict

405

1527

1.88

29.35

1.4

2.63

3.00

g/l

3.42

275

1046

Systemic lupus erythematosus

5.81

29.27

1.6

1.4

2.69

2.65

g/l

0.04

Disturbances of skin sensation

255

1186

2.17

29.23

1.3

2.93

2.98

g/l

0.16

188

807

Polyneuropathies and other disorders of the peripheral nervous system

188

769

2.47

29.14

1.4

1.3

2.75

2.93

g/l

0.71

139

542

Other/unspecified dorsalgia

293

1424

2.05

29.12

1.3

1.4

2.89

3.00

g/l

0.46

202

977

Coronary revascularization (ANGIO or CABG)

597

2179

1.69

29.07

1.4

2.80

2.94

g/l

1.09

437

1508

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

454

2496

1.78

29.05

1.6

1.3

2.85

2.94

g/l

0.54

352

1731

Other and unspecified tonsillitis

279

1118

2.11

28.99

1.4

2.82

3.05

g/l

1.53

202

737

Hypoparathyroidism

5.97

28.98

2.4

1.3

2.58

2.67

g/l

0.11

Weight loss

105

315

3.39

28.92

1.4

2.99

2.89

g/l

0.20

227

Zoster [herpes zoster]

161

614

2.65

28.88

1.5

1.3

2.38

2.87

g/l

3.35

125

423

Abnormal weight loss

277

3.57

28.85

1.4

3.12

2.88

g/l

0.58

199

Other encephalitis

6.60

28.80

1.3

3.17

2.77

g/l

0.36

Shoulder lesions

554

1964

1.72

28.79

1.4

1.3

2.91

3.03

g/l

0.79

398

1330

Other and unspecified polyneuropathies, also in other diseases

166

645

2.61

28.68

1.4

1.3

2.72

2.95

g/l

0.89

123

453

Atrial fibrillation and flutter with reimbursement

194

490

2.54

28.68

1.4

2.77

3.14

g/l

1.72

131

333

Unknown and unspecified causes of morbidity

175

4.30

28.64

1.3

2.52

3.03

g/l

2.16

131

Benzodiazepine use

779

3449

1.56

28.55

1.3

1.4

2.90

2.98

g/l

0.62

531

2396

Emergency coronary revascularization (for ACS)

630

2329

1.65

28.42

1.4

2.83

2.94

g/l

0.84

461

1600

Intracranial trauma

431

1669

1.82

28.41

1.5

1.4

2.93

3.01

g/l

0.38

298

1173

COPD-related respiratory insufficiency

101

299

3.43

28.37

1.4

2.19

3.09

g/l

5.90

213

Any mental disorder

852

2767

1.55

28.16

1.4

2.81

3.00

g/l

2.30

600

1907

Seropositive rheumatoid arthritis, wide

223

998

2.26

28.14

1.5

1.4

2.68

2.86

g/l

0.87

166

690

Other Crohn's disease

249

3.69

28.11

1.2

1.3

3.47

2.97

g/l

1.27

174

All-cause Heart Failure

394

1496

1.87

28.06

1.4

2.64

3.01

g/l

3.23

269

1024

Other nutritional deficiencies

534

3003

1.68

27.95

1.4

2.83

2.98

g/l

1.18

376

2119

Encephalitis

6.12

27.94

1.3

3.11

2.72

g/l

0.36

Congenital malformations of the respiratory system

6.87

27.58

1.5

1.4

2.49

2.35

g/l

0.15

Other complications of surgical and medical care, not elsewhere classified

105

325

3.29

27.53

1.4

2.81

2.96

g/l

0.34

235

Non-follicular lymphoma

286

3.45

27.48

1.4

2.14

2.97

g/l

4.10

199

Anxiety (asthma-related co-morbidities)

506

2295

1.71

27.47

1.4

2.96

2.97

g/l

0.06

385

1591

Concussion

376

1652

1.87

27.46

1.5

1.4

2.88

3.01

g/l

0.71

262

1163

Agranulocytosis

116

382

3.09

27.42

1.3

1.4

2.49

2.89

g/l

1.53

265

Lung cancer and mesothelioma

247

3.46

27.27

1.2

1.3

2.72

3.03

g/l

0.83

160

Alcohol-induced chronic pancreatitis

213

3.90

27.26

1.2

3.19

2.97

g/l

0.35

148

Other diseases of lip and oral mucosa

332

1744

1.92

27.19

1.4

1.3

2.79

2.94

g/l

0.81

242

1204

Hypokalaemia

115

379

3.08

27.12

1.3

2.66

2.95

g/l

0.79

262

Follow-up examination after treatment for conditions other than malignant neoplasms

297

965

2.05

27.11

1.4

1.3

2.86

3.04

g/l

0.97

222

573

Disorders of orbit

126

4.89

27.01

1.6

1.4

3.02

2.92

g/l

0.14

Hard cardiovascular diseases

635

2337

1.63

26.95

1.4

2.79

2.95

g/l

1.43

463

1607

Cerebrovascular diseases (FINNGEN)

235

751

2.23

26.94

1.3

2.85

3.09

g/l

1.19

168

517

Other skin changes

160

630

2.57

26.93

1.7

1.3

2.87

2.82

g/l

0.10

118

440

Vasculitis limited to skin, not elsewhere classified

7.08

26.89

1.4

1.2

2.73

2.71

g/l

0.02

Symptoms and signs involving cognition, perception, emotional state and behaviour

740

3251

1.56

26.87

1.4

2.95

2.97

g/l

0.13

519

2264

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

440

2525

1.75

26.83

1.4

2.83

2.96

g/l

0.69

312

1757

Valvular heart disease excluding rheumatic fever

335

1257

1.94

26.63

1.4

2.83

2.94

g/l

0.46

227

868

Cystitis

641

2365

1.62

26.60

1.4

1.3

2.86

2.98

g/l

0.90

457

1668

Non-rheumatic valve diseases

332

1243

1.94

26.50

1.4

2.84

2.95

g/l

0.44

225

856

All anxiety disorders

514

2419

1.69

26.47

1.4

1.3

2.95

2.96

g/l

0.04

390

1665

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

7.14

26.45

1.3

1.79

2.70

g/l

0.93

Multiple myeloma

7.14

26.45

1.3

1.79

2.70

g/l

0.93

Disorders of oesophagus in diseases classified elsewhere

9.02

26.45

1.5

1.1

3.37

2.63

g/l

0.89

Insulin, combination of fast acting with intermediate-acting or long-acting

461

2454

1.73

26.39

1.5

1.3

2.80

2.98

g/l

1.21

295

1717

Congenital malformations, deformations and chromosomal abnormalities

529

2947

1.66

26.37

1.4

1.3

2.87

2.93

g/l

0.35

362

2054

Disorders of skin appendages

398

2231

1.79

26.36

1.3

1.4

3.02

2.93

g/l

0.43

286

1544

Deviated nasal septum

242

1148

2.12

26.30

1.3

3.00

3.07

g/l

0.24

160

747

Suppurative and necrotic conditions of lower respiratory tract

149

4.46

26.27

1.4

1.3

2.69

2.99

g/l

0.57

102

Personal history of allergy to drugs, medicaments and biological substances

9.50

26.25

1.6

1.1

2.83

2.85

g/l

0.02

Adalimumab

115

388

3.02

26.11

1.3

3.39

2.95

g/l

1.35

272

Cirrhosis of liver, NAS

146

4.49

26.04

1.2

1.3

3.29

2.78

g/l

1.05

Dentofacial anomalies [including malocclusion]

569

2810

1.63

25.97

1.4

3.00

2.90

g/l

0.60

382

1978

Allergic conjunctivitis

470

2702

1.70

25.95

1.6

1.3

2.85

2.92

g/l

0.45

366

1874

Asthma mixed form (mode), excluding more controls

6.09

25.93

1.7

1.3

2.53

2.94

g/l

0.93

Other/unspecified seropositive rheumatoid arthritis

216

988

2.21

25.89

1.5

1.4

2.67

2.87

g/l

0.92

162

684

Presence of other functional implants

412

1598

1.80

25.86

1.4

2.75

2.97

g/l

1.37

221

1143

Other overlap syndromes

9.51

25.79

1.6

1.3

2.45

2.60

g/l

0.13

Papulosquamous disorders

315

1656

1.92

25.76

1.4

3.15

2.89

g/l

1.49

226

1141

Other and unspecified vasculitis limited to skin

7.11

25.63

1.4

1.2

2.80

2.71

g/l

0.07

Pain in thoracic spine

136

507

2.71

25.58

1.4

1.3

2.79

3.02

g/l

0.82

103

346

Lymphoid leukaemia

144

4.48

25.56

1.4

1.2

1.88

2.74

g/l

3.36

102

Thyroiditis, ILD-related definition

114

388

2.98

25.44

1.5

1.3

2.76

2.84

g/l

0.18

276

Use of hypnotics and sedatives

811

3078

1.52

25.41

1.3

1.4

2.82

3.03

g/l

2.80

581

2120

Congenital malformations, deformations and chromosomal abnormalities

484

2756

1.68

25.34

1.5

1.4

2.83

2.94

g/l

0.69

333

1919

Gout, FINNGEN

198

879

2.26

25.32

1.4

2.64

3.06

g/l

2.62

132

604

Temporal arteritis

6.11

25.23

1.2

1.5

2.72

2.67

g/l

0.05

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

213

980

2.19

25.18

1.5

1.4

2.62

2.87

g/l

1.46

159

681

Iridocyclitis

202

910

2.24

25.17

1.5

1.3

3.00

2.90

g/l

0.32

143

638

Paralytic ileus and intestinal obstruction

190

833

2.30

25.17

1.4

1.3

2.77

2.97

g/l

0.78

124

572

Factors influencing health status and contact with health services

202

423

2.41

25.15

1.3

2.96

3.14

g/l

0.61

144

268

Other (seronegative) rheumatoid arthritis, wide

162

664

2.47

25.08

1.5

1.3

2.64

2.86

g/l

0.81

120

457

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

136

513

2.69

25.04

1.3

1.4

3.37

2.96

g/l

1.20

359

Glomerulonephritis

105

345

3.10

24.97

1.7

1.4

2.54

2.94

g/l

1.20

246

Other diseases of urinary system

748

2742

1.54

24.84

1.4

2.84

3.00

g/l

1.65

514

1935

Major coronary heart disease event

609

2299

1.61

24.61

1.4

2.83

2.95

g/l

0.83

445

1581

Giant cell arteritis with polymyalgia rheumatica

5.95

24.57

1.2

1.4

2.72

2.80

g/l

0.08

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

164

683

2.43

24.56

1.2

1.4

2.96

2.98

g/l

0.04

481

Diseases of spleen

8.21

24.46

1.7

1.2

2.76

2.78

g/l

0.02

Ulcerative colitis (strict definition, require KELA)

169

715

2.39

24.44

1.2

1.4

2.96

2.98

g/l

0.04

101

501

Cervicobrachial syndrome

181

789

2.32

24.38

1.6

1.3

3.12

3.02

g/l

0.33

141

528

Insulin medication

461

2301

1.69

24.38

1.5

1.3

2.80

2.98

g/l

1.21

295

1616

GI-bleeding

229

1099

2.10

24.25

1.4

1.3

2.95

2.94

g/l

0.04

155

769

Non-selective monoamine reuptake inhibitors

287

1436

1.94

24.24

1.4

2.73

2.98

g/l

1.81

201

1003

Secondary hypertension

205

3.72

24.10

1.3

1.2

2.73

2.97

g/l

0.39

142

Other symptoms and signs involving the circulatory and respiratory systems

155

4.20

24.06

1.4

1.3

2.86

3.06

g/l

0.37

108

Rotator cuff syndrome

427

1776

1.73

23.89

1.4

1.3

2.98

3.02

g/l

0.17

314

1198

Other viral diseases

330

1793

1.84

23.78

1.5

1.3

2.68

2.94

g/l

2.02

241

1262

Somatoform disorder

154

633

2.46

23.74

1.4

1.3

2.95

2.91

g/l

0.08

106

430

Sequelae with surgical and medical care as external cause

175

762

2.32

23.69

1.4

2.84

2.90

g/l

0.16

130

515

Disorders of parathyroid gland

159

655

2.42

23.65

1.7

1.3

2.56

2.87

g/l

1.29

112

446

Drug-induced osteoporosis

9.32

23.54

2.1

1.4

2.24

2.48

g/l

0.27

Emphysema

137

4.37

23.42

1.2

1.3

2.54

2.94

g/l

0.83

Cervical disc disorders

262

1338

1.97

23.39

1.4

2.77

3.06

g/l

2.05

179

913

Asthma mixed form (mode)

5.50

23.37

1.7

1.3

2.53

2.97

g/l

1.05

Secondary right heart disease

5.41

23.32

1.3

2.39

2.76

g/l

0.69

Systemic sclerosis (FG)

6.90

23.09

1.3

2.99

2.68

g/l

0.37

Paroxysmal tachycardia

173

625

2.33

23.01

1.4

1.3

3.04

3.01

g/l

0.06

115

425

Psychiatric diseases

750

2484

1.52

22.85

1.3

1.4

2.82

3.00

g/l

1.81

514

1719

Pain and other conditions associated with female genital organs and menstrual cycle

178

724

2.28

22.81

1.4

2.85

2.89

g/l

0.12

126

506

Herpesviral [herpes simplex] infections

221

1073

2.08

22.79

1.4

1.3

2.98

2.96

g/l

0.07

162

736

Migraine without aura and triptan purchases

160

683

2.37

22.71

1.3

1.4

3.03

2.97

g/l

0.17

119

482

Disorders of synovium and tendon

387

1961

1.74

22.65

1.5

1.3

2.93

3.02

g/l

0.56

266

1344

Acute and subacute iridocyclitis

172

760

2.29

22.53

1.4

1.3

3.03

2.92

g/l

0.30

116

538

Diseases of arteries, arterioles and capillaries

449

1985

1.68

22.52

1.3

1.4

2.78

2.98

g/l

1.47

310

1370

Cutaneous abscess, furuncle and carbuncle

224

1098

2.06

22.51

1.3

2.88

2.97

g/l

0.32

165

768

130

507

2.60

22.43

1.6

1.3

2.97

2.93

g/l

0.06

342

Other or unspecified ileus, impaction or obstruction

140

565

2.50

22.42

1.3

1.4

2.59

2.93

g/l

1.49

392

Arthrosis

487

1610

1.67

22.40

1.3

1.4

2.92

3.04

g/l

0.74

341

1100

Atopic dermatitis

453

2242

1.66

22.37

1.3

2.91

2.95

g/l

0.19

338

1577

Sequelae of external causes of morbidity and mortality

210

1008

2.10

22.34

1.5

1.4

2.78

2.91

g/l

0.46

155

690

Other pulmonary heart/vessel disease

102

4.91

22.30

1.4

1.3

2.42

2.80

g/l

0.76

Other diseases of the digestive system

225

1109

2.04

22.23

1.3

1.4

2.98

2.93

g/l

0.12

154

776

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

173

771

2.27

22.22

1.2

1.4

2.97

g/l

0.01

104

539

Hypogonadotropic hypogonadism

5.02

22.18

1.2

2.96

3.13

g/l

0.16

Idiopathic thrombocytopenic purpura

5.41

22.15

1.4

1.3

2.70

2.67

g/l

0.03

Recurrent aphthous stomatitis , including avohilmo

135

542

2.52

21.95

1.4

2.90

2.81

g/l

0.24

109

381

Other specified/unspecified soft tissue disorders

104

4.80

21.78

1.5

1.4

2.87

g/l

0.00

Gastroduodenal ulcer

172

769

2.25

21.70

1.3

3.13

2.90

g/l

0.68

110

518

Disorders of the thyroid gland

692

3000

1.51

21.61

1.5

1.3

2.97

2.96

g/l

0.04

456

2126

Heart failure and coronary heart disease

270

993

1.94

21.57

1.4

1.3

2.61

3.01

g/l

2.85

191

654

Triptan medication for migraine, min. 3 purchases

458

2132

1.65

21.54

1.4

1.3

2.96

2.97

g/l

0.06

336

1488

Other abnormal immunological findings in serum

6.79

21.44

1.7

1.2

3.66

2.74

g/l

1.37

Obesity and other hyperalimentation

486

2930

1.61

21.39

1.4

2.83

2.99

g/l

1.11

345

2066

Other anxiety disorders

373

1883

1.73

21.32

1.3

2.93

2.98

g/l

0.25

288

1291

Viral pneumonia (known virus, not influenza)

5.84

21.30

1.5

1.3

2.55

2.82

g/l

0.27

Triptan medication for migraine, single purchase ok

606

2669

1.54

21.30

1.4

2.98

2.92

g/l

0.39

422

1857

Migraine, single triptan purchase ok & required. ICD-code if available is included

606

2669

1.54

21.30

1.4

2.98

2.92

g/l

0.39

422

1857

Anterior Iridocyclitis

178

817

2.20

21.29

1.4

1.3

3.00

2.92

g/l

0.21

121

568

Extracorporeal dialysis

184

3.72

21.26

1.5

1.3

1.98

2.83

g/l

3.41

131

Ascites

170

3.82

21.25

1.3

1.2

2.71

3.04

g/l

0.63

123

Lung diseases due to external agents

107

390

2.77

21.10

1.2

1.4

2.76

2.93

g/l

0.38

284

Otitis media, unspecified

115

399

2.69

20.92

1.3

2.59

2.82

g/l

0.78

298

Other inflammation of eyelid

122

478

2.58

20.89

1.6

1.3

3.10

2.84

g/l

0.80

332

Volume depletion

244

3.28

20.85

1.4

1.3

2.42

2.93

g/l

1.78

161

Hypothyroidism, other/unspecified

645

2808

1.52

20.77

1.4

1.3

3.01

2.96

g/l

0.26

426

1993

Obesity

482

2928

1.60

20.70

1.4

2.84

2.99

g/l

1.03

341

2066

Nonorganic sleeping disorders, excluding more controls

164

738

2.24

20.59

1.3

2.94

3.02

g/l

0.22

112

500

Nonalcoholic fatty liver disease

106

391

2.76

20.53

1.3

1.4

3.13

2.99

g/l

0.42

273

Other viral diseases, not elsewhere classified

176

814

2.18

20.52

1.4

2.60

2.87

g/l

1.32

133

585

Hypothyreosis and Thyroxine purchase for inclusion criteria

668

2931

1.50

20.47

1.4

3.01

2.95

g/l

0.36

444

2081

Total colectomy operation

118

4.43

20.45

1.6

1.4

3.04

2.81

g/l

0.30

Total colectomy

118

4.43

20.45

1.6

1.4

3.04

2.81

g/l

0.30

Other arthrosis

352

1398

1.75

20.43

1.3

1.4

2.94

3.02

g/l

0.35

249

965

Other infectious diseases

273

3.12

20.42

1.4

1.3

2.98

g/l

0.01

190

Behavioural syndromes associated with physiological disturbances and physical factors

694

3329

1.48

20.41

1.3

1.4

3.02

2.94

g/l

0.55

482

2320

Seronegative rheumatoid arthritis

326

2.92

20.36

1.4

1.3

2.78

2.84

g/l

0.09

214

Bronchitis, not specified as acute or chronic

223

3.36

20.33

1.5

1.3

2.86

2.99

g/l

0.33

150

Exposure to unspecified factor

744

3677

1.46

20.30

1.4

2.82

2.96

g/l

1.35

468

2611

Deforming dorsopathies

211

1052

2.02

20.27

1.5

1.4

2.74

2.94

g/l

0.98

161

720

Non-Hodgkin lymphoma, all

4.84

20.16

1.5

1.2

2.45

3.02

g/l

0.93

Acute laryngitis and tracheitis

108

399

2.69

20.06

1.3

2.97

2.98

g/l

0.00

263

Dermatitis due to substances taken internally

150

3.94

20.04

1.5

2.20

2.95

g/l

2.01

107

Dizziness and giddiness

539

2763

1.55

19.99

1.4

3.02

2.94

g/l

0.44

382

1925

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

4.81

19.95

1.4

1.3

2.98

2.79

g/l

0.23

Stomatitis and related lesions

175

820

2.16

19.91

1.3

2.84

2.88

g/l

0.11

138

578

Acute tubulo-interstitial nephritis

439

2346

1.62

19.86

1.4

2.63

3.01

g/l

4.07

310

1658

Chronic gastritis

180

853

2.13

19.83

1.3

1.4

2.93

2.89

g/l

0.09

142

586

Congenital malformations of the musculoskeletal system, not elsewhere classified

6.09

19.81

1.4

1.2

2.62

2.68

g/l

0.08

Glomerular disorders in diseases classified elsewhere

104

387

2.72

19.78

1.4

2.30

3.07

g/l

4.25

274

Myocarditis

117

4.35

19.71

1.4

1.2

2.72

3.05

g/l

0.65

Other viral diseases, not elsewhere classified

236

1231

1.92

19.60

1.4

2.69

2.88

g/l

0.99

180

870

Other and unspecified urticaria

178

845

2.13

19.59

1.4

1.3

2.72

2.90

g/l

0.73

123

587

Heart failure and bmi 25plus

219

736

2.02

19.58

1.4

1.3

2.68

2.94

g/l

1.04

138

462

Systemic sclerosis

5.82

19.58

1.3

2.99

2.67

g/l

0.43

Non-ischemic cardiomyopathy

207

827

2.03

19.37

1.3

2.89

2.95

g/l

0.15

144

558

Endocarditis

5.18

19.37

1.4

1.2

3.09

3.20

g/l

0.09

Convulsions, not elsewhere classified

165

753

2.18

19.34

1.5

1.3

2.75

3.06

g/l

1.09

118

521

Ehlers-Danlos syndrome

7.57

19.27

1.4

1.3

2.59

2.79

g/l

0.21

Other diseases of hard tissues of teeth

408

1260

1.68

19.26

1.4

1.3

2.93

3.01

g/l

0.37

282

855

Other metabolic disorders

122

499

2.47

19.13

1.7

1.3

2.90

2.99

g/l

0.17

343

Insulin, fast-acting

275

1525

1.81

19.12

1.5

1.3

2.80

2.97

g/l

0.80

179

1077

Other viral diseases

258

1401

1.85

19.07

1.6

1.3

2.63

2.89

g/l

1.72

188

994

6-mercaptopurine

5.32

18.96

2.1

1.2

2.56

2.73

g/l

0.22

Sleep disorders

657

3233

1.47

18.80

1.3

1.4

3.06

2.94

g/l

1.02

456

2242

Care involving dialysis

271

3.04

18.79

1.4

1.3

2.27

2.96

g/l

2.42

192

Other diseases of intestine

113

451

2.53

18.66

1.4

1.3

2.88

2.96

g/l

0.16

310

Persons with potential health hazards related to communicable diseases

320

1855

1.72

18.53

1.4

1.3

2.64

2.93

g/l

1.96

195

1329

Psoriatic and enteropathic arthropathies

101

384

2.66

18.44

1.3

3.02

3.00

g/l

0.04

259

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

301

2.90

18.40

1.5

1.3

2.54

2.99

g/l

1.56

214

Adverse effects, not elsewhere classified

175

846

2.09

18.39

1.6

1.3

2.72

2.90

g/l

0.79

126

599

Cervicalgia

151

689

2.21

18.37

1.8

1.3

3.07

3.03

g/l

0.08

111

466

Other arrhythmias

447

2128

1.59

18.36

1.4

2.90

2.99

g/l

0.48

294

1488

Chronic iridocyclitis

151

3.79

18.29

1.5

1.3

3.08

2.88

g/l

0.28

108

Other enthesopathies

215

1120

1.93

18.26

1.6

1.3

2.82

2.98

g/l

0.71

155

768

Intestinal stricture

221

1163

1.91

18.21

1.3

1.4

2.92

2.90

g/l

0.04

148

806

Benign neoplasm: Transverse colon

336

2.78

18.19

1.5

1.4

2.72

2.97

g/l

0.75

234

Hernia

675

3114

1.46

18.07

1.4

2.86

2.98

g/l

0.94

468

2147

Senile cataract

411

1550

1.63

17.98

1.3

1.4

2.74

2.95

g/l

1.34

285

1097

Selective serotonin reuptake inhibitors

714

2575

1.45

17.87

1.3

1.4

2.88

3.04

g/l

1.59

494

1794

Invasive ventilation

217

3.23

17.79

1.3

1.81

2.84

g/l

6.94

153

Misadventures to patients during surgical and medical care

120

504

2.41

17.79

1.3

3.07

2.93

g/l

0.31

358

Other infectious diseases

222

3.20

17.79

1.4

1.3

2.92

2.95

g/l

0.04

157

Malignant neoplasm of pancreas, including Hilmo

217

3.22

17.76

1.6

1.4

3.10

3.03

g/l

0.14

158

Diseases of tongue

159

3.64

17.69

1.5

1.3

2.88

2.96

g/l

0.12

110

Other disorders of ear

658

2963

1.46

17.64

1.5

1.3

2.84

2.95

g/l

0.88

464

2083

Other medical care

318

1686

1.70

17.62

1.2

1.4

2.74

2.97

g/l

1.27

222

1165

Diabetes mellitus

753

3095

1.43

17.55

1.5

1.4

2.92

2.96

g/l

0.17

497

2194

Other cataract

296

1288

1.75

17.43

1.4

1.3

2.92

2.93

g/l

0.04

202

914

Internal derangement of knee

256

1425

1.80

17.35

1.5

1.4

2.92

3.03

g/l

0.50

173

991

Gonarthrosis [arthrosis of knee](FG)

454

1675

1.58

17.34

1.3

2.92

3.04

g/l

0.80

324

1143

Viral infections of the central nervous system

273

2.94

17.34

1.3

1.4

2.74

2.97

g/l

0.36

187

Insulin, intermediate and long-acting

379

2288

1.62

17.33

1.4

2.80

2.98

g/l

1.12

246

1608

Fissure and fistula of anal and rectal regions

174

858

2.04

17.33

1.2

1.3

3.08

3.00

g/l

0.20

116

577

Insomnia

637

3195

1.46

17.32

1.3

1.4

3.07

2.93

g/l

1.16

449

2214

Radiculopathy

115

480

2.42

17.27

1.4

1.3

2.86

2.97

g/l

0.29

337

Pyothorax

108

4.25

17.25

1.4

1.3

2.83

2.96

g/l

0.14

Type 2 diabetes

706

2876

1.44

17.24

1.5

1.4

2.93

2.99

g/l

0.34

470

2023

SLE, strict definition

117

4.13

17.21

1.6

1.4

2.62

2.72

g/l

0.11

SLE, ICD10

117

4.13

17.21

1.6

1.4

2.62

2.72

g/l

0.11

Heartburn

312

2.79

17.21

1.3

1.2

2.70

3.00

g/l

0.94

215

Insulin, fast-acting or short human

276

1582

1.75

17.21

1.5

1.3

2.80

2.96

g/l

0.71

180

1107

Dermatographic urticaria

232

3.11

17.20

1.8

1.4

2.82

2.95

g/l

0.28

159

L04AC Interleukin inhibitors

207

3.25

17.13

1.4

1.3

2.88

3.05

g/l

0.25

141

Haemorrhoids and perianal venous thrombosis

210

1107

1.90

17.11

1.2

1.4

2.87

3.01

g/l

0.64

140

760

Hepatic failure, not elsewhere classified

4.65

17.11

1.4

1.3

2.84

2.72

g/l

0.14

Diabetes, varying definitions

747

3092

1.42

17.06

1.5

1.4

2.91

2.96

g/l

0.25

490

2193

Ocular pain

298

2.83

16.99

1.5

3.01

2.92

g/l

0.19

208

Panhypopituitarism

6.27

16.98

1.7

1.3

2.82

2.76

g/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

682

3050

1.44

16.82

1.4

3.00

2.98

g/l

0.08

460

2133

Coxibs

198

518

2.02

16.79

1.3

2.98

3.16

g/l

0.66

140

355

Vascular disorders of the intestines

137

3.77

16.71

1.2

1.3

2.78

2.93

g/l

0.20

Ulcerative enterocolitis

4.56

16.67

1.4

1.3

2.95

2.93

g/l

0.03

Other disorders of eye and adnexa

126

558

2.28

16.58

1.4

2.82

2.90

g/l

0.23

389

Crohn's disease of small intestine

243

3.01

16.50

1.3

1.4

3.33

2.88

g/l

0.94

172

Gastric ulcer

114

484

2.37

16.49

1.3

3.07

2.94

g/l

0.22

334

Chorioretinal inflammation

5.06

16.49

1.4

1.3

3.20

2.69

g/l

0.65

Systemic sclerosis, icd10

4.96

16.49

1.3

2.99

2.59

g/l

0.63

Conjunctivitis (acute, non atopic)

221

1198

1.85

16.48

1.4

1.3

2.79

2.89

g/l

0.32

164

838

Keratitis

265

1523

1.75

16.44

1.4

3.00

2.94

g/l

0.21

178

1047

Other diseases of stomach and duodenum

158

3.53

16.37

1.3

3.01

2.93

g/l

0.09

108

Other and unspecified effects of external causes

226

1242

1.83

16.34

1.5

1.3

2.85

2.93

g/l

0.26

161

866

Symptoms and signs involving the urinary system

527

2700

1.49

16.30

1.5

1.4

2.95

g/l

0.01

370

1871

Gout, idiopatic and unspecified

163

805

2.04

16.21

1.4

1.3

2.63

3.04

g/l

2.21

108

565

Congenital malformations of the musculoskeletal system, not elsewhere classified

5.81

16.18

1.4

1.2

2.55

2.68

g/l

0.16

Other and unspecified types of non-Hodgkin lymphoma, hilmo

105

4.18

16.13

1.7

1.3

2.50

2.78

g/l

0.33

Secondary and unspecified malignant neoplasm of lymph nodes

257

2.92

16.12

1.4

2.45

2.99

g/l

1.28

180

Unspecified kidney failure

246

2.96

16.11

1.3

1.4

2.58

3.08

g/l

1.23

174

Localized swelling, mass and lump of skin and subcutaneous tissue

229

1269

1.82

16.10

1.6

1.3

2.88

2.90

g/l

0.07

190

861

Viral infections of the central nervous system

247

2.96

16.04

1.4

2.58

2.96

g/l

0.95

166

Benign neoplasm: Colon, unspecified

171

863

2.00

16.02

1.5

1.4

2.82

2.95

g/l

0.37

119

596

Type 2 diabetes, wide definition

496

2103

1.51

16.00

1.4

1.3

2.79

2.98

g/l

1.35

360

1533

Seropositive rheumatoid arthritis, strict definition

121

535

2.29

16.00

1.4

1.3

2.65

2.86

g/l

0.80

364

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

314

2.71

15.94

1.3

1.4

2.76

2.98

g/l

0.46

226

Postviral fatigue syndrome

12.65

15.88

2.0

1.4

3.03

2.90

g/l

0.08

Chronic apical periodontitis

806

3323

1.39

15.87

1.4

2.95

2.97

g/l

0.08

533

2337

Chronic ulcer of skin, not elsewhere classified

167

3.40

15.74

1.9

1.3

3.12

3.05

g/l

0.07

119

Psoriasis

215

1178

1.84

15.72

1.3

1.4

3.31

2.94

g/l

1.97

153

814

Algoneurodystrophy

103

4.18

15.70

1.4

1.3

2.79

2.76

g/l

0.04

Excessive, frequent and irregular menstruation

284

895

1.75

15.68

1.4

2.79

2.87

g/l

0.33

193

615

Crohn's disease NAS

224

3.04

15.64

1.1

1.3

3.16

2.92

g/l

0.40

158

Soft tissue disorders related to use, overuse and pressure

185

968

1.92

15.60

1.4

1.3

2.87

2.97

g/l

0.34

140

656

Congenital malformations and deformations of the musculoskeletal system

386

2.51

15.55

1.6

1.3

2.75

2.60

g/l

0.42

291

Coronary atherosclerosis

407

1643

1.57

15.54

1.4

2.84

2.98

g/l

0.96

287

1117

Disorders of ocular muscles, binocular movement, accommodation and refraction

353

2199

1.60

15.53

1.5

1.4

3.09

2.87

g/l

1.36

255

1544

Dental operations

407

1320

1.59

15.53

1.4

1.3

2.98

2.99

g/l

0.06

280

924

Cerebral cysts

174

3.33

15.48

1.8

1.3

2.91

2.84

g/l

0.11

124

Rare circulating lymphoid malignancy, including Hilmo

4.67

15.47

1.9

1.2

2.00

2.69

g/l

1.36

Pneumothorax

169

3.36

15.46

1.3

1.2

2.72

3.08

g/l

0.75

121

Other CVD (FINNGEN)

218

2.83

15.44

1.3

3.00

3.05

g/l

0.07

142

Atopic dermatitis, strict definition

250

1411

1.75

15.36

1.4

2.82

2.89

g/l

0.26

193

990

Cluster headache, strict

4.25

15.36

1.3

3.02

3.19

g/l

0.25

Abnormal findings on diagnostic imaging of central nervous system

151

3.51

15.28

1.6

1.3

3.06

2.97

g/l

0.10

109

Chronic nephritic syndrome

114

3.95

15.27

1.9

1.3

2.83

2.81

g/l

0.02

Obesity due to excess calories

350

2207

1.59

15.22

1.3

1.4

2.85

2.96

g/l

0.56

243

1535

Other peripheral vascular diseases

249

2.89

15.21

1.3

1.4

2.85

2.89

g/l

0.08

176

Pruritus

357

2.55

15.16

1.6

1.4

2.92

2.81

g/l

0.20

258

Missing teeth due to accident, extraction or parodontitis

394

2404

1.55

15.09

1.5

1.4

2.80

2.95

g/l

0.88

269

1665

Panniculitis, unspecified

15.87

15.07

1.5

1.4

2.90

2.94

g/l

0.02

Congenital malformations and deformations of the musculoskeletal system

112

490

2.30

15.02

1.5

1.4

2.94

2.65

g/l

1.08

370

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

5.92

15.01

1.5

1.3

3.29

2.76

g/l

0.56

Genitourinary diseases

434

1405

1.55

15.00

1.3

2.89

2.99

g/l

0.51

304

969

Haemolytic anaemias

4.18

14.97

1.6

1.3

2.49

2.59

g/l

0.10

Other/unspecified rheumatoid arthritis

377

2.49

14.97

1.5

1.4

2.49

2.83

g/l

1.04

256

Spondylolisthesis/Spondylolysis

128

597

2.16

14.86

1.7

1.3

2.72

3.01

g/l

1.20

411

Cluster headache, wide

103

4.06

14.82

1.3

2.97

3.09

g/l

0.17

Diseases of oral cavity, salivary glands and jaws

388

1263

1.59

14.70

1.4

1.3

2.91

3.00

g/l

0.45

274

858

Acute pharyngitis

116

518

2.24

14.67

1.3

2.75

2.89

g/l

0.47

349

Pyogenic arthritis

170

3.28

14.63

1.3

2.60

3.07

g/l

1.03

117

Exclusions for E4_PCOS_CONSORTIUM

538

2312

1.46

14.62

1.4

2.81

2.92

g/l

0.79

327

1668

Subjective visual disturbances

189

1019

1.87

14.59

1.4

1.3

2.88

2.87

g/l

0.02

137

687

Other disorders of bone

157

798

1.98

14.48

1.5

1.3

2.92

2.89

g/l

0.08

115

564

Acute lymphadenitis

208

3.03

14.42

1.9

1.3

2.84

2.87

g/l

0.05

150

Ulcerative ileocolitis

133

3.61

14.39

1.2

1.3

3.12

3.05

g/l

0.09

Personality disorders, excluding more controls

188

1016

1.86

14.38

1.3

2.75

3.07

g/l

1.92

129

685

Disorders of mineral metabolism

263

2.77

14.33

1.3

1.4

2.69

2.92

g/l

0.42

183

Meniscus derangement

347

1471

1.60

14.28

1.3

1.4

2.98

3.02

g/l

0.16

217

1006

Brachial plexus disorders

356

2.50

14.27

1.5

1.4

3.16

2.97

g/l

0.42

248

Gout, unspecified

133

640

2.09

14.26

1.4

1.3

2.64

3.00

g/l

1.62

453

Other meningitis

5.85

14.23

1.6

1.3

2.56

2.65

g/l

0.10

Disorders of optic nerve and visual pathways

345

2.52

14.20

1.5

1.4

2.73

2.87

g/l

0.28

243

Polyarthritis, unspecified

4.24

14.18

1.8

1.4

2.59

2.90

g/l

0.50

Rash and other nonspecific skin eruption

328

2.56

14.14

1.4

2.81

2.86

g/l

0.08

237

Postprocedural disorders of nervous system

254

2.80

14.12

1.5

1.4

2.83

2.94

g/l

0.18

181

Coeliac disease

101

439

2.33

13.97

1.7

1.4

2.95

2.79

g/l

0.34

310

Cardiac murmurs and other cardiac sounds

263

2.73

13.96

1.2

1.3

2.68

2.79

g/l

0.22

195

Nephrotic syndrome

4.04

13.96

1.9

1.3

2.07

2.34

g/l

0.43

Diseases of the myoneural junction and muscle

396

2.40

13.95

1.5

1.4

3.05

2.93

g/l

0.28

287

Other disorders of skin and subcutaneous tissue, not elsewhere classified

107

477

2.26

13.93

1.7

1.3

2.80

2.93

g/l

0.29

336

Enthesopathies of lower limb, excluding foot

156

802

1.96

13.93

1.5

1.3

2.83

3.05

g/l

0.88

114

539

Small fibre neuropathy

4.38

13.91

1.5

1.3

2.76

2.86

g/l

0.10

Demyelinating diseases of the central nervous system

331

2.54

13.90

1.4

2.84

2.97

g/l

0.22

231

Crohn's disease of large intestine

176

3.18

13.88

1.3

2.87

2.99

g/l

0.17

127

Acetic acid derivatives and related substances

187

507

1.92

13.86

1.5

1.3

2.87

3.16

g/l

1.33

130

347

Exposure to other specified factors

540

3482

1.43

13.78

1.5

1.4

2.83

2.97

g/l

1.14

382

2425

Other abnormalities of plasma proteins

6.69

13.74

1.8

1.4

2.74

3.00

g/l

0.18

Postprocedural endocrine and metabolic disorders, not elsewhere classified

102

452

2.28

13.50

1.8

1.3

2.95

2.98

g/l

0.05

312

Reactive arthropathies, FINNGEN

216

2.91

13.49

1.4

1.3

3.29

2.96

g/l

0.63

149

Hypersensitivity pneumonitis due to organic dust

6.26

13.48

1.1

1.4

3.21

2.71

g/l

0.50

Persons encountering health services for specific procedures, not carried out

289

2.63

13.47

1.3

1.4

2.95

2.98

g/l

0.04

203

Abscess of lung

5.76

13.47

1.4

2.65

2.64

g/l

0.01

Lichen simplex chronicus and prurigo

169

3.18

13.44

1.1

1.5

2.80

3.03

g/l

0.46

121

Postmenopausal osteoporosis with pathological fracture

139

3.43

13.44

1.3

1.4

1.97

2.73

g/l

2.96

Ovarian cyst

253

856

1.71

13.29

1.3

1.4

2.82

2.87

g/l

0.15

176

584

Carpal tunnel syndrome

409

2417

1.50

13.27

1.4

2.94

2.98

g/l

0.19

297

1680

Disorders of calcium metabolism

181

3.08

13.24

1.3

1.4

2.77

2.94

g/l

0.21

124

Substance abuse, excluding more controls

372

2085

1.53

13.19

1.3

1.4

2.82

3.08

g/l

1.79

247

1417

Benign neoplasm: Stomach

310

2.55

13.17

1.8

1.4

2.84

2.80

g/l

0.09

213

Inflammatory diseases of female pelvic organs

425

2103

1.49

13.16

1.4

2.79

2.91

g/l

0.80

301

1482

Ankylosing spondylitis

287

2.61

13.12

1.3

3.49

3.05

g/l

1.08

202

Tonsillectomy and adenotomy

441

2080

1.48

13.09

1.4

1.3

2.71

2.98

g/l

3.12

329

1438

Other and unspecified drugs and medicaments

282

2.62

13.07

1.4

2.68

2.94

g/l

0.58

192

Disease of hard tissues of teeth, NOS

366

1233

1.56

13.02

1.4

1.3

2.97

3.02

g/l

0.20

246

835

Other diseases of oesophagus

248

2.73

13.01

1.2

1.3

3.09

2.90

g/l

0.43

172

Oxicams

157

452

1.98

13.01

1.3

3.03

3.16

g/l

0.40

118

309

Ischaemic heart disease, wide definition

498

2134

1.45

13.01

1.5

1.4

2.86

2.97

g/l

0.67

345

1471

Pleural plaque

204

2.92

13.00

1.4

1.2

2.94

3.05

g/l

0.16

148

Diabetes medication

733

3209

1.36

13.00

1.4

2.93

2.96

g/l

0.17

488

2265

Ulcerative colitis (strict definition, all Crohn cases excluded)

122

590

2.09

12.99

1.2

1.4

2.97

2.96

g/l

0.01

423

Gonarthrosis

387

1444

1.53

12.98

1.3

1.4

2.91

3.03

g/l

0.64

276

995

Obesity, other/unspecified

255

1551

1.65

12.95

1.5

1.4

2.85

2.98

g/l

0.60

200

1076

Type 2 diabetes, definitions combined

645

2740

1.39

12.95

1.4

2.93

2.99

g/l

0.35

430

1933

Cardiomyopathy

115

544

2.13

12.94

1.4

1.3

2.89

3.03

g/l

0.35

382

Chronic tubulo-interstitial nephritis

4.02

12.93

1.3

1.5

3.44

2.88

g/l

1.04

Benign neoplasm: Pancreas

4.54

12.91

1.5

1.3

2.89

2.65

g/l

0.28

Other neurological diseases

468

2538

1.45

12.90

1.4

2.78

2.96

g/l

1.42

326

1756

Marginal zone B-cell lymphoma, including Hilmo

5.52

12.87

1.5

1.3

1.87

2.66

g/l

1.09

Covid-19 suspected case

176

968

1.83

12.83

1.3

3.06

3.02

g/l

0.12

155

662

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

654

2866

1.38

12.79

1.4

2.85

2.95

g/l

0.69

430

2028

Crohn disease (strict definition, require KELA, min 2 HDR)

234

2.78

12.78

1.2

1.3

3.95

2.96

g/l

2.74

163

Viral and other specified intestinal infections

212

1187

1.73

12.76

1.5

1.3

2.76

2.94

g/l

0.86

147

830

Substance use, excluding alcohol

159

850

1.88

12.69

1.3

2.57

2.99

g/l

2.41

112

588

Viral and other specified intestinal infections

162

850

1.87

12.65

1.6

1.3

2.77

2.89

g/l

0.43

109

597

Meningitis

160

3.18

12.65

1.6

1.3

2.53

2.97

g/l

1.41

112

Crohn disease (strict definition, require KELA)

237

2.74

12.48

1.2

1.3

3.95

2.97

g/l

2.70

166

Retention of urine

209

991

1.74

12.47

1.5

1.4

2.88

2.98

g/l

0.33

143

677

Acquired haemolytic anaemia

4.53

12.45

1.6

1.4

2.12

2.82

g/l

0.99

Hyperlipidaemia, other/unspecified

235

1298

1.67

12.43

1.4

2.71

3.06

g/l

2.61

172

881

Hyperkinetic disorders, excluding more controls

103

453

2.20

12.41

1.3

2.70

2.97

g/l

0.99

313

Otalgia

284

2.57

12.38

1.7

1.3

2.56

2.84

g/l

0.83

205

Adenocarcinoma and ductal carcinoma of pancreas

4.16

12.35

1.1

1.4

3.34

2.88

g/l

0.85

Other disorders of conjunctiva

101

463

2.20

12.35

1.5

1.3

2.75

2.86

g/l

0.26

320

Panic disorder

124

615

2.03

12.34

1.3

2.97

3.03

g/l

0.14

421

Disorders of muscles

320

2.46

12.32

1.3

3.06

2.90

g/l

0.35

223

392

2394

1.49

12.32

1.3

1.4

2.98

3.00

g/l

0.06

234

1657

Other coagulation defects

256

2.65

12.29

1.5

1.4

2.56

2.90

g/l

1.01

176

Diffuse large B-cell lymphoma

123

3.47

12.24

1.4

2.05

2.96

g/l

2.10

Diffuse large B-cell lymphoma, helper endpoint

123

3.47

12.24

1.4

2.05

2.96

g/l

2.10

Diffuse large B-cell lymphoma, including Hilmo

123

3.47

12.24

1.4

2.05

2.96

g/l

2.10

Other demyelinating diseases of the central nervous system

138

3.33

12.23

1.4

2.99

g/l

0.00

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

4.45

12.21

1.3

1.2

1.59

2.83

g/l

3.51

Chronic lymphocytic leukaemia

4.45

12.21

1.3

1.2

1.59

2.83

g/l

3.51

Chronic lymphocytic leukaemia, helper endpoint

4.45

12.21

1.3

1.2

1.59

2.83

g/l

3.51

Other bursopathies

414

2.27

12.21

1.5

1.3

3.00

2.92

g/l

0.12

283

Nonorganic sleeping disorders

164

897

1.84

12.20

1.3

1.4

2.94

2.95

g/l

0.01

112

620

Fentanyl

239

2.70

12.20

1.7

1.2

2.40

3.03

g/l

1.84

174

Injuries to the abdomen, lower back, lumbar spine and pelvis

260

1596

1.62

12.19

1.3

1.4

2.92

2.93

g/l

0.02

186

1100

Alcohol use disorder, Swedish definition

368

2258

1.50

12.17

1.3

1.4

3.01

3.00

g/l

0.01

219

1564

Faecal incontinence

218

2.78

12.10

1.4

1.2

2.51

2.73

g/l

0.37

148

Other external causes of accidental injury

601

2167

1.39

12.10

1.4

1.3

2.78

3.03

g/l

2.79

419

1526

Sacroiliitis, not elsewhere classified

139

3.29

12.06

1.4

1.5

3.04

2.82

g/l

0.30

Type 2 diabetes, strict (exclude DM1)

645

2774

1.37

12.06

1.4

2.93

2.99

g/l

0.33

430

1948

Extreme obesity with alveolar hypoventilation

110

3.61

12.04

1.4

1.3

2.45

2.89

g/l

0.53

Psoriatic arthropathies

342

2.39

12.03

1.3

3.15

3.07

g/l

0.13

233

Colectomy operation

115

561

2.07

11.99

1.4

1.3

3.27

2.86

g/l

1.29

385

Psoriasis vulgaris

139

726

1.93

11.94

1.2

1.3

3.28

2.94

g/l

1.36

100

503

Hypothyroidism, strict autoimmune, 3 medication purchases required

559

2717

1.39

11.93

1.3

2.99

2.94

g/l

0.25

387

1930

Vitamin deficiency, wide

135

3.31

11.93

1.2

1.3

2.58

2.88

g/l

0.52

Vitamin deficiency

135

3.31

11.93

1.2

1.3

2.58

2.88

g/l

0.52

Coxarthrosis [arthrosis of hip](FG)

295

1317

1.58

11.92

1.3

2.88

3.01

g/l

0.68

229

890

Erythema nodosum

4.14

11.90

1.6

1.4

2.84

2.68

g/l

0.17

Trochanteric bursitis

438

2.21

11.89

1.5

1.4

2.87

2.81

g/l

0.12

305

Injuries to the knee and lower leg

828

3497

1.32

11.87

1.4

2.81

2.98

g/l

2.06

590

2417

Tongue abnormality

177

2.98

11.85

1.6

1.5

2.85

2.83

g/l

0.02

124

Cluster headache, strict, including avohilmo

167

3.04

11.79

1.3

2.87

3.01

g/l

0.25

112

Raynaud syndrome

310

2.45

11.71

1.3

1.5

2.79

2.97

g/l

0.45

219

Acute generalized exanthematous pustulosis

142

3.23

11.68

1.4

1.3

2.03

2.80

g/l

2.14

Rosacea

442

2.19

11.66

1.3

1.4

3.21

2.93

g/l

0.69

304

409

2482

1.46

11.63

1.3

1.4

3.02

3.00

g/l

0.08

246

1720

STROKE

354

1599

1.51

11.58

1.3

1.4

2.80

3.02

g/l

1.54

255

1091

Generalized skin eruption due to drugs and medicaments

118

3.45

11.56

1.5

1.3

1.94

2.67

g/l

1.75

Haemorrhage, not elsewhere classified

4.23

11.55

1.4

1.3

2.49

2.99

g/l

0.68

Diseases of pulp and periapical tissues, including avohilmo

736

2859

1.34

11.55

1.4

2.99

2.96

g/l

0.14

509

1999

Abnormal findings on examination of urine, without diagnosis

123

3.39

11.53

1.3

2.77

g/l

0.00

Secondary uncertain malignant neoplasm

412

2.23

11.50

1.4

2.72

2.91

g/l

0.29

290

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

164

3.03

11.50

1.6

1.4

3.22

2.97

g/l

0.27

123

Synovial cyst of popliteal space [Baker]

180

2.92

11.49

1.3

3.11

2.82

g/l

0.36

128

Hodgkin lymphoma, hilmo

4.11

11.45

1.6

1.3

2.29

2.93

g/l

0.86

Other diseases of anus and rectum

180

1030

1.75

11.42

1.2

1.4

2.82

2.98

g/l

0.61

131

715

Cluster headache, wide,, including avohilmo

176

2.94

11.37

1.3

2.83

3.10

g/l

0.56

119

Other and unspecified visual disturbances

345

2.34

11.36

1.7

1.3

3.07

2.86

g/l

0.52

238

Dental caries, including avohilmo

494

1780

1.42

11.35

1.4

1.3

2.88

2.97

g/l

0.52

336

1251

Cytomegalovirus infection, IBD co-morbidity

4.42

11.30

1.4

1.2

1.99

2.55

g/l

0.76

External causes of morbidity and mortality

476

1669

1.43

11.29

1.4

1.3

2.81

3.03

g/l

1.96

330

1176

Carrier of infectious disease

4.07

11.27

1.6

1.3

2.88

2.69

g/l

0.14

Vitamin D deficiency

4.69

11.26

1.2

1.3

2.58

2.50

g/l

0.07

Hyperhidrosis

4.50

11.22

1.4

1.2

2.66

3.07

g/l

0.53

Other diseases of arteries and capillaries

251

2.58

11.16

1.6

1.4

2.61

2.95

g/l

0.77

176

Cardiomyopathy, other and unspecified

211

2.73

11.14

1.4

1.3

2.89

3.04

g/l

0.19

154

Malignant neoplasm of pancreas

162

3.00

11.11

1.2

1.4

3.20

2.98

g/l

0.49

117

Type 2 diabetes, definitions combined, including avohilmo

642

2774

1.35

11.09

1.4

2.95

2.99

g/l

0.20

431

1946

Falls/tendency to fall

781

2975

1.32

11.06

1.3

1.4

2.83

2.98

g/l

1.45

547

2066

Autonomic disorders

4.73

11.00

1.4

2.67

2.58

g/l

0.11

Oter anti-inflammatory and antirheumatic agents, non-steroids

142

407

1.94

10.99

1.2

1.3

2.98

3.17

g/l

0.51

104

280

Ulcerative rectosigmoiditis

295

2.44

10.98

1.3

2.77

3.03

g/l

0.52

207

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

172

873

1.76

10.97

1.3

2.60

2.92

g/l

2.03

126

618

Disorders of vestibular function (Vertigo)

297

1922

1.53

10.84

1.3

1.4

2.72

2.91

g/l

1.26

200

1340

Oesophagitis

128

3.24

10.83

1.3

1.2

2.88

2.94

g/l

0.07

Hernia of abdominal wall

294

1932

1.53

10.83

1.5

1.4

2.79

3.00

g/l

1.16

205

1345

Benign neoplasm: Caecum

334

2.33

10.82

1.6

1.4

2.67

2.96

g/l

0.81

235

Systemic lupus erythematosus, unspecified

3.62

10.81

1.4

2.87

2.68

g/l

0.16

Erythema multiforme

4.51

10.79

1.3

2.58

2.71

g/l

0.11

Phlebitis and thrombophlebitis (not including DVT)

154

860

1.80

10.76

1.4

2.68

2.90

g/l

0.81

104

614

Gout, strict definition

111

557

2.01

10.76

1.4

1.3

2.59

3.01

g/l

1.76

395

Iron deficiency anaemia secondary to blood loss (chronic)

103

503

2.06

10.75

1.5

1.3

2.65

2.92

g/l

0.81

348

Reactive arthropathies

286

2.44

10.73

1.4

1.3

3.27

2.99

g/l

0.56

192

Hyperparathyroidism

111

551

2.00

10.71

1.4

1.3

2.48

2.83

g/l

1.48

375

Complications of internal orthopaedic prosthetic devices, implants and grafts

136

732

1.87

10.70

1.3

1.4

2.83

2.93

g/l

0.25

501

Viral warts

361

2.27

10.69

1.5

1.4

2.63

2.94

g/l

1.05

249

Cytomegaloviral disease

4.22

10.68

1.4

1.3

1.99

2.76

g/l

1.17

Aortic aneurysm

131

683

1.89

10.67

1.4

1.3

2.92

3.11

g/l

0.54

478

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

257

2.52

10.67

1.2

1.4

3.95

2.93

g/l

2.87

181

Hepatomegaly and splenomegaly, not elsewhere classified

9.61

10.65

1.3

1.2

2.81

2.73

g/l

0.05

Other or ill-defined heart diseases

145

3.07

10.62

1.4

1.2

2.89

3.10

g/l

0.32

Other CVD

114

580

1.98

10.61

1.4

1.3

2.85

2.89

g/l

0.08

408

Bullous disorders

156

2.99

10.59

1.4

2.96

2.85

g/l

0.15

108

Accidents

589

2167

1.36

10.58

1.4

1.3

2.79

3.03

g/l

2.60

413

1526

Cerebral palsy and other paralytic syndromes

414

2.17

10.57

1.5

1.4

2.78

2.93

g/l

0.32

295

conjunctival haemorrhage

212

2.67

10.51

1.6

1.3

2.86

2.91

g/l

0.08

149

Subacute thyroiditis

101

3.53

10.48

1.5

1.4

2.83

2.88

g/l

0.06

Etanercept

242

2.56

10.44

1.4

1.3

3.21

2.82

g/l

0.97

174

Scleritis and episcleritis

213

2.67

10.43

1.4

1.5

3.36

2.97

g/l

0.90

155

Neuromuscular dysfunction of bladder

278

2.43

10.41

1.3

2.71

2.89

g/l

0.27

195

Other obstetric conditions, not elsewhere classified

242

961

1.61

10.38

1.3

1.4

3.03

3.04

g/l

0.02

175

683

Menorrhagia

233

794

1.64

10.36

1.4

2.78

2.85

g/l

0.23

155

545

Failure and rejection of transplanted organs and tissues

5.07

10.35

1.3

1.4

2.62

2.65

g/l

0.02

Myelodysplastic syndrome, including Hilmo

4.34

10.34

1.3

1.5

3.20

2.67

g/l

0.63

Other and unspecified rosacea

316

2.34

10.33

1.3

1.4

3.22

2.89

g/l

0.70

220

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

236

931

1.62

10.33

1.3

1.4

3.07

3.05

g/l

0.04

170

662

Hyperkalaemia

132

3.14

10.31

1.6

1.3

2.48

2.98

g/l

1.25

Dystonia

181

2.80

10.25

1.4

1.5

3.03

2.85

g/l

0.26

122

Other noninfective disorders of lymphatic vessels and lymph nodes

3.61

10.23

1.4

2.98

2.74

g/l

0.27

Neuralgia and neuritis, unspecified

138

3.08

10.22

1.4

1.3

2.47

2.82

g/l

0.90

Chronic suppurative otitis media, including avohilmo

275

2.43

10.18

1.7

1.4

2.97

2.79

g/l

0.39

198

Procreative management

255

1366

1.56

10.17

1.5

1.4

2.56

2.85

g/l

2.17

172

950

Special screening examination for other diseases and disorders

299

2.36

10.17

1.3

3.13

2.95

g/l

0.25

171

Benign neoplasm: Small intestine

113

3.33

10.16

1.2

1.5

3.02

2.76

g/l

0.34

Achalasia of cardia

5.39

10.16

1.3

1.4

2.72

2.59

g/l

—

Diabetes, insulin treatment (Kela reimbursement)

675

3096

1.32

10.09

1.4

2.85

2.96

g/l

0.80

446

2178

Irregular menses

332

1781

1.48

10.09

1.5

1.4

2.68

2.96

g/l

2.87

237

1276

Coxarthrosis

276

1183

1.55

10.08

1.3

1.4

2.93

3.01

g/l

0.35

214

824

Other localized connective tissue disorders

4.90

10.06

1.5

1.2

2.20

2.63

g/l

0.51

Viral meningitis

114

3.30

10.03

1.4

1.3

2.92

2.90

g/l

0.02

Special screening examination for infectious and parasitic diseases

148

606

1.81

9.97

1.4

1.3

2.93

3.09

g/l

0.51

109

355

Chronic hepatitis NAS

5.31

9.92

1.2

3.08

2.68

g/l

—

Any death

378

1886

1.44

9.92

1.2

1.4

2.65

2.99

g/l

2.25

266

1277

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

183

1095

1.67

9.88

1.2

1.3

2.74

3.07

g/l

1.65

122

752

Allergic urticaria

279

2.39

9.87

1.3

1.4

2.96

2.87

g/l

0.19

193

Tuberculosis, IBD comorbidity

157

2.89

9.85

2.1

1.4

2.63

2.83

g/l

0.30

111

Cellulitis

151

862

1.76

9.84

1.4

1.3

2.55

2.92

g/l

1.86

117

603

Fall on same level

798

3388

1.29

9.83

1.3

1.4

2.83

2.98

g/l

1.42

561

2354

Adhesive capsulitis of shoulder

107

548

1.97

9.83

1.3

3.02

2.94

g/l

0.19

380

Injury, poisoning and certain other consequences of external causes

384

1331

1.45

9.79

1.5

1.3

2.81

3.01

g/l

1.37

274

906

Acute bronchiolitis

223

2.50

9.77

1.4

1.3

2.56

2.49

g/l

0.09

180

Hypotension

461

2.05

9.74

1.3

3.00

2.85

g/l

0.32

323

Disorders of refraction and accommodation

200

1230

1.63

9.72

1.3

3.09

2.86

g/l

1.12

149

866

Conductive and sensorineural hearing loss

492

2426

1.37

9.70

1.5

1.3

2.89

2.94

g/l

0.23

334

1695

Caries of dentine, including avohilmo

524

1960

1.37

9.70

1.4

2.78

2.99

g/l

1.79

354

1391

Isolated proteinuria

3.55

9.67

1.3

2.73

2.78

g/l

0.05

Cutaneous lupus erythematosus

4.37

9.63

1.2

3.10

2.70

g/l

0.41

Benign neoplasm: salivary glands, exclude unknown (D119)

270

2.40

9.62

1.6

1.4

2.81

2.95

g/l

0.29

187

Thyroiditis

252

2.45

9.61

1.5

2.79

2.90

g/l

0.24

176

Other follicular disorders

277

2.38

9.57

1.4

3.49

2.94

g/l

1.24

191

Other retinal disorders

382

2097

1.42

9.56

1.4

2.86

2.98

g/l

0.56

255

1458

Disorders of continuity of bone

353

2.20

9.54

1.4

1.3

3.04

2.88

g/l

0.25

243

Optic neuritis

155

2.89

9.52

1.6

1.4

2.67

2.90

g/l

0.37

109

Fenamates

321

2.06

9.46

1.5

1.3

3.13

3.24

g/l

0.26

226

Combined immunodeficiencies

8.36

9.45

1.4

1.2

1.78

2.79

g/l

1.24

Primary adrenocortical insufficiency

5.33

9.45

1.8

1.2

2.70

2.58

g/l

0.09

Nummular dermatitis

236

2.48

9.44

1.4

3.17

3.05

g/l

0.18

170

Anaemia in chronic diseases classified elsewhere

4.30

9.42

1.5

1.2

1.93

2.35

g/l

0.46

Other congenital malformations

355

2.19

9.40

1.3

1.4

3.04

2.68

g/l

1.07

259

Seborrhoeic keratosis

137

771

1.79

9.40

1.5

1.4

2.85

g/l

0.01

108

535

Other bullous disorders

3.81

9.37

1.2

1.4

2.68

2.73

g/l

0.05

Disorders of vitreous body and globe

311

2046

1.47

9.36

1.4

2.85

2.91

g/l

0.26

230

1418

Diplopia

455

2.04

9.36

1.8

1.3

3.12

2.92

g/l

0.39

319

Benign neoplasm of major salivary glands

305

2.28

9.34

1.5

1.4

2.72

2.95

g/l

0.56

214

Amyloidosis

4.76

9.33

1.5

1.4

1.62

2.83

g/l

2.17

Lesion of ulnar nerve

103

531

1.96

9.32

1.5

1.3

2.95

3.04

g/l

0.21

371

Unspecified/other endometriosis

350

2.19

9.32

1.4

2.71

3.03

g/l

0.92

240

Vasomotor rhinitis (mode)

220

2.53

9.29

1.7

1.4

2.86

2.87

g/l

0.02

152

Operations 2 for CAVS

151

849

1.73

9.27

1.4

2.79

2.96

g/l

0.46

109

596

Calcific aortic valvular stenosis, diagnosis (helper)

151

849

1.73

9.27

1.4

2.79

2.96

g/l

0.46

109

596

Umbilical hernia

177

1074

1.66

9.25

1.6

1.4

2.94

2.98

g/l

0.13

121

750

Endometriosis

226

835

1.59

9.23

1.2

1.4

2.86

2.85

g/l

0.04

165

569

Mouth breathing

274

1837

1.50

9.21

1.4

2.81

2.94

g/l

0.61

182

1293

Adenocarcinoma of pancreas

4.21

9.21

1.1

1.3

3.37

2.74

g/l

1.01

Unspecified misadventure during surgical and medical care

158

2.82

9.19

1.3

1.4

3.53

2.85

g/l

1.09

108

Ulcer of lower limb, not elsewhere classified

431

2.06

9.19

1.3

2.68

2.94

g/l

0.49

302

Other abnormal findings of blood chemistry

131

3.02

9.18

1.6

1.3

2.75

2.90

g/l

0.20

Calcific aortic valvular stenosis, including rheumatic fever

151

851

1.73

9.17

1.4

2.79

2.96

g/l

0.46

109

596

Childhood allergy (age < 16)

117

516

1.88

9.16

1.3

2.59

2.76

g/l

0.59

367

Other symptoms and signs involving cognitive functions and awareness

268

1629

1.50

9.12

1.4

2.91

2.95

g/l

0.14

186

1117

Disorders of vitreous body

302

1999

1.46

9.10

1.4

2.89

2.91

g/l

0.08

221

1388

Calcific aortic valvular stenosis, operated

151

854

1.72

9.09

1.4

2.79

2.95

g/l

0.45

109

601

Calcific aortic valvular stenosis

151

854

1.72

9.09

1.4

2.79

2.95

g/l

0.45

109

601

Disorders of choroid and retina

501

2642

1.35

9.07

1.4

2.88

2.97

g/l

0.47

339

1836

Viral encephalitis, not elsewhere classified/unspecified

4.17

9.03

1.3

2.08

2.92

g/l

1.19

Diseases of inner ear

336

2275

1.43

9.03

1.3

1.4

2.72

2.97

g/l

2.03

222

1588

Other enthesopathy of foot (+metatarsalgia)

316

2.23

9.02

1.6

1.3

2.65

2.83

g/l

0.44

218

Injuries to the ankle and foot

488

3226

1.35

9.00

1.4

1.3

2.95

g/l

0.01

354

2234

Disorders of lipoprotein metabolism and other lipidaemias

500

2292

1.35

9.00

1.4

2.74

3.05

g/l

3.94

361

1577

Allergic purpura

3.60

8.98

1.3

2.53

2.70

g/l

0.24

Postprocedural disorders of digestive system, not elsewhere classified

3.59

8.98

2.1

1.3

3.25

2.46

g/l

0.98

Nonspecific lymphadenitis

212

2.53

8.97

1.5

1.3

3.02

2.86

g/l

0.27

154

Fibroblastic disorders

131

738

1.78

8.97

1.4

1.3

2.87

3.01

g/l

0.45

514

Colonic or urogenital fistula

179

1099

1.64

8.95

1.2

1.4

3.12

2.95

g/l

0.49

120

761

Symptoms and signs involving emotional state

3.36

8.93

1.1

1.3

2.75

2.70

g/l

0.06

Episcleritis

172

2.71

8.92

1.5

1.4

3.51

2.96

g/l

1.23

125

Other/unspecified reactive arthropathies

231

2.45

8.89

1.4

3.33

2.98

g/l

0.62

163

Sensorineural hearing loss

457

2275

1.37

8.88

1.5

1.3

2.83

2.94

g/l

0.61

305

1591

Benign neoplasm: Duodenum

3.85

8.83

1.3

2.98

2.80

g/l

0.17

Supplementary factors related to causes of morbidity and mortality classified elsewhere

213

1368

1.56

8.82

1.7

1.3

3.02

2.92

g/l

0.33

152

943

Other specified/unspecified bacterial intestinal infections

196

2.58

8.82

1.2

1.4

2.71

2.88

g/l

0.24

136

Unspecified haematuria

248

1357

1.52

8.81

1.6

1.4

3.02

2.93

g/l

0.30

182

926

Gingivitis and periodontal diseases

691

2761

1.29

8.77

1.4

2.93

2.99

g/l

0.33

502

1889

Hypertensive heart and/or renal disease

145

624

1.74

8.73

1.4

2.80

2.95

g/l

0.32

105

409

Paracetamol or NSAID medication

108

277

1.97

8.73

1.4

1.3

2.77

3.16

g/l

1.38

206

Other and unspecified nerve root and plexus disorders, also in other diseases

136

782

1.75

8.71

1.5

1.3

3.08

3.01

g/l

0.15

538

Diseases of external ear

221

1437

1.55

8.67

1.4

2.83

2.90

g/l

0.23

165

990

Stenosis and insufficiency of lacrimal passages

277

2.29

8.66

1.3

2.86

2.79

g/l

0.11

194

Osteonecrosis

175

2.66

8.63

1.4

1.3

2.31

2.93

g/l

1.17

119

Olecranon bursitis

175

2.66

8.62

1.4

1.2

2.76

2.99

g/l

0.40

118

Post-traumatic stress disorder

297

2.24

8.59

1.3

3.19

2.97

g/l

0.47

199

Dipeptidyl peptidase 4 (DPP-4) inhibitors

328

1840

1.43

8.58

1.3

1.4

2.87

2.96

g/l

0.37

230

1278

Fracture of lumbar spine and pelvis

127

719

1.77

8.53

1.3

2.99

2.89

g/l

0.24

503

Atherosclerosis, excluding cerebral and coronary sclerosis

209

1059

1.57

8.49

1.4

2.69

2.95

g/l

1.19

150

727

Tuberculosis, wide

171

2.65

8.45

2.1

1.4

2.63

2.89

g/l

0.42

122

Cervicocranial syndrome

312

2.20

8.44

1.5

1.3

2.93

g/l

0.00

222

Ankylosing spondylitis, ICD10

332

2.16

8.43

1.3

3.49

2.98

g/l

1.37

231

Other/unspecified cytomegaloviral diseases

4.07

8.39

1.4

1.2

1.96

2.68

g/l

1.00

Perforation of tympanic membrane

313

2.19

8.39

1.3

1.4

3.08

2.94

g/l

0.25

220

Later onset COPD

130

588

1.77

8.37

1.1

1.4

2.73

2.99

g/l

0.99

414

Superficial injury of lower leg

166

1018

1.64

8.37

1.3

2.85

2.93

g/l

0.28

127

702

Benign neoplasm: Ascending colon

440

1.99

8.37

1.4

1.3

2.78

2.92

g/l

0.33

307

Smoking dependency

314

2.19

8.34

1.3

1.4

2.32

2.98

g/l

2.99

215

Injuries to the thorax

274

1878

1.46

8.31

1.5

1.4

2.90

3.00

g/l

0.43

202

1288

Other hearing loss

152

893

1.67

8.29

1.5

1.3

2.70

2.92

g/l

0.85

614

Arthropathic psoriasis

422

2.01

8.25

1.3

1.4

3.09

2.94

g/l

0.31

297

Other diseases of gallbladder

3.37

8.22

1.4

1.3

2.51

2.84

g/l

0.55

Mental and behavioural disorders due to tobacco

316

2.17

8.21

1.3

1.4

2.32

2.98

g/l

2.98

217

Metatarsalgia

290

2.23

8.21

1.6

1.3

2.67

2.86

g/l

0.42

201

Other and unspecified disorders of vitreous body

252

1682

1.48

8.18

1.4

2.88

2.87

g/l

0.05

190

1167

Other noninflammatory disorders of vulva and perineum

330

2.14

8.15

1.4

1.3

2.91

2.88

g/l

0.04

226

Fracture of rib(s), sternum and thoracic spine

179

1127

1.60

8.12

1.5

1.3

2.80

2.91

g/l

0.41

132

771

Cramp and spasm

152

2.74

8.11

1.4

2.60

3.00

g/l

0.81

105

Non-allergic asthma

285

2.23

8.11

1.9

1.5

2.57

2.79

g/l

0.42

201

Other/unspecified synovitis and tenosynovitis

364

2.08

8.09

1.6

1.3

2.71

2.89

g/l

0.50

254

Juvenile arthritis (FINNGEN)

158

2.69

8.08

1.3

1.4

2.63

2.62

g/l

0.02

115

Benign neoplasm: Descending colon

205

2.47

8.07

1.3

1.4

2.88

3.01

g/l

0.23

140

Acute nasopharyngitis (common cold)

396

2.02

8.02

1.3

2.79

3.03

g/l

0.64

251

Polycystic ovarian syndrome, consortium definition

466

2058

1.34

8.02

1.4

2.68

2.94

g/l

2.95

327

1456

Chronic suppurative otitis media

200

2.47

7.98

1.8

1.3

2.92

2.85

g/l

0.10

140

Ulcer of oesophagus

165

2.63

7.94

1.3

1.2

3.05

3.09

g/l

0.05

113

Artrosis, including avohilmo

545

2273

1.32

7.94

1.3

1.4

2.96

3.00

g/l

0.26

389

1546

Peritonsillar abscess

120

685

1.76

7.92

1.3

1.4

2.86

3.04

g/l

0.55

447

Endometriosis of pelvic peritoneum

115

617

1.79

7.91

1.4

2.95

2.91

g/l

0.09

430

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

110

3.03

7.90

1.4

1.2

3.15

3.06

g/l

0.06

Idiopathic gout

263

2.26

7.89

1.3

2.62

2.96

g/l

0.84

180

Dental pulpitis, including avohilmo

627

3176

1.28

7.87

1.4

2.97

2.98

g/l

0.04

417

2216

Anogenital herpesviral [herpes simplex] infection

423

1.98

7.85

1.4

1.5

3.06

3.00

g/l

0.13

294

Type of accident

195

1263

1.55

7.84

1.7

1.3

3.05

2.92

g/l

0.47

139

875

Glaucoma

318

1943

1.41

7.84

1.3

1.4

2.78

2.94

g/l

0.86

209

1360

Prurigo nodularis

4.11

7.83

1.1

1.4

2.30

2.99

g/l

1.35

Restless leg syndrome

486

1.91

7.83

1.7

1.3

2.73

2.85

g/l

0.27

337

Appendectomy

431

3082

1.34

7.82

1.3

1.4

2.87

2.98

g/l

0.71

290

2148

Peripheral artery disease

223

1176

1.51

7.80

1.3

1.4

2.67

2.95

g/l

1.43

164

807

Duodenal ulcer

258

2.26

7.78

1.2

1.3

3.83

2.85

g/l

1.49

181

Other and unspecified coagulation defects

173

2.58

7.77

1.5

1.4

2.48

2.85

g/l

0.91

117

Other and unspecified follicular disorders

122

2.91

7.77

1.6

1.3

3.55

2.95

g/l

0.77

Hordeolum and other deep inflammation of eyelid

191

2.49

7.75

1.6

1.3

2.83

2.94

g/l

0.16

131

Benign paroxysmal vertigo

177

1125

1.58

7.74

1.3

1.4

2.62

2.88

g/l

1.43

117

783

CR(E)ST syndrome

4.43

7.73

1.4

1.3

2.62

2.50

g/l

0.12

Oral lichen planus

3.59

7.73

1.8

1.3

3.19

2.78

g/l

0.42

Disorders of plasma-protein metabolism, not elsewhere classified

8.44

7.72

1.3

1.4

2.30

2.88

g/l

—

Other endocrine disorders

212

2.38

7.70

1.3

2.41

2.39

g/l

0.02

168

Vascular diseases of the intestine

3.37

7.67

1.1

1.3

2.52

2.85

g/l

0.37

Other aneurysm

134

2.79

7.65

1.5

1.2

2.85

2.89

g/l

0.05

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

248

2.28

7.63

1.5

1.4

2.71

2.88

g/l

0.31

174

Disturbance of activity and attention

100

536

1.84

7.62

1.3

1.4

2.66

2.88

g/l

0.74

375

Hallux valgus (acquired)

189

870

1.57

7.61

1.4

2.98

2.96

g/l

0.05

140

610

Other obstructive and reflux uropathy

118

2.92

7.60

1.2

1.3

3.31

2.79

g/l

0.83

Other juvenile arthritis

146

2.71

7.60

1.3

1.4

2.63

2.68

g/l

0.06

103

Substance abuse

372

2569

1.36

7.57

1.3

1.4

2.82

3.01

g/l

1.16

247

1767

Arthropathies in other diseases classified elsewhere

3.20

7.56

1.3

2.64

3.05

g/l

0.44

Ulcerative proctitis

212

2.38

7.53

1.4

1.3

2.92

3.01

g/l

0.14

152

Kidney transplant status

188

2.48

7.51

1.7

1.3

2.38

2.79

g/l

0.59

134

Other bacterial agents as the cause of diseases classified to other chapters

6.65

7.48

1.2

1.3

2.31

2.65

g/l

0.33

Open wound of lower leg

101

558

1.82

7.48

1.5

1.3

2.34

2.98

g/l

3.82

391

Adult respiratory distress syndrome

6.63

7.48

1.1

1.2

2.31

2.57

g/l

0.13

Other disorders of eyelid

244

1591

1.46

7.46

1.5

1.3

2.69

2.90

g/l

1.15

181

1117

Other disorders of kidney and ureter

445

1.92

7.45

1.4

2.64

2.90

g/l

0.77

315

Malignant neoplasm, wide definition for exclusion

581

2651

1.29

7.38

1.3

1.4

2.74

3.04

g/l

3.33

386

1871

Other sleep disorders

357

2.03

7.37

1.4

2.75

2.93

g/l

0.43

257

Lichen planus

433

1.93

7.36

1.8

1.3

2.97

2.83

g/l

0.24

305

Other diseases of blood and blood-forming organs

202

2.40

7.35

1.3

1.4

2.94

2.88

g/l

0.05

138

Injuries to the wrist and hand

666

3666

1.26

7.33

1.3

1.4

2.82

2.98

g/l

1.60

475

2538

Other congenital malformations

540

1.83

7.32

1.3

1.4

3.01

2.77

g/l

0.73

390

Inflammation of lacrimal passages (acute and unspecified)

4.22

7.31

1.7

1.2

3.07

2.79

g/l

0.27

Mental and behavioural disorders due to psychoactive substance use

382

2627

1.35

7.31

1.3

1.4

2.82

3.01

g/l

1.24

250

1806

Hypertensive Heart Disease

125

573

1.72

7.29

1.5

1.4

2.93

2.97

g/l

0.07

383

Other keratitis

429

1.93

7.22

1.4

2.67

2.93

g/l

0.57

305

Pure hypercholesterolaemia

427

2091

1.34

7.21

1.4

2.79

3.06

g/l

2.49

309

1437

Presence of cardiac and vascular implants and grafts

228

1145

1.48

7.21

1.4

2.81

3.02

g/l

1.11

173

800

Abnormal involuntary movements

479

1.87

7.19

1.3

2.78

2.89

g/l

0.25

338

Other contact dermatitis

261

2.20

7.18

1.5

3.11

2.90

g/l

0.48

191

Diseases of pulp and periapical tissues and dental caries

420

1601

1.35

7.17

1.4

1.3

2.89

2.96

g/l

0.32

284

1126

Myeloid leukaemia

3.60

7.17

1.5

1.3

2.79

2.87

g/l

0.06

Superficial injury of abdomen, lower back and pelvis

102

573

1.79

7.17

1.2

1.4

2.70

2.94

g/l

0.90

407

Other embolism and thrombosis

437

1.91

7.17

1.7

1.3

3.08

2.85

g/l

0.45

309

Polyuria

135

820

1.65

7.15

1.3

3.03

2.92

g/l

0.25

571

Cardiomyopathies, Primary/intrinsic

368

2.00

7.15

1.4

1.3

2.91

3.09

g/l

0.46

260

Conduction disorders

160

815

1.60

7.14

1.3

2.97

2.94

g/l

0.07

107

569

Oesophageal varices

106

2.96

7.14

1.6

1.3

3.18

2.80

g/l

0.39

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

303

2.10

7.12

1.3

1.4

2.31

2.64

g/l

0.83

230

Atypical facial pain

157

2.58

7.11

1.7

1.4

2.84

2.98

g/l

0.21

112

Disorders resulting from impaired renal tubular function

107

2.94

7.03

1.3

2.03

2.76

g/l

1.66

Decubitus ulcer and pressure area

129

2.74

7.02

1.5

1.2

2.84

2.78

g/l

0.06

Juvenile rheumatoid arthirtis

3.55

7.02

1.3

1.4

2.52

3.02

g/l

0.83

Abnormal blood-pressure reading, without diagnosis

107

2.93

7.02

1.7

1.4

2.55

3.00

g/l

0.73

Ganglion

128

771

1.67

7.01

1.5

1.3

2.89

2.96

g/l

0.19

532

Intestinal adhesions without obstruction

219

2.30

7.01

1.7

1.3

2.71

2.99

g/l

0.49

152

Psoriatic arthropathies, ICD10

420

1.92

6.99

1.3

1.4

3.15

2.91

g/l

0.55

296

Lesion of lateral popliteal nerve

141

2.65

6.98

1.5

1.3

3.00

3.01

g/l

0.01

Excessive vomiting in pregnancy

324

2.06

6.98

1.4

1.5

2.94

2.91

g/l

0.05

224

MS-disease / Multiple Sclerosis

278

2.14

6.95

1.4

2.58

2.98

g/l

1.00

196

Cardiodefibrillation

189

1249

1.52

6.91

1.3

1.4

2.78

2.96

g/l

0.60

113

860

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

202

1344

1.49

6.83

1.4

2.83

2.96

g/l

0.54

158

947

Other disorders of optic [2nd] nerve and visual pathways

203

2.34

6.83

1.6

1.3

2.72

2.80

g/l

0.10

146

Corneal ulcer

124

747

1.67

6.81

1.5

1.3

2.96

2.95

g/l

0.02

528

Other extrapyramidal and movement disorders in other diseases

144

902

1.60

6.77

1.5

1.4

2.87

2.90

g/l

0.07

106

623

Nail disorders

288

2.10

6.75

1.2

1.4

2.79

2.93

g/l

0.30

202

Other epidermal thickening

121

2.76

6.72

1.4

1.2

2.48

2.74

g/l

0.56

Hyperkinetic disorders

105

594

1.74

6.72

1.3

1.4

2.70

2.82

g/l

0.34

421

Trigeminal neuralgia

180

2.41

6.70

1.8

1.4

2.50

2.96

g/l

1.16

127

Cardiomyopathy (excluding other)

377

1.95

6.70

1.4

1.3

2.91

3.10

g/l

0.49

265

Acute peritonitis

180

2.41

6.70

1.5

1.3

3.20

2.94

g/l

0.21

126

Superficial injury of hip and thigh

455

1.86

6.66

1.3

2.82

2.91

g/l

0.18

316

Nonischemic cardiomyopathy

276

2.11

6.64

1.3

3.27

2.86

g/l

0.78

195

Drug-induced neutropenia

231

2.23

6.64

1.4

1.5

2.66

2.87

g/l

0.27

160

Phobic anxiety disorders

542

1.78

6.64

1.5

1.3

3.00

3.03

g/l

0.08

373

Viral warts

146

923

1.59

6.62

1.5

1.3

2.75

2.91

g/l

0.64

104

644

Lateral epicondylitis

458

1.85

6.55

1.5

1.3

2.68

2.96

g/l

0.95

318

Myocardial infarction

252

1244

1.43

6.53

1.3

1.4

2.80

3.01

g/l

1.12

179

824

Vulvovaginal ulceration/inflammation in other diseases

220

2.25

6.52

1.5

1.4

3.14

2.96

g/l

0.28

156

Exophthalmic conditions

5.87

6.52

1.6

1.2

3.00

2.78

g/l

0.19

Other specified and unspecified retinal disorders

3.04

6.52

1.6

1.3

2.70

2.80

g/l

0.09

Other and unspecified glaucoma

170

2.43

6.52

1.5

1.3

2.49

2.85

g/l

0.58

120

Infective dermatitis

403

1.90

6.47

1.4

1.3

3.02

2.97

g/l

0.10

291

Glaucoma suspect

202

1377

1.47

6.46

1.4

2.69

2.89

g/l

0.96

132

966

Elevated blood glucose level

261

2.12

6.39

2.1

1.3

2.89

2.94

g/l

0.07

177

Urethritis and urethral syndrome

3.78

6.39

1.4

1.3

2.31

2.60

g/l

0.40

Other and unspecified psoriasis

203

2.29

6.38

1.2

1.5

2.87

2.95

g/l

0.09

142

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

280

2.08

6.37

1.1

1.4

2.55

3.04

g/l

1.32

199

Personality disorders

188

1268

1.49

6.36

1.3

2.75

2.99

g/l

1.31

129

874

Barrett oesophagus

119

2.72

6.35

1.5

1.3

3.15

2.98

g/l

0.26

Desensitization to allergens

223

2.22

6.33

1.3

1.4

2.65

2.72

g/l

0.13

154

Other and unspecified diseases of blood and blood-forming organs

3.39

6.30

1.4

1.3

3.24

2.76

g/l

0.29

Disorders of adult personality and behaviour

199

1360

1.47

6.30

1.3

1.4

2.74

3.00

g/l

1.54

140

942

Unspecified fall

308

2238

1.36

6.27

1.5

1.4

2.82

2.91

g/l

0.37

204

1576

Hypercalcemia

120

2.70

6.26

1.2

1.4

2.45

2.84

g/l

0.60

Viral hepatitis, IBD co-morbidity

103

2.83

6.26

1.0

1.2

3.30

3.47

g/l

0.14

Other (not insulin) diabetes medications

611

2902

1.25

6.24

1.3

1.4

2.94

2.99

g/l

0.29

411

2029

Pleural plaque with presence of asbestos

180

2.35

6.23

1.3

1.2

3.13

3.00

g/l

0.15

130

Myocardial infarction, strict

233

1159

1.44

6.23

1.3

1.4

2.82

3.02

g/l

1.03

167

765

Unspecific neurodegenerative disorder

955

0.56

6.23

1.2

1.4

2.76

2.95

g/l

0.46

658

Neovascular glaucoma

2.89

6.22

1.4

1.2

2.86

2.64

g/l

0.24

Lichen simplex chronicus

3.09

6.21

1.2

1.3

3.22

3.08

g/l

0.14

Pneumonitis due to solids and liquids

199

2.28

6.21

1.3

1.2

2.64

2.82

g/l

0.27

143

Dislocation, sprain and strain of joints and ligaments of knee

393

2770

1.31

6.18

1.4

1.3

2.89

3.03

g/l

0.96

273

1908

Otitis externa

147

947

1.56

6.18

1.3

2.89

2.91

g/l

0.06

120

663

Glaucoma secondary to other eye disorders

2.86

6.11

1.4

1.3

2.86

2.74

g/l

0.12

Anogenital herpesviral [herpes simplex] infection

233

2.17

6.10

1.5

1.4

2.96

2.97

g/l

0.02

161

Acne

404

1.87

6.08

1.3

3.24

2.83

g/l

1.32

280

Diabetes insipidus

5.73

6.07

1.9

1.3

2.90

2.91

g/l

—

Eustachian salpingitis and obstruction

335

1.96

6.06

1.6

1.3

3.08

3.13

g/l

0.07

235

Hidradenitis suppurativa

134

2.57

6.06

1.3

1.4

3.55

2.82

g/l

1.14

Autoimmune hyperthyroidism

170

2.37

6.05

1.4

2.80

2.90

g/l

0.14

121

Speech and linguistic disorders, excluding more controls

282

2.02

6.03

1.2

1.3

2.58

2.76

g/l

0.46

200

Other psoriatic arthropathies

406

1.86

6.03

1.3

1.4

3.17

2.93

g/l

0.54

285

Tuberculosis

134

2.56

6.03

1.9

1.3

2.68

2.88

g/l

0.25

Crohn disease (strict definition, all UC cases excluded)

183

2.32

6.03

1.1

1.3

3.98

2.85

g/l

1.97

126

Pacemaker

156

980

1.53

6.02

1.2

1.4

2.86

2.92

g/l

0.13

105

694

Excessive attrition of teeth

363

2763

1.32

6.01

1.5

1.4

2.97

2.96

g/l

0.02

251

1938

Thoracic aortic aneurysm

458

1.80

5.96

1.5

1.3

3.10

3.07

g/l

0.03

321

Other and unspecified myopathies

242

2.12

5.95

1.4

1.3

2.93

3.02

g/l

0.13

168

Other and unspecified acquired haemolytic anaemias

6.58

5.92

1.9

1.2

1.71

2.71

g/l

—

Injuries to the head

724

3653

1.22

5.91

1.5

1.3

2.80

2.97

g/l

1.75

505

2546

Disorder of the sleep-wake schedule

3.59

5.91

1.3

1.4

2.81

2.57

g/l

0.19

Dialysis

130

2.57

5.89

1.4

1.3

2.39

2.74

g/l

0.47

Appendicitis, broad definition

473

3375

1.27

5.86

1.4

2.92

3.00

g/l

0.44

311

2350

Infections with a predominantly sexual mode of transmission

262

1773

1.38

5.86

1.3

2.89

3.00

g/l

0.53

183

1213

Oral lichen planus, including avohilmo , including avohilmo

224

2.16

5.86

1.5

2.89

2.85

g/l

0.05

156

Diseases of appendix

476

3388

1.27

5.85

1.4

2.91

2.99

g/l

0.51

314

2362

Familial hypercholesterolemia

468

1.78

5.84

1.6

1.4

2.48

2.94

g/l

1.93

322

Noninflammatory disorders of female genital tract

254

907

1.41

5.79

1.4

2.81

2.88

g/l

0.29

175

625

Alcoholic liver disease

320

1.95

5.77

1.3

3.48

2.96

g/l

0.81

224

Adjustment and management of implanted device

559

1.71

5.76

1.1

1.4

2.70

3.00

g/l

0.93

396

Abnormality of white blood cells, not elsewhere classified

5.78

5.76

1.3

1.2

2.31

2.84

g/l

—

Dermatophytosis

449

1.79

5.74

1.6

1.4

3.21

2.91

g/l

0.65

315

Sleep disorders, other/unspecified

120

2.62

5.74

1.2

1.4

3.04

2.82

g/l

0.28

Impingement syndrome of shoulder

132

845

1.57

5.73

1.4

1.3

2.83

2.96

g/l

0.33

100

589

Spondylopathies in diseases classified elsewhere

5.71

5.73

1.2

1.3

2.42

2.28

g/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

144

2.46

5.72

1.3

1.4

2.12

2.57

g/l

0.76

108

Spasmodic torticollis

103

2.76

5.72

1.6

1.4

2.57

2.73

g/l

0.20

Right bundle-branch block

2.99

5.70

1.1

2.41

3.05

g/l

1.31

Paralytic ileus

2.99

5.70

1.3

1.2

2.99

3.01

g/l

0.02

Impetigo

163

2.36

5.67

1.4

1.2

2.28

2.74

g/l

1.00

119

Other/unspecified enthesopathies, not elsewhere classified

247

2.08

5.66

1.8

1.3

3.13

2.86

g/l

0.53

176

Diabetic maculopathy, excluding more controls

351

1.89

5.62

1.5

1.3

2.87

3.09

g/l

0.35

244

Benign neoplasm: Rectum

103

624

1.66

5.62

1.5

1.3

2.64

2.95

g/l

1.21

431

Use of pramipexole

128

818

1.57

5.61

1.4

2.73

2.85

g/l

0.29

570

Angina pectoris

294

1449

1.36

5.61

1.5

1.4

2.83

2.98

g/l

0.74

196

973

Papilloedema, unspecified

3.33

5.61

1.4

3.00

2.55

g/l

0.44

Other specified and unspecified disorders of eyelid

5.12

5.60

1.9

1.3

2.04

2.98

g/l

—

Type 1 diabetes

162

1089

1.49

5.59

1.5

1.3

2.85

2.95

g/l

0.23

109

771

Acute appendicitis, no complications

359

2746

1.30

5.57

1.4

2.94

3.00

g/l

0.35

236

1915

Diseases of peritoneum

332

1.91

5.53

1.5

1.4

3.21

2.95

g/l

0.32

229

Sudden idiopathic hearing loss

318

1.93

5.53

1.8

1.3

2.93

2.92

g/l

0.01

225

Bell's palsy

418

1.81

5.52

1.3

2.19

2.95

g/l

5.04

292

Excessive earwax

317

2339

1.33

5.52

1.5

1.4

2.79

2.94

g/l

0.74

207

1646

Spontaneous rupture of synovium and tendon

223

2.12

5.51

1.8

1.3

2.81

2.83

g/l

0.03

160

Heterophoria

305

1.95

5.49

1.6

1.5

3.15

2.76

g/l

0.66

210

Benign neoplasm of mouth and pharynx

383

1.84

5.48

1.4

2.51

2.93

g/l

1.48

266

Contact with and exposure to communicable diseases

217

1543

1.41

5.47

1.4

2.80

2.94

g/l

0.47

111

1100

Chronic Coagulation defects

3.00

5.44

1.7

1.3

2.69

2.48

g/l

0.19

Other and unspecified epidermal thickening

2.99

5.44

1.3

2.38

2.75

g/l

0.73

Injuries to the shoulder and upper arm

521

3376

1.25

5.42

1.4

3.03

2.93

g/l

0.56

368

2333

Hypertrophic disorders of skin

192

2.21

5.42

1.3

1.4

3.00

2.96

g/l

0.05

135

Testicular hypofunction

118

2.58

5.40

1.3

1.2

2.90

3.23

g/l

0.26

Allergic contact dermatitis

511

1.71

5.36

1.3

1.4

2.93

2.86

g/l

0.16

357

Visual impairment including blindness (binocular or monocular)

180

2.24

5.35

1.3

2.79

2.75

g/l

0.04

128

Benign neoplasm: Rectum, anus and anal canal

113

710

1.60

5.35

1.4

1.3

2.63

2.95

g/l

1.31

496

Other disorders of central nervous system

4.83

5.35

1.4

2.21

2.64

g/l

0.34

Major coronary heart disease event excluding revascularizations

311

1558

1.33

5.34

1.3

1.4

2.85

3.00

g/l

0.72

222

1046

Other abnormal uterine and vaginal bleeding

137

637

1.55

5.34

1.2

1.4

2.97

2.78

g/l

0.56

436

Haemorrhage in early pregnancy

181

1223

1.45

5.34

1.2

1.4

2.70

2.93

g/l

0.95

132

871

Acne vulgaris

301

1.94

5.34

1.2

1.3

3.30

2.84

g/l

1.12

206

Localized scleroderma [morphea]

4.82

5.34

1.4

1.2

2.44

2.66

g/l

0.19

Complications following infusion, transfusion and therapeutic injection

4.81

5.33

1.5

1.3

2.54

2.74

g/l

—

Autoimmune thyroiditis

3.34

5.33

1.3

2.74

2.90

g/l

0.15

Acute epiglottitis

4.81

5.33

1.6

1.3

3.50

2.40

g/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

131

853

1.54

5.32

1.7

1.4

3.03

2.90

g/l

0.32

590

Other disorders of bladder

358

1.85

5.31

1.2

1.3

3.48

2.95

g/l

0.95

255

Extrapyramidal and movement disorders

209

1492

1.41

5.29

1.5

1.3

2.82

2.93

g/l

0.41

143

1037

Plantar fascial fibromatosis

302

1.93

5.29

1.4

1.3

2.71

2.89

g/l

0.42

213

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

536

1.69

5.27

1.4

2.42

2.94

g/l

1.58

378

Fracture at wrist and hand level

221

1591

1.39

5.27

1.3

1.4

2.84

2.98

g/l

0.51

146

1094

Benign neoplasm: Parotid gland

241

2.05

5.25

1.5

1.4

2.96

2.92

g/l

0.06

167

Pleural plaque without asbestos

3.08

5.23

1.5

1.2

2.58

2.60

g/l

0.01

Fracture of foot, except ankle

157

1068

1.48

5.18

1.4

1.3

2.75

2.92

g/l

0.73

113

742

Other disorders of nervous system

196

2.16

5.16

1.3

1.5

2.49

2.94

g/l

1.09

139

Infections with a predominantly sexual mode of transmission

202

1439

1.41

5.15

1.3

1.4

2.91

3.02

g/l

0.43

144

985

Caries of enamel

579

3416

1.22

5.11

1.4

2.97

2.93

g/l

0.18

444

2340

Atrophic disorders of skin

541

1.67

5.11

1.5

1.4

2.72

2.82

g/l

0.23

377

Bacterial, viral and other infectious agents

356

1.84

5.10

1.3

1.4

2.76

2.97

g/l

0.46

246

Otitis externa, unspecified

429

1.76

5.10

1.4

2.98

2.89

g/l

0.15

306

Tinnitus

137

910

1.51

5.09

1.4

2.89

2.96

g/l

0.23

629

Other hammer toe(s) (acquired)

477

1.69

5.08

1.5

3.05

2.90

g/l

0.35

331

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

272

1.96

5.07

1.3

2.53

3.06

g/l

0.97

185

Alopecia areata

2.94

5.05

1.5

1.3

3.16

2.76

g/l

0.40

Nonpyogenic thrombosis of intracranial venous system

4.85

5.05

1.3

3.75

2.77

g/l

—

Other and unspecified aplastic anaemias

4.82

5.04

1.3

4.15

2.19

g/l

—

Injuries to the neck

145

979

1.49

4.99

1.4

1.3

2.81

2.97

g/l

0.56

108

673

AV-block

415

1.72

4.98

1.2

1.3

3.35

3.08

g/l

0.45

300

Other disorders starting during childhood or adolecense, excluding more controls

190

2.14

4.98

1.3

2.22

2.55

g/l

0.85

143

Injuries to the hip and thigh

257

1735

1.34

4.94

1.3

1.4

2.87

2.93

g/l

0.24

191

1199

Osteomyelitis

180

2.18

4.94

1.5

1.2

2.71

2.98

g/l

0.37

128

Hypocalcemia

3.16

4.94

1.4

1.3

3.14

2.70

g/l

0.28

Malignant neoplasm

533

2559

1.23

4.93

1.3

1.4

2.73

3.03

g/l

3.02

360

1800

Injury of muscle and tendon at forearm level

3.27

4.92

1.3

3.57

2.68

g/l

0.67

Maternal care for other conditions predominantly related to pregnancy

142

940

1.49

4.88

1.2

1.4

2.84

3.00

g/l

0.58

100

673

Problems related to lifestyle

376

1.79

4.87

1.3

2.92

3.05

g/l

0.20

251

Abscess of anal and rectal regions

297

1.90

4.87

1.3

3.33

3.01

g/l

0.57

203

Other disorders of patella

101

634

1.60

4.84

1.2

1.4

3.14

2.98

g/l

0.52

425

Disorder of lipoprotein metabolism, unspecified

406

1.76

4.84

1.3

1.4

3.03

3.01

g/l

0.04

277

Occupational exposure to risk-factors

2.66

4.84

1.7

1.3

3.80

2.91

g/l

1.20

Striking against or struck by other objects

213

1550

1.38

4.83

1.4

1.3

2.66

2.96

g/l

1.71

142

1075

Squamous cell neoplasms and carcinomas of the skin

175

2.18

4.83

1.1

1.3

2.71

3.02

g/l

0.42

128

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

177

1250

1.42

4.82

1.2

1.3

2.97

2.99

g/l

0.05

124

855

Other/unspecified enthesopathies of lower limb, excluding foot

222

2.04

4.81

1.2

1.4

3.39

2.93

g/l

0.72

161

Follicular lymphoma, hilmo

119

2.46

4.81

1.7

1.4

2.06

2.83

g/l

1.38

Female infertility

177

749

1.44

4.79

1.4

2.92

2.89

g/l

0.07

127

517

Amenorrhoea

264

1.95

4.78

1.8

1.5

2.52

3.03

g/l

1.70

183

Other maternal disorders predominantly related to pregnancy

360

1760

1.29

4.76

1.2

1.4

2.99

2.89

g/l

0.48

256

1253

Disorders of psychological development

475

1.67

4.75

1.3

1.4

2.53

2.74

g/l

0.62

335

D07AA Corticosteroids, weak (group I)

106

676

1.57

4.74

1.4

2.82

2.81

g/l

0.04

492

Gluteal tendinitis

102

2.57

4.73

1.4

1.5

2.24

2.87

g/l

1.77

DVT of lower extremities

104

662

1.58

4.71

1.4

1.3

3.01

2.80

g/l

0.46

467

Chronic mastoiditis

3.06

4.69

1.9

1.3

2.88

2.70

g/l

0.18

Ptosis of eyelid

330

1.83

4.67

1.7

1.3

2.38

2.84

g/l

1.75

227

Scar conditions and fibrosis of skin

127

2.39

4.66

1.2

1.4

2.51

2.99

g/l

0.84

Other superficial mycoses

3.15

4.66

1.6

1.2

2.94

2.76

g/l

0.16

Acute gastritis

198

2.08

4.65

1.5

1.3

2.67

2.77

g/l

0.15

139

Intracranial injury

350

2600

1.28

4.64

1.6

1.4

2.83

2.95

g/l

0.68

242

1817

Female infertility, cervical, vaginal, other or unspecified origin

163

734

1.45

4.64

1.4

2.95

2.90

g/l

0.13

119

505

Alcohol abuse, main dg, excluding more controls

548

1.63

4.64

1.3

3.06

3.07

g/l

0.01

371

Acute appendicitis

434

3267

1.24

4.63

1.4

2.91

3.00

g/l

0.57

288

2281

Convalescence

172

2.17

4.63

1.5

1.4

2.86

2.92

g/l

0.07

121

Artificial joint operation, meniscal resection

538

2863

1.22

4.62

1.4

2.91

2.97

g/l

0.35

361

1986

Vitamin B12 deficiency anaemia

267

1.92

4.62

1.1

1.3

3.47

2.98

g/l

0.89

185

Testicular dysfunction

134

2.34

4.61

1.3

1.2

2.82

3.22

g/l

0.35

Acute posthaemorrhagic anaemia

2.93

4.61

1.3

3.06

2.60

g/l

0.32

Tubulo-interstitial nephritis, not specified as acute or chronic

179

2.14

4.59

1.3

1.4

3.15

2.87

g/l

0.34

125

Valvular operations

413

1.73

4.58

1.5

1.3

2.89

3.01

g/l

0.20

296

Congenital malformations of the urinary system

213

2.04

4.57

1.2

1.3

3.21

2.78

g/l

0.62

156

Specific personality disorders

157

1097

1.44

4.56

1.3

1.4

2.76

2.98

g/l

1.01

113

758

Respiratory tuberculosis, confirmed and not-confirmed

122

2.39

4.56

2.1

1.3

2.57

2.78

g/l

0.26

Respiratory tuberculosis

122

2.39

4.56

2.1

1.3

2.57

2.78

g/l

0.26

Other specified/unspecified dorsopathies

2.83

4.56

1.6

1.5

3.05

2.90

g/l

0.12

Trigger finger

474

1.67

4.56

1.3

3.12

2.90

g/l

0.51

331

Abrasion of teeth

208

1526

1.37

4.55

1.3

1.4

2.99

2.93

g/l

0.15

147

1068

Anti-inflammatory and antirheumatic products, non-steroids

167

581

1.45

4.53

1.4

1.3

2.69

3.08

g/l

2.15

120

409

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

2.75

4.53

1.3

1.4

2.35

2.76

g/l

0.81

Ventral hernia

131

886

1.48

4.51

1.4

1.3

2.71

2.87

g/l

0.48

617

Sequelae of injuries, of poisoning and of other consequences of external causes

145

1001

1.45

4.50

1.4

1.3

2.84

2.96

g/l

0.27

695

Panniculitis affecting regions of neck and back

2.67

4.50

1.6

1.5

2.96

2.95

g/l

0.01

Endometriosis ASRM stages 1,2

117

774

1.52

4.49

1.4

2.95

2.89

g/l

0.14

540

Viral conjunctivitis

117

2.42

4.49

1.3

2.74

2.93

g/l

0.20

Superficial injury of wrist and hand

135

920

1.47

4.48

1.4

2.62

2.93

g/l

1.57

650

Other erythematous conditions

2.55

4.48

1.3

1.4

2.44

2.74

g/l

0.44

Unspecified nephritic syndrome

2.97

4.46

1.5

1.3

2.77

2.74

g/l

0.03

Other shoulder lesions

299

1.85

4.46

1.3

2.39

2.98

g/l

1.79

211

Recurrent dislocation of patella

162

2.18

4.43

1.1

1.4

2.90

2.94

g/l

0.05

107

Generalized anxiety disorder

101

649

1.56

4.43

1.3

2.96

3.00

g/l

0.09

440

Hyperfunction of pituitary gland

169

2.15

4.41

1.3

2.23

2.97

g/l

3.10

115

Benign neoplasm: Pituitary gland, craniopharyngeal duct

169

2.15

4.41

1.4

1.3

2.96

2.86

g/l

0.09

118

Arterial embolism and thrombosis

124

2.35

4.40

1.3

1.2

2.08

2.85

g/l

1.82

Paralytic strabismus

210

2.01

4.37

1.7

1.4

3.20

2.95

g/l

0.34

146

Campylobacter enteritis

2.76

4.37

1.2

1.4

2.94

2.62

g/l

0.35

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

302

1.83

4.34

1.3

1.4

2.50

2.90

g/l

1.19

210

Hyperaldosteronism

2.81

4.30

1.6

1.2

2.77

2.83

g/l

0.06

Pure hyperglyceridaemia

2.99

4.30

1.4

2.81

2.91

g/l

—

Oesophageal obstruction

2.80

4.29

1.2

3.40

2.90

g/l

0.52

Abdominal aortic aneurysm (AAA)

223

1.97

4.29

1.3

1.2

2.59

3.03

g/l

1.24

159

Endometriosis of rectovaginal septum and vagina

254

1.90

4.25

1.5

2.58

2.89

g/l

0.72

175

Artificial opening status

152

2.19

4.25

1.4

2.81

3.01

g/l

0.32

114

Other disorders of glucose regulation and pancreatic internal secretion

283

1.85

4.23

1.8

1.3

2.90

2.91

g/l

0.03

196

Bruxism

2.79

4.21

1.3

1.4

3.87

2.81

g/l

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

279

1875

1.30

4.21

1.5

1.4

3.10

2.89

g/l

1.16

204

1332

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

618

1.56

4.20

1.2

1.4

2.90

2.95

g/l

0.11

437

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

107

706

1.52

4.19

1.4

1.3

2.74

2.90

g/l

0.38

489

Benign neoplasm: Sigmoid colon

103

675

1.53

4.16

1.5

1.4

2.63

2.93

g/l

1.15

472

Visual field defects

249

1.90

4.15

1.5

1.3

2.92

2.86

g/l

0.08

169

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

109

2.41

4.15

2.0

1.3

3.33

2.78

g/l

0.65

Iron deficiency

2.51

4.15

1.2

1.3

3.04

2.73

g/l

0.37

Mixed and other personality disorders

329

1.78

4.14

1.5

1.3

2.89

3.00

g/l

0.13

233

Schizophrenia

690

0.50

4.10

1.1

1.4

2.49

3.05

g/l

1.39

473

Speech therapy

149

1054

1.42

4.09

1.5

1.4

2.74

2.89

g/l

0.55

137

725

Alzheimer disease, including avohilmo

761

0.60

4.08

1.4

2.77

2.91

g/l

0.33

534

Poisoning by drugs, medicaments and biological substances

152

1080

1.41

4.08

1.3

2.72

2.98

g/l

0.92

106

751

Congenital malformations of the urinary system

230

1.93

4.06

1.2

1.3

3.18

2.80

g/l

0.55

166

Other condition

577

1.57

4.03

1.7

1.3

3.19

2.95

g/l

0.73

405

Cholesteatoma of middle ear

136

2.22

4.03

1.9

1.3

2.76

2.87

g/l

0.09

Mature T/NK-cell lymphomas, hilmo

3.97

4.02

1.3

1.2

2.98

2.27

g/l

—

Convergence insufficiency and excess

3.96

4.02

1.2

1.3

2.98

2.73

g/l

—

Radial styloid tenosynovitis [de Quervain]

169

2.09

4.02

1.7

1.4

3.04

2.88

g/l

0.29

124

Normotensive glaucoma

217

1.95

4.01

1.4

1.3

2.70

2.83

g/l

0.17

157

Hydronephrosis

347

1.74

4.01

1.4

1.3

2.81

3.01

g/l

0.47

250

Thyrotoxicosis

145

1026

1.42

3.99

1.5

1.4

2.94

2.85

g/l

0.25

702

Other disorders of the musculoskeletal system and connective tissue

547

1.58

3.99

1.6

1.3

2.54

2.89

g/l

1.08

386

Persistent mood disorders

113

763

1.49

3.98

1.3

2.79

2.90

g/l

0.30

517

Myocardial infarction, without ST-elevation

185

1240

1.36

3.98

1.4

2.89

2.94

g/l

0.18

144

838

Idiopathic urticaria

2.85

3.97

1.4

1.3

2.91

2.60

g/l

0.53

Epilepsy

168

1217

1.38

3.95

1.3

1.4

2.67

2.89

g/l

0.75

128

871

Spirochaetal infections, other/unspecified

297

1.80

3.95

1.2

1.4

2.86

2.94

g/l

0.12

200

Tuberculosis of other organs, strict

3.16

3.94

2.1

1.3

2.60

2.83

g/l

—

Benign neoplasm of other and unspecified endocrine glands

510

1.60

3.93

1.4

1.3

2.92

2.85

g/l

0.12

359

Type 1 diabetes, wide definition, subgroup 1

122

838

1.46

3.92

1.4

1.3

2.82

2.92

g/l

0.22

625

Tuberculosis of other organs

3.30

3.92

2.1

1.3

2.60

2.95

g/l

—

2.67

3.91

1.2

3.24

2.88

g/l

0.31

Suppurative otitis media, unspecified

2.91

3.91

1.7

1.4

2.78

2.89

g/l

0.06

Other dialysis

2.48

3.90

1.3

2.71

2.64

g/l

0.05

Other symptoms and signs involving general sensations and perceptions

100

2.42

3.90

1.2

1.3

2.88

2.69

g/l

0.16

Calculus of kidney and ureter

160

1157

1.39

3.89

1.4

1.3

3.13

3.00

g/l

0.32

110

808

Left ventricular outflow tract obstruction (LVOTO), broad definition

419

1.66

3.87

1.6

1.3

2.91

2.93

g/l

0.02

299

Bacterial, viral and other infectious agents

336

1.74

3.87

1.3

2.85

3.01

g/l

0.29

231

Poisoning by medicine

138

974

1.42

3.87

1.3

1.4

2.72

2.99

g/l

0.93

668

Other specified disorders of muscle

2.80

3.86

1.6

1.2

3.52

2.84

g/l

0.93

192

1310

1.35

3.85

1.5

1.4

2.69

2.93

g/l

1.10

137

896

Disorders of tooth development and eruption

482

1.55

3.84

1.5

1.3

2.66

2.98

g/l

0.98

334

Presbycusis

304

1.77

3.83

1.6

1.2

2.26

2.99

g/l

2.54

218

Respiratory tuberculosis, not confirmed

2.55

3.80

2.3

1.3

2.54

2.72

g/l

0.20

Injury of nerves at forearm level

3.24

3.80

1.4

2.85

2.65

g/l

—

Myopia

538

1.57

3.80

1.3

1.4

3.11

2.94

g/l

0.40

376

Tobacco use

173

2.04

3.80

1.3

2.63

3.01

g/l

0.65

117

Other peripheral vertigo

301

1.77

3.79

1.5

1.4

2.83

2.85

g/l

0.03

213

Respiratory conditions due to other external agents

3.22

3.79

1.4

1.2

2.13

2.84

g/l

—

Herpesviral keratitis and keratoconjunctivitis

114

2.30

3.79

1.6

1.3

3.37

2.83

g/l

0.47

KRA_PSY_EATING, excluding more controls

285

1.79

3.78

1.2

1.3

2.85

3.03

g/l

0.36

195

Alzheimer disease

636

0.57

3.78

1.2

1.3

2.69

2.89

g/l

0.38

449

Thyrotoxicosis, other and/or unspecified

114

780

1.47

3.78

1.4

2.90

2.86

g/l

0.08

543

Scoliosis

272

1.81

3.78

1.3

1.4

2.66

2.86

g/l

0.38

194

Infliximab

2.77

3.78

1.1

1.3

3.68

2.74

g/l

—

Strabismus

163

1186

1.38

3.77

1.7

1.3

3.01

2.83

g/l

0.53

110

839

Gonarthrosis,primary

497

2545

1.20

3.76

1.3

1.4

2.91

2.96

g/l

0.27

348

1766

Delirium, not induced by alcohol and other psychoactive substances

301

1.76

3.76

1.4

1.3

2.71

3.00

g/l

0.61

214

Lichen planus, including avohilmo

107

724

1.48

3.76

1.7

1.4

3.09

2.83

g/l

0.63

497

Other diseases of spinal cord

2.67

3.74

1.3

2.60

2.64

g/l

0.02

Contusion of toe(s) without damage to nail

2.60

3.73

1.1

1.2

2.73

2.62

g/l

0.08

Open wound of ankle and foot

393

1.66

3.72

1.3

2.98

2.95

g/l

0.04

273

Speech and linguistic disorders

377

1.66

3.71

1.4

1.3

2.46

2.61

g/l

0.37

278

Benign lipomatous neoplasm of other sites/unspecified

252

1.84

3.71

1.2

1.4

2.79

2.89

g/l

0.09

177

Other and unspecified local infections of skin and subcutaneous tissue

326

1.73

3.69

1.4

1.3

2.73

2.96

g/l

0.41

233

Psychotic depression

182

1.99

3.68

1.1

1.5

3.33

2.94

g/l

0.46

124

Propionic acid derivatives

161

581

1.40

3.67

1.3

2.72

3.08

g/l

1.97

116

409

Degenerative diseases of the nervous system

779

0.62

3.66

1.2

1.4

2.84

2.91

g/l

0.12

548

Degeneration of macula and posterior pole

223

1357

1.31

3.66

1.4

2.81

2.91

g/l

0.38

155

947

Sequelae of injuries of neck and trunk

2.50

3.64

1.6

1.3

2.90

2.77

g/l

0.09

Cardiac arrest

120

2.15

3.64

1.2

1.3

2.57

3.22

g/l

0.92

Left hemicolectomy

2.89

3.64

1.4

1.2

2.66

2.68

g/l

—

Benign neoplasm of middle ear and respiratory system

232

1.86

3.64

1.7

1.3

3.22

2.96

g/l

0.39

156

Other and unspecified disorders of skin and subcutaneous tissue

176

2.00

3.64

1.5

1.4

2.56

2.99

g/l

0.86

123

Golimumab

123

2.22

3.62

1.1

1.3

3.10

2.86

g/l

0.28

Hemiplegia

136

2.15

3.61

1.3

2.74

2.90

g/l

0.16

Other specified and unspecified personality disorders

351

1.69

3.60

1.3

1.4

2.85

3.00

g/l

0.26

243

Superficial injury of ankle and foot

506

1.57

3.60

1.4

2.69

2.88

g/l

0.42

355

Other acquired deformities of musculoskeletal system and connective tissue

150

2.09

3.58

2.0

1.3

2.56

2.97

g/l

0.61

Other disorders of binocular movement

2.68

3.58

1.5

1.3

2.87

2.64

g/l

0.30

Other local infections of skin and subcutaneous tissue

352

1.69

3.57

1.4

1.3

2.69

2.95

g/l

0.50

250

Flat foot [pes planus] (acquired)

292

1.76

3.57

1.2

1.5

2.90

2.88

g/l

0.05

208

Follicular cysts of skin and subcutaneous tissue

107

733

1.47

3.55

1.4

1.3

2.78

2.94

g/l

0.40

511

Actinic keratosis

170

1166

1.35

3.55

1.5

1.4

2.70

2.95

g/l

1.07

119

789

Oral lichen planus and hypothyroidism or thyroxine medication

3.09

3.55

1.8

1.3

1.94

2.71

g/l

—

Melanocytic naevi

176

1314

1.34

3.54

1.3

2.66

2.97

g/l

1.62

137

907

Routine general health check-up of defined subpopulation

3.07

3.54

1.4

1.2

2.73

2.65

g/l

0.06

Artificial joint re-operation

185

1.96

3.53

1.3

1.5

3.49

2.93

g/l

0.86

133

Erosion of teeth , including avohilmo

156

1145

1.37

3.51

1.3

1.4

2.74

2.96

g/l

0.86

106

793

Other misadventures during surgical and medical care

2.73

3.50

1.1

1.3

2.62

2.78

g/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

183

1377

1.33

3.50

1.2

1.4

2.74

3.00

g/l

1.20

122

960

Malignant neoplasm of breast, HER2-negative

137

1240

0.72

3.49

1.1

1.4

2.71

2.93

g/l

0.75

890

Malignant neoplasm of breast

139

1251

0.72

3.49

1.2

1.4

2.69

2.93

g/l

0.86

898

Other facial nerve disorders

2.50

3.47

1.5

1.3

2.37

2.70

g/l

0.51

Achilles tendinitis

332

1.70

3.47

1.8

1.3

2.78

3.00

g/l

0.57

232

Persons encountering health services in circumstances related to reproduction

373

2052

1.23

3.47

1.3

1.4

2.82

2.89

g/l

0.34

258

1438

Chondropathies

639

1.49

3.47

1.5

1.4

2.91

2.89

g/l

0.03

438

Other and unspecified injuries of lower leg

280

1.76

3.47

1.5

1.3

2.51

3.00

g/l

1.37

191

Leisure time condition

107

738

1.46

3.44

1.8

1.3

2.90

g/l

0.01

517

Dementia, including avohilmo

117

1138

0.71

3.44

1.2

1.4

2.89

2.92

g/l

0.05

778

Mixed conductive and sensorineural hearing loss

379

1.64

3.43

1.3

2.95

2.91

g/l

0.08

264

Heart failure and hypertrophic cardiomyopathy

3.02

3.43

1.4

1.3

2.16

2.54

g/l

—

Skin changes due to chronic exposure to nonionizing radiation

176

1216

1.34

3.43

1.5

1.4

2.71

2.95

g/l

1.08

123

824

Mental and behavioural disorders due to alcohol

288

2214

1.25

3.42

1.3

1.4

2.97

3.02

g/l

0.15

180

1514

Mantle cell lymphoma, including Hilmo

3.81

3.41

2.1

1.3

2.34

2.77

g/l

—

Ankylosing spondylitis, strict definition

160

2.02

3.40

1.2

1.3

3.73

3.03

g/l

0.85

113

Status epilepticus

2.41

3.40

1.3

2.34

2.75

g/l

0.56

Other degenerative diseases of the nervous system

129

684

1.41

3.40

1.4

1.3

2.82

2.99

g/l

0.43

465

Chromosomal abnormalities, not elsewhere classified

107

2.27

3.39

1.4

1.3

2.21

2.40

g/l

0.19

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

108

725

1.45

3.39

1.3

1.4

2.83

2.79

g/l

0.07

535

Abnormalities of gait and mobility

373

1.64

3.38

1.5

1.3

2.29

2.91

g/l

2.01

270

Hypertrophy of breast in women and men

120

850

1.42

3.36

1.4

1.3

2.93

2.89

g/l

0.09

590

Speech disturbances, not elsewhere classified

246

1.80

3.35

1.3

1.4

2.52

2.89

g/l

0.99

171

Deep endometriosis

351

1.66

3.35

1.5

1.4

2.56

2.84

g/l

0.78

247

Monoamine oxidase A inhibitors

413

1.61

3.34

1.2

1.3

2.72

3.01

g/l

0.78

282

Glaucoma-related operations

134

2.10

3.34

1.4

2.97

2.80

g/l

0.21

Primary open-angle glaucoma

144

1017

1.37

3.33

1.3

1.4

2.87

g/l

0.00

699

Dementia

107

1051

0.70

3.33

1.2

1.4

2.77

2.96

g/l

0.55

718

Chondrocostal junction syndrome [Tietze]

108

2.24

3.33

1.5

1.4

2.97

2.68

g/l

0.41

Benign neoplasm of eye and adnexa

329

1.68

3.32

1.7

1.4

2.69

2.89

g/l

0.28

236

Dissociative [conversion] disorders

128

2.13

3.30

1.2

1.3

3.00

2.97

g/l

0.04

Female genital prolapse

159

660

1.37

3.28

1.5

1.4

2.77

2.80

g/l

0.07

110

458

Seborrhoeic dermatitis

315

1.69

3.28

1.3

3.03

3.06

g/l

0.04

232

Cerebrovascular diseases

399

2322

1.21

3.27

1.3

1.4

2.85

2.94

g/l

0.50

286

1588

Event of undetermined intent

241

1.80

3.27

1.2

1.3

3.22

2.91

g/l

0.41

170

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

251

1.77

3.27

1.3

2.28

2.50

g/l

0.50

190

Hypertrophic cardiomyopathy

122

2.15

3.27

1.4

1.3

2.16

2.77

g/l

1.45

Amiodarone users

293

1.72

3.26

1.2

1.4

2.91

3.01

g/l

0.15

206

Hypertrophy of tongue papillae

3.40

3.24

1.6

1.3

2.79

2.64

g/l

—

Pilonidal cyst

339

1.66

3.24

1.4

1.3

3.43

3.09

g/l

0.65

234

Early lumbar disc prolapse, operated

370

1.63

3.23

1.3

3.08

3.10

g/l

0.03

247

Use of other anti-dementia drugs

582

0.57

3.23

1.3

2.73

2.89

g/l

0.24

414

Use of memantine

582

0.57

3.23

1.3

2.73

2.89

g/l

0.24

414

Melanoma in situ

116

2.17

3.23

1.5

1.4

3.00

2.88

g/l

0.07

L01XX Other antineoplastic agents

143

2.04

3.21

1.2

1.4

2.17

2.83

g/l

1.12

105

Other problems related to primary support group, including family circumstances

514

1.52

3.21

1.4

2.70

2.78

g/l

0.19

374

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

112

767

1.42

3.20

1.3

1.4

2.85

2.79

g/l

0.12

562

Primary open-angle glaucoma, strict

118

839

1.41

3.20

1.3

1.4

2.83

2.87

g/l

0.07

575

Dislocation, sprain and strain of joint and ligaments of hip

2.33

3.18

1.1

1.3

2.94

2.58

g/l

0.41

Cauda equina syndrome

3.31

3.16

1.2

1.4

2.44

2.55

g/l

—

Ingrowing nail

186

1.90

3.15

1.2

1.3

2.99

2.89

g/l

0.15

129

Urolithiasis

167

1262

1.33

3.14

1.4

1.3

3.12

3.00

g/l

0.30

112

876

Use of antiglaucoma preparations and miotics

179

1.91

3.14

1.3

2.93

2.83

g/l

0.09

128

Dronedarone medication

2.56

3.13

1.3

1.1

2.76

3.00

g/l

—

Muscle strain

2.49

3.13

1.2

3.08

2.92

g/l

—

Melanocytic naevi, other sites/unspecified

275

1.72

3.10

1.7

1.4

2.86

2.99

g/l

0.20

193

Acidosis

2.83

3.10

1.1

1.3

2.38

3.03

g/l

—

Embedded teeth, including avohilmo

359

1.62

3.10

1.4

2.90

2.88

g/l

0.03

247

Impotence

166

1.94

3.09

1.4

1.3

2.84

3.20

g/l

0.62

107

Hypoglycaemia, other or unspecified

216

1.82

3.09

2.0

1.3

2.88

2.82

g/l

0.10

148

Biguanides

564

2947

1.17

3.07

1.4

2.94

2.98

g/l

0.17

388

2054

IgA nephropathy (IgA glomerulonephritis)

2.53

3.05

1.4

2.51

2.91

g/l

0.42

Other disorders of bone density and structure

2.61

3.05

1.4

1.3

2.85

2.49

g/l

0.40

N06DA Anticholinesterases

798

0.65

3.05

1.3

2.73

2.90

g/l

0.39

550

Use of anticholinesterases

798

0.65

3.05

1.3

2.73

2.90

g/l

0.39

550

Dysplasia of cervi uteri

132

697

1.37

3.01

1.3

1.4

2.65

2.90

g/l

1.23

484

Hypertrophic scar

175

1.90

3.00

1.4

1.3

2.79

2.92

g/l

0.17

124

Other secondary gonarthrosis

154

1.96

3.00

1.2

1.5

3.77

2.98

g/l

0.50

108

Exposure to other and unspecified inanimate mechanical forces

278

1.70

2.99

1.4

1.3

2.82

2.92

g/l

0.22

198

Malignant neoplasm of eye, brain and central nervous system

120

2.10

2.99

1.5

1.2

2.45

2.84

g/l

0.46

Postmenopausal bleeding

138

537

1.37

2.98

1.3

2.82

2.71

g/l

0.26

369

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

341

2229

1.21

2.98

1.4

2.84

2.96

g/l

0.60

230

1596

Other female pelvic inflammatory diseases

628

1.45

2.98

1.2

1.4

2.71

2.81

g/l

0.22

436

Other specified/unspecified hearing loss

241

1.75

2.97

1.6

1.4

2.78

3.00

g/l

0.45

172

Complications of other internal prosthetic devices, implants and grafts

2.25

2.97

1.1

1.3

2.68

2.83

g/l

0.11

Gestational [pregnancy-induced] hypertension

152

1142

1.33

2.96

1.6

1.4

3.15

2.97

g/l

0.63

109

801

Oligomenorrhoea

114

2.12

2.95

1.6

1.4

2.55

2.88

g/l

0.61

Salpingitis and oophoritis

103

729

1.42

2.95

1.4

2.41

2.84

g/l

2.46

509

Tooth eruption problems

638

1.44

2.94

1.4

1.3

2.95

2.85

g/l

0.25

459

Corns and callosities

198

1.83

2.93

1.2

1.4

3.26

3.04

g/l

0.19

140

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

171

1311

1.31

2.93

1.2

1.3

3.02

3.00

g/l

0.05

127

910

Benign neoplasm: Skin, unspecified

121

2.08

2.93

1.2

1.4

2.86

2.92

g/l

0.05

Social phobias

318

1.64

2.93

1.5

1.3

2.95

3.06

g/l

0.22

213

2.34

2.92

1.8

1.3

3.48

2.87

g/l

0.81

Kyphosis

3.49

2.91

1.2

1.3

3.16

2.62

g/l

—

Unstable angina pectoris

161

963

1.32

2.89

1.4

1.3

2.95

3.00

g/l

0.12

124

621

Aortic valve malfunction, age under 60 years

374

1.59

2.89

1.6

1.3

3.10

2.95

g/l

0.18

264

Allergic contact dermatitis due to drugs in contact with skin

2.53

2.88

1.3

3.07

2.48

g/l

—

Diseases of male genital organs

297

1216

1.23

2.88

1.3

1.4

2.99

3.04

g/l

0.17

205

827

Discitis, unspecified

3.20

2.86

1.5

1.3

3.20

2.74

g/l

—

Dilated cardiomyopathy

391

1.57

2.85

1.4

1.3

3.06

2.99

g/l

0.15

270

Diabetic retinopathy, excluding more controls

144

599

1.35

2.84

1.4

2.98

3.03

g/l

0.08

380

Inflammatory disease of uterus

585

1.46

2.84

1.4

1.3

2.60

2.93

g/l

0.99

406

Medicines for HER+ breast cancer

116

1496

0.73

2.84

1.2

1.4

2.68

2.80

g/l

0.30

1063

Malignant neoplasm of endocrine gland

245

1.72

2.83

1.7

1.4

2.66

2.84

g/l

0.17

170

Use of donepezil

473

0.52

2.83

1.3

1.2

2.62

2.85

g/l

0.33

340

Other benign neoplasms of skin

197

1547

1.28

2.82

1.6

1.3

2.95

2.89

g/l

0.15

139

1071

Dissection of aorta

2.36

2.82

1.8

1.3

2.67

2.76

g/l

0.06

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

163

1250

1.31

2.81

1.2

1.4

2.93

3.02

g/l

0.30

116

865

Glucagon-like peptide-1 (GLP-1) analogues

163

1250

1.31

2.81

1.2

1.4

2.93

3.02

g/l

0.30

116

865

Malignant neoplasm of breast, including Hilmo

149

1270

0.76

2.81

1.1

1.4

2.72

2.93

g/l

0.75

912

Malignant neoplasm of breast, HER2-negative, including Hilmo

149

1270

0.76

2.80

1.1

1.4

2.72

2.93

g/l

0.75

912

Injuries to unspecified part of trunk, limb or body region

361

1.59

2.80

1.6

1.3

2.49

2.98

g/l

1.55

257

Contraceptive management

259

1466

1.24

2.80

1.3

1.4

2.93

2.95

g/l

0.06

180

1033

Dermatophytosis

342

2849

1.20

2.80

1.4

2.88

2.97

g/l

0.46

232

1991

535

1.46

2.80

1.3

2.79

2.88

g/l

0.19

380

Other chondrocalcinosis

3.63

2.80

1.9

1.2

2.42

2.93

g/l

—

Unspecified privation

385

1.57

2.79

1.6

1.4

2.80

2.98

g/l

0.25

271

Unspecified event, undetermined intent

2.33

2.75

1.4

1.3

3.36

2.68

g/l

0.47

Statin medication

433

2062

1.18

2.75

1.4

2.92

3.02

g/l

0.59

300

1403

Other predominantly sexually transmitted diseases, not elsewhere classified

128

952

1.35

2.74

1.2

1.4

2.94

3.02

g/l

0.21

661

Transport accidents

271

1904

1.23

2.71

1.5

1.3

2.96

3.07

g/l

0.48

187

1337

Pain associated with micturition

404

1.54

2.71

1.3

1.4

2.75

2.85

g/l

0.19

286

Embedded and impacted teeth

168

1070

1.30

2.71

1.3

2.98

2.90

g/l

0.23

134

744

Drug-induced systemic lupus erythematosus

3.85

2.70

1.4

1.3

3.36

2.77

g/l

—

Retinal vascular occlusion

318

1.61

2.68

1.2

1.3

2.79

2.92

g/l

0.19

222

Malignant neoplasm of breast, HER-positive

1059

0.72

2.68

1.2

1.4

2.74

2.95

g/l

0.50

760

Other disorders starting during childhood or adolescence

247

1.70

2.67

1.3

1.4

2.22

2.41

g/l

0.42

190

Impacted teeth

122

803

1.36

2.67

1.3

3.00

2.92

g/l

0.20

556

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

126

2.00

2.66

1.4

1.3

2.56

2.80

g/l

0.38

Sub-endpoint used in defining T1D endpoints

162

1231

1.30

2.66

1.4

1.3

2.79

2.91

g/l

0.31

111

868

Other congenital malformations of skin

140

1.94

2.66

1.3

3.28

2.69

g/l

1.37

103

Malignant neoplasm of digestive organs

181

1116

1.28

2.65

1.3

1.4

3.00

3.03

g/l

0.06

112

774

Obsessive-compulsive disorder

228

1.72

2.63

1.4

1.3

2.85

2.86

g/l

0.01

152

Disorders of breast

279

2084

1.22

2.62

1.5

1.4

2.85

2.89

g/l

0.14

201

1463

Hyperprolactinaemia

120

2.02

2.61

1.3

1.2

2.46

2.92

g/l

1.26

L01XE Protein kinase inhibitors

148

1.90

2.61

1.4

2.57

2.82

g/l

0.32

103

Crossbite

296

1.60

2.60

1.3

1.4

2.44

2.67

g/l

0.49

229

119

767

1.35

2.59

1.2

1.4

2.82

2.94

g/l

0.29

537

Malignant neoplasm of thyroid gland

229

1.71

2.59

1.8

1.4

2.66

2.87

g/l

0.20

158

Familial hypercholesterolemia, with ischemic heart disease

229

1.71

2.59

1.5

1.2

2.59

3.11

g/l

1.27

163

Disorders of speech understanding and production

174

1.82

2.58

1.4

1.3

2.32

2.46

g/l

0.26

140

Dislocation, sprain and strain of joints and ligaments at neck level

648

1.41

2.57

1.5

1.4

2.85

2.95

g/l

0.26

442

Retinal vascular disorders

322

1.59

2.56

1.2

1.3

2.79

2.91

g/l

0.18

225

Mental and behavioural disorders due to opioids

135

1.94

2.56

1.3

2.65

2.89

g/l

0.23

Other and unspecified trigeminal disorders

2.89

2.56

1.2

1.5

3.37

2.70

g/l

—

Other appendicitis

307

1.60

2.55

1.2

1.4

3.03

2.96

g/l

0.09

210

Malignant neoplasm of breast, ER-positive, including Hilmo

102

1074

0.73

2.55

1.2

1.4

2.74

2.94

g/l

0.51

770

Suicide or other Intentional self-harm

143

1094

1.31

2.55

1.3

2.86

2.96

g/l

0.26

760

Secondary polycythaemia

2.44

2.55

1.5

1.3

2.22

2.80

g/l

—

Other noninflammatory disorders of vagina

261

1.66

2.54

1.3

3.05

2.82

g/l

0.38

178

Palmar fascial fibromatosis [Dupuytren]

427

1.50

2.53

1.4

1.3

3.12

2.98

g/l

0.23

294

Prolonged pregnancy

635

0.63

2.52

1.2

1.4

3.15

3.07

g/l

0.15

448

Malignant neoplasm of bronchus and lung, including Hilmo

549

1.41

2.51

1.2

1.5

2.60

2.99

g/l

1.41

387

Pregnancy hypertension

240

1751

1.23

2.51

1.5

1.4

3.10

2.91

g/l

0.91

174

1243

Status post-ami

106

589

1.37

2.51

1.2

1.3

3.11

3.10

g/l

0.03

391

Major anomalies of jaw size

2.13

2.50

1.4

1.3

3.09

2.65

g/l

0.61

Specific development disorders of scholastic skills

199

1.75

2.49

1.4

1.3

2.45

2.70

g/l

0.44

145

Any dementia

868

0.72

2.48

1.2

1.4

2.75

2.96

g/l

0.58

599

Congenital malformations of eye, ear, face and neck

255

1.66

2.48

1.3

2.89

2.79

g/l

0.14

179

Other otitis externa (chronic)

217

1.71

2.48

1.4

1.3

2.39

2.91

g/l

1.23

158

Other predominantly sexually transmitted diseases, not elsewhere classified

107

788

1.36

2.48

1.2

1.4

2.99

3.00

g/l

0.03

543

Chalazion

413

1.51

2.48

1.7

1.4

2.97

2.95

g/l

0.02

285

Superficial injury of forearm

381

1.53

2.47

1.4

2.92

2.85

g/l

0.11

268

Dislocation, sprain and strain of joints and ligaments of head

151

1.87

2.47

1.5

1.3

2.96

2.73

g/l

0.22

104

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

240

1.68

2.47

1.4

1.3

2.44

2.97

g/l

1.37

167

Alzheimer’s disease, strict definition

525

0.61

2.47

1.1

1.3

2.89

2.85

g/l

0.06

373

Benign neoplasm: Skin of trunk

130

1.94

2.46

2.1

1.3

3.16

2.90

g/l

0.29

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

2.15

2.45

1.2

1.3

3.64

2.75

g/l

1.40

Benign neoplasm of meninges

334

1.56

2.45

1.6

1.4

2.47

2.82

g/l

0.86

233

Stroke, excluding SAH

296

1797

1.20

2.45

1.3

1.4

2.91

2.93

g/l

0.07

215

1224

Acute nephritic syndrome

2.57

2.45

1.2

2.39

2.93

g/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

225

1820

1.23

2.45

1.4

1.3

3.05

2.92

g/l

0.46

168

1263

Malignant neoplasm of small intestine, including Hilmo

2.26

2.45

1.1

1.4

2.65

2.82

g/l

—

Gonarthrosis, primary, with knee surgery

285

1883

1.21

2.45

1.4

2.89

2.93

g/l

0.11

195

1311

Necrosis of pulp, including avohilmo

342

2886

1.18

2.43

1.4

2.83

3.00

g/l

0.91

226

2016

Cystic kidney disease

2.10

2.43

1.3

3.23

2.63

g/l

0.57

Malignant neoplasm of thyroid gland, including Hilmo

272

1.63

2.43

1.8

1.4

2.61

2.82

g/l

0.24

192

Benign neoplasm: Skin of eyelid, including canthus

547

1.43

2.41

1.7

1.4

3.21

2.82

g/l

0.86

380

Thyrotoxicosis with diffuse goitre

539

1.43

2.41

1.5

1.3

2.83

2.87

g/l

0.09

379

L02BG Aromatase inhibitors

1234

0.73

2.40

1.2

1.4

2.61

2.77

g/l

0.41

862

Injury of unspecified body region

242

1.66

2.40

1.5

1.3

2.48

2.90

g/l

0.85

171

Type 1 diabetes, wide definition

126

955

1.32

2.40

1.4

1.3

2.80

2.93

g/l

0.33

686

Residual foreign body in soft tissue

160

1.82

2.39

1.4

1.3

2.70

2.93

g/l

0.49

108

Other disorders of veins

215

1734

1.24

2.39

1.3

1.4

2.98

2.91

g/l

0.19

143

1233

Emotional disorders and disorders of social functioning with onset specific to childhood

201

1.72

2.39

1.3

1.4

2.16

2.69

g/l

1.93

148

Effects of foreign body entering through natural orifice

138

1062

1.30

2.38

1.3

1.4

2.86

2.96

g/l

0.24

729

Contusion of other and unspecified parts of foot

175

1.78

2.38

1.2

1.3

2.76

g/l

0.00

119

Papillary adenocarcinoma of thyroid gland

168

1.80

2.37

2.0

1.5

2.72

2.87

g/l

0.11

116

Foreign body in respiratory tract

168

1.80

2.37

1.5

1.4

3.07

2.74

g/l

0.29

119

Somnolence, stupor and coma

118

1.96

2.35

1.3

1.4

1.87

2.84

g/l

3.52

Superficial injury of head

123

933

1.32

2.35

1.6

1.3

2.60

2.80

g/l

0.80

100

644

Coxarthrosis, primary

290

2051

1.20

2.35

1.3

1.4

2.89

2.92

g/l

0.09

232

1407

Congenital malformations of the circulatory system

631

1.39

2.35

1.6

1.4

2.62

2.77

g/l

0.39

463

Presence of other devices

104

768

1.35

2.32

1.3

1.4

2.73

2.98

g/l

0.92

558

Congenital malformations of ovaries, fallopian tubes and broad ligaments

214

1.69

2.32

1.2

1.4

2.73

2.94

g/l

0.32

150

Alcohol abuse, main dg

644

1.39

2.32

1.3

3.06

2.92

g/l

0.28

441

Urethral stricture

140

1.87

2.32

1.2

3.33

3.02

g/l

0.32

101

Hallux rigidus

436

1.47

2.32

1.4

1.5

3.19

2.93

g/l

0.74

304

Disturbances of smell and taste

119

1.95

2.31

1.3

1.6

3.17

2.98

g/l

0.15

Certain conditions originating in the perinatal period

350

1.50

2.30

1.3

2.32

2.68

g/l

1.03

259

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

177

1.76

2.30

2.2

1.5

2.18

2.80

g/l

1.79

124

Personal history of other diseases and conditions

484

1.45

2.30

1.5

1.4

2.48

2.78

g/l

0.93

360

Alcohol use disorder, ICD-based

223

1826

1.22

2.29

1.2

1.4

2.96

3.04

g/l

0.21

138

1256

112

1.97

2.28

1.3

1.2

2.99

2.80

g/l

0.23

Other specified disorders of kidney and ureter

2.08

2.27

1.5

1.3

3.07

2.74

g/l

0.43

Other menopausal disorders

147

640

1.30

2.27

1.8

1.4

2.96

2.79

g/l

0.55

104

443

Scabies

163

1.79

2.27

1.7

1.3

3.35

2.97

g/l

0.39

111

Injury of muscle and tendon at shoulder and upper arm level

178

1424

1.25

2.27

1.4

2.98

g/l

0.01

122

982

All dysplastic lesions of the vagina

2.17

2.25

1.5

1.4

3.07

2.88

g/l

0.15

Primary hyperparathyroidism

358

1.51

2.24

1.6

1.4

2.46

2.79

g/l

0.85

247

Degenerative macular diseases

318

1.55

2.23

1.4

1.3

2.72

2.88

g/l

0.29

224

Hypertrophy of breast

102

760

1.35

2.23

1.5

1.3

2.91

2.87

g/l

0.08

527

Use of glatiramer acetate

2.36

2.23

1.4

3.45

2.83

g/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

538

1.38

2.22

1.2

1.5

2.75

3.01

g/l

0.65

377

Biomechanical lesions, not elsewhere classified

135

1.86

2.22

1.2

1.4

2.57

2.84

g/l

0.29

Periodontal disease, other/unspecified

2.21

1.3

2.88

2.73

g/l

0.09

Other abnormal findings in urine

2.89

2.21

1.5

1.2

2.67

3.06

g/l

—

Benign neoplasm: Cerebral meninges

303

1.56

2.21

1.7

1.4

2.50

2.77

g/l

0.53

213

Meralgia paraesthetica

100

2.02

2.21

1.6

1.4

2.88

2.99

g/l

0.09

Cystic kidney disease

100

2.02

2.21

1.3

3.23

2.67

g/l

0.54

Other symptoms and signs involving the urinary system

335

1.53

2.21

1.5

1.3

2.83

3.03

g/l

0.33

231

Benign neoplasm: Long bones of lower limb

107

1.98

2.21

1.9

1.4

2.50

2.72

g/l

0.27

Agoraphobia

107

1.98

2.21

1.2

1.4

3.18

2.93

g/l

0.32

Other/unspecified disorders of vestibular function

114

1.94

2.21

1.1

1.4

3.06

2.83

g/l

0.22

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

100

747

1.34

2.16

1.3

1.4

2.97

g/l

0.01

505

Blepharochalasis

135

1052

1.29

2.15

1.5

1.4

2.91

2.86

g/l

0.11

736

Cyst of kidney

196

1.69

2.15

1.5

1.4

2.89

2.95

g/l

0.07

132

Endometriosis of ovary

629

1.37

2.15

1.3

1.4

3.00

2.83

g/l

0.38

434

Amputation

250

1.60

2.14

1.3

1.2

2.79

3.02

g/l

0.24

173

Open wound of wrist and hand

256

2092

1.20

2.13

1.3

1.4

2.84

3.03

g/l

1.17

188

1440

Benign neoplasm: Choroid

174

1.73

2.13

1.2

1.5

2.84

2.93

g/l

0.09

120

Autism spe, excluding more controls

2.12

2.13

1.4

2.34

2.80

g/l

—

Any event in cancer register

554

2880

1.13

2.12

1.3

1.4

2.75

3.04

g/l

3.11

375

2028

Short stature starting before birth

2.82

2.11

1.4

1.2

1.86

2.14

g/l

—

Family history of other conditions

2.48

2.11

1.1

1.3

2.59

2.66

g/l

—

Infective bursitis

2.22

2.11

1.3

2.61

3.17

g/l

—

Sixth [abducent] nerve palsy

2.02

2.11

1.6

1.3

2.88

2.79

g/l

0.07

Disorders of synovium and tendon in diseases classified elsewhere

2.47

2.11

1.4

1.3

2.80

2.78

g/l

—

Other noninflammatory disorders of uterus, except cervix

105

530

1.34

2.11

1.5

1.4

3.00

2.71

g/l

0.88

366

Arthropod-borne viral fevers and viral haemorrhagic fevers

331

1.52

2.11

1.4

1.3

2.63

2.97

g/l

0.98

233

Myeloproliferative diseases

236

1.62

2.10

1.2

1.4

2.40

2.93

g/l

1.06

163

Varicose veins

315

2023

1.18

2.09

1.5

1.4

2.87

2.91

g/l

0.17

208

1434

Other and unspecified mood [affective] disorders

260

1.58

2.09

1.2

1.4

2.91

2.86

g/l

0.07

179

Other conjunctival vascular disorders and cysts

2.28

2.08

1.6

1.2

2.80

2.59

g/l

—

UC patients in KELA-register (code 208), prior to 1994

131

1.84

2.08

1.6

1.3

2.84

2.91

g/l

0.07

Other eating disorders

191

1.68

2.06

1.2

1.4

2.97

2.67

g/l

0.55

127

Other puerperal infections

333

1.51

2.06

1.5

1.4

3.00

2.95

g/l

0.07

233

Sequelae of other external causes

176

1.71

2.06

1.6

1.3

2.67

2.92

g/l

0.36

125

Benign neoplasm: Tongue

2.19

2.05

1.5

1.3

2.65

2.92

g/l

—

Other strabismus

127

986

1.29

2.05

1.6

1.3

3.04

2.82

g/l

0.52

693

Pustular psoriasis

154

1.76

2.04

1.2

1.5

4.12

2.84

g/l

1.45

105

Other benign neoplasms of connective and other soft tissue

342

1.50

2.03

1.5

1.4

2.56

2.95

g/l

0.95

239

Mental and behavioural disorders due to sedatives or hypnotics

254

1.58

2.03

1.3

1.4

2.71

3.09

g/l

0.70

180

Background retinopathy and retinal vascular changes

2.42

2.03

1.3

1.2

2.81

2.82

g/l

—

Other congenital malformations of circulatory system

2.12

2.03

2.6

1.3

2.96

2.76

g/l

—

Inflammatory diseases of prostate (prostatitis)

416

1.45

2.03

1.1

1.4

2.97

3.19

g/l

0.42

281

Bicipital tendinitis

125

1.85

2.02

1.3

2.56

3.04

g/l

1.06

Ischaemic Stroke, excluding all haemorrhages

269

1686

1.19

2.02

1.3

1.4

2.93

2.92

g/l

0.05

191

1150

Specific development disorders of speech and language

245

1.58

2.01

1.4

1.3

2.43

2.55

g/l

0.24

187

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

2.24

2.01

1.5

1.4

3.27

2.65

g/l

—

Emotional disorders starting during childhood or adolecense, excluding more controls

158

1.74

2.01

1.4

1.3

2.06

2.88

g/l

2.82

112

Transient ischemic attack

249

1688

1.20

2.01

1.4

2.81

2.93

g/l

0.47

176

1162

Emotionally unstable personality disorder

534

1.39

2.01

1.3

1.4

2.62

2.98

g/l

1.18

366

Psoriasis (vulgaris), strict definition

2.01

1.1

1.3

3.08

2.92

g/l

0.18

Wet age-related macular degeneration

412

1.44

2.00

1.2

1.4

2.75

2.85

g/l

0.13

304

Lesion of sciatic nerve

2.01

2.00

1.3

3.35

2.77

g/l

0.41

Pustulosis palmaris et plantaris

133

1.82

2.00

1.1

1.5

4.07

2.92

g/l

1.15

Fracture of femur

108

749

1.31

1.98

1.4

2.70

2.89

g/l

0.56

526

Stroke, including SAH

314

1947

1.17

1.97

1.2

1.4

2.88

2.93

g/l

0.21

229

1323

Peripheral arterial reconstruction

477

1.41

1.97

1.2

1.4

2.31

3.02

g/l

2.71

340

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

163

1.72

1.97

1.5

1.4

3.43

2.90

g/l

0.85

114

Contact with other hot fluids

105

1.92

1.96

1.5

1.3

2.48

2.63

g/l

0.19

Glucosamine medication

224

1487

1.20

1.96

1.3

1.4

2.83

2.89

g/l

0.15

154

1039

Benign neoplasm of bone and articular cartilage

321

1.50

1.95

2.0

1.4

2.67

2.97

g/l

0.62

225

Viral haemorrhagic fevers, not elsewhere classified/unspecified

257

1.56

1.95

1.4

1.3

2.60

3.05

g/l

1.37

178

Atlantoaxial subluxation

3.81

1.94

1.2

1.6

2.37

2.72

g/l

—

Astigmatism

249

1.57

1.94

1.2

1.4

2.67

2.71

g/l

0.06

180

Disorders of porphyrin and bilirubin metabolism

2.76

1.94

2.0

1.3

2.83

2.62

g/l

—

Behavioural disorders, excluding more controls

2.20

1.94

1.3

2.64

2.79

g/l

—

Peripheral artery operations in Hilmo

330

1.49

1.92

1.3

2.62

3.04

g/l

0.61

231

Mental and behavioural disorders due to alcohol, excluding acute intoxication

235

1963

1.19

1.92

1.2

1.4

2.92

3.05

g/l

0.43

145

1351

Congenital malformations of genital organs

427

1.43

1.92

1.2

1.4

2.52

2.77

g/l

0.67

315

Malignant neoplasm, without specification of site, including Hilmo

1.93

1.90

1.4

3.78

2.87

g/l

0.47

Unspecified urinary incontinence

267

1.54

1.89

1.4

2.68

2.70

g/l

0.01

183

Other disorders of pigmentation

121

1.83

1.88

1.4

2.68

2.97

g/l

0.34

Medical abortion

361

1694

1.16

1.88

1.3

1.4

2.83

2.89

g/l

0.24

252

1198

Impacted maxillary molar

220

1.60

1.88

1.5

1.4

3.09

2.80

g/l

0.42

148

Melanocytic naevi of lower limb, including hip

144

1.75

1.85

1.5

1.3

2.39

2.88

g/l

0.92

Carbimazole or st.post thyroidectomy, condition for graves disease

112

873

1.29

1.84

1.8

1.4

2.76

2.87

g/l

0.31

601

Arthropod-borne viral fevers and viral haemorrhagic fevers

750

1.31

1.84

1.4

1.3

2.67

2.88

g/l

0.78

530

Implicit parasitic Sepsis

4.25

1.83

1.6

1.3

2.16

2.26

g/l

—

Exposure to other and unspecified animate mechanical forces

101

1.89

1.81

1.2

1.3

2.78

2.68

g/l

0.10

Lesion of femoral nerve

3.09

1.81

1.1

1.4

4.30

2.88

g/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

233

1330

1.19

1.79

1.6

1.4

2.67

3.00

g/l

2.36

162

935

Fracture of lower leg, including ankle

297

2535

1.16

1.78

1.5

1.3

2.88

2.98

g/l

0.40

216

1755

Brain meningioma, including Hilmo

154

1.70

1.76

1.5

2.28

2.78

g/l

0.95

104

Other salmonella infections

124

1.78

1.76

1.6

1.3

2.96

2.84

g/l

0.10

Disorder of external ear, unspecified

1.94

1.75

1.6

1.3

3.54

2.74

g/l

—

Carcinoma in situ of skin of other and unspecified parts of face

185

1.63

1.75

1.2

1.3

2.42

2.70

g/l

0.33

139

Haemangioma, any site

305

1.48

1.75

1.6

1.3

2.98

2.91

g/l

0.10

211

Arterial embolism and thrombosis of lower extremity artery

2.04

1.75

1.1

1.2

2.38

2.88

g/l

—

Cysts of oral region, not elsewhere classified

193

1.61

1.75

1.8

1.4

2.95

3.03

g/l

0.09

135

Haemangioma and lymphangioma, any site

338

1.46

1.74

1.5

1.4

3.08

2.91

g/l

0.27

239

Malignant neoplasm of small intestine

2.24

1.74

1.1

1.2

2.13

2.78

g/l

—

Endometriosis ASRM stages 3,4

122

969

1.26

1.74

1.3

1.4

2.81

2.85

g/l

0.10

668

!Aliquae complicationes praecoces traumatis

132

1.75

1.74

1.4

1.3

2.33

2.93

g/l

1.27

Early complications of trauma

132

1.75

1.74

1.4

1.3

2.33

2.93

g/l

1.27

Cerebral aneurysm, nonruptured

314

1.47

1.73

1.3

1.4

2.63

2.86

g/l

0.39

214

Female infertility, associated with anovulation

314

1.47

1.73

1.5

3.03

3.10

g/l

0.10

216

Glaucoma, exfoliation

225

1.56

1.72

1.3

3.25

2.74

g/l

0.63

167

Essential (haemorrhagic) thrombocythaemia

103

1.86

1.72

1.1

1.4

2.50

2.81

g/l

—

Parkinson's disease

446

0.63

1.71

1.3

2.33

2.93

g/l

1.39

315

Congenital ovarian cysts

171

1.65

1.71

1.3

1.4

2.57

2.89

g/l

0.52

120

Myeloproliferative diseases (CML excluded)

210

1.58

1.70

1.1

1.4

2.57

2.87

g/l

0.45

143

Any dementia, excluding more controls

774

0.76

1.70

1.2

1.4

2.78

2.98

g/l

0.53

536

Other and unspecified injuries of ankle and foot

133

1.74

1.70

1.8

1.2

3.09

2.75

g/l

0.63

Other congenital malformations of skin

299

1.48

1.70

1.3

3.01

2.86

g/l

0.31

210

Varicella [chickenpox]

187

1.61

1.69

1.2

1.3

2.58

2.85

g/l

0.35

131

Acute alcohol intoxication, ICD10

106

831

1.28

1.69

1.4

2.90

2.94

g/l

0.08

577

Fracture of neck

156

1.67

1.69

1.0

1.3

2.12

3.01

g/l

1.61

109

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

275

1.50

1.68

1.3

1.4

2.56

2.91

g/l

0.79

191

Maltreatment syndromes

195

1.60

1.68

1.2

1.3

3.31

2.88

g/l

0.56

139

Ménière disease

308

1.47

1.68

1.5

1.4

2.49

2.88

g/l

0.85

215

Bursitis of shoulder

2.20

1.68

1.4

1.5

2.79

2.86

g/l

—

Fall on same level involving ice and snow

312

2715

1.15

1.68

1.5

1.4

2.88

2.95

g/l

0.33

219

1897

Congenital lens malformations

3.23

1.67

1.2

1.4

2.32

2.22

g/l

—

Single spontaneous delivery

152

986

0.81

1.67

1.4

2.76

2.70

g/l

0.15

729

Whooping cough

2.53

1.67

1.2

2.91

2.45

g/l

—

Additional codes for the location of defect, injury or illness

180

1.62

1.66

1.2

1.4

2.88

2.93

g/l

0.05

125

Open wound of abdomen, lower back and pelvis

1.87

1.66

1.1

1.2

2.85

g/l

0.00

Eating disorders

442

1.38

1.66

1.2

1.4

2.89

2.88

g/l

0.01

308

Other salmonella infections

1.90

1.65

1.4

1.3

3.17

2.75

g/l

0.30

Postprocedural musculoskeletal disorders, not elsewhere classified

212

1.56

1.65

1.5

2.37

2.94

g/l

1.17

146

Other superficial mycoses

401

1.40

1.65

1.2

1.4

2.57

2.94

g/l

1.26

279

Benign neoplasm of urinary organs

127

1.74

1.64

1.2

1.4

2.49

2.80

g/l

0.42

Injuries to the elbow and forearm

402

3130

1.13

1.63

1.4

2.95

2.90

g/l

0.19

282

2201

Laparoscopic right hemicolectomy

150

1.67

1.63

1.2

1.3

3.44

2.97

g/l

0.59

107

Diabetic nephropathy, excluding more controls

442

1.34

1.61

1.4

1.5

2.86

2.98

g/l

0.20

276

Female infertility, tubal origin

182

1.60

1.1

1.4

3.16

2.86

g/l

0.30

134

Benign lipomatous neoplasm

146

1196

1.22

1.60

1.3

1.4

2.89

2.93

g/l

0.07

835

Coxarthrosis, primary, with hip surgery

215

1707

1.18

1.60

1.3

1.4

2.83

2.92

g/l

0.31

170

1167

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

151

1.67

1.60

1.6

1.3

3.15

3.06

g/l

0.07

113

Other and unspecified mononeuropathies of lower limb

2.01

1.59

1.2

1.3

4.15

2.85

g/l

—

Sequelae of cerebrovascular disease

154

1093

1.22

1.59

1.2

1.4

3.00

2.91

g/l

0.24

114

741

Hypermetropia

279

1.47

1.58

1.5

1.4

2.87

2.65

g/l

0.34

206

Viral haemorrhagic fevers, not elsewhere classified/unspecified

654

1.30

1.58

1.4

2.67

2.87

g/l

0.68

473

Retinal detachments and breaks

163

1353

1.21

1.57

1.6

1.4

2.84

2.96

g/l

0.43

120

947

Alzheimer’s disease (Late onset)

468

0.68

1.57

1.1

1.3

2.84

g/l

0.00

330

Amputation of toe

184

1.58

1.54

1.1

1.3

2.51

2.97

g/l

0.60

125

Parkinson's disease, strict definition

396

0.63

1.53

1.3

2.27

2.94

g/l

1.47

278

Anomalies of dental arch relationship, including avohilmo

117

848

1.25

1.53

1.3

3.12

2.81

g/l

1.00

598

Vitreous haemorrhage

315

1.43

1.52

1.6

1.4

3.29

2.91

g/l

0.60

219

Hydatidiform mole

0.00

1.52

0.0

1.5

—

2.90

—

Bitten or struck by other mammals

468

1.35

1.51

1.4

2.93

g/l

0.00

326

Nontoxic multinodular goitre

686

1.29

1.50

1.5

1.3

2.73

2.78

g/l

0.10

479

Preterm labour and delivery

139

1142

1.22

1.50

1.4

3.08

2.85

g/l

0.51

814

Diffuse brain injury

1.91

1.49

1.1

1.4

3.07

2.97

g/l

—

Superficial injury of thorax

547

1.32

1.49

1.5

1.3

2.86

3.00

g/l

0.27

388

Endometriosis diagnosis and infertility diagnosis occurring together

478

1.34

1.49

1.4

3.28

2.93

g/l

0.84

328

Benign neoplasm of ovary

635

1.29

1.48

1.2

1.4

2.62

2.76

g/l

0.37

438

Insulin, fast-acting (human)

548

1.32

1.47

1.3

3.05

3.02

g/l

0.04

374

LSIL lesion of the cervix uteri, vagina or vulva

627

1.30

1.47

1.3

1.4

2.73

2.94

g/l

0.64

429

Primary gonarthrosis, bilateral

242

1789

1.16

1.47

1.3

1.4

2.94

g/l

0.02

177

1244

Conductive hearing loss, unspecified

277

1.45

1.44

1.3

3.14

2.99

g/l

0.20

198

Non-small cell lung cancer, adenocarcinoma

148

1.63

1.44

1.1

1.4

2.83

3.08

g/l

0.35

110

Retinal haemorrhage

1.98

1.44

1.5

1.3

2.35

2.64

g/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

208

1217

1.17

1.43

1.6

1.4

2.64

3.00

g/l

2.44

146

849

Fracture of shoulder and upper arm

179

1513

1.18

1.42

1.5

1.3

3.03

2.87

g/l

0.49

131

1052

Contusion of ankle

133

1.66

1.42

1.5

1.3

2.76

2.80

g/l

0.03

Alzheimer disease, excluding more controls

337

0.68

1.42

1.3

1.5

2.73

2.93

g/l

0.26

225

Entropion and trichiasis of eyelid

180

1.56

1.42

1.5

1.3

2.61

2.86

g/l

0.41

128

Sequelae of injuries of upper limb

379

1.38

1.42

1.2

1.4

2.75

3.00

g/l

0.46

269

Impacted cerumen

303

1.42

1.4

2.63

2.87

g/l

0.36

214

Malignant neoplasm of prostate, including Hilmo

611

0.78

1.41

1.1

1.4

3.45

3.20

g/l

0.53

424

Outcome of delivery

481

0.74

1.41

1.2

1.4

2.94

2.95

g/l

0.02

349

Open wound of forearm

337

1.40

1.41

1.3

2.91

3.01

g/l

0.12

233

Brain meningioma

149

1.62

1.41

1.5

2.35

2.77

g/l

0.73

101

Wide developmental disorders, excluding more controls

124

1.68

1.40

1.3

2.10

2.63

g/l

0.87

Mental disorders, not otherwise specified

321

1.41

1.39

1.3

1.4

3.21

2.89

g/l

0.55

226

Pediculosis, acariasis and other infestations

222

1.49

1.38

1.6

1.3

3.43

2.94

g/l

0.60

152

Persistent delusional disorders

249

0.56

1.37

1.1

1.4

3.36

3.06

g/l

—

169

malignant neoplasm of male genital organs

629

0.78

1.36

1.3

1.4

3.47

3.19

g/l

0.63

435

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

135

1.64

1.36

1.2

1.4

2.89

2.82

g/l

0.06

Peripheral retinal degeneration

1.84

1.36

1.4

1.3

2.71

2.90

g/l

—

Sequelae of infectious and parasitic diseases

256

1.45

1.35

1.4

1.3

2.69

2.94

g/l

0.35

177

Benign neoplasm: Adrenal gland

248

1.46

1.35

1.2

1.4

2.94

2.92

g/l

0.02

172

Complications predominantly related to the puerperium

144

1203

1.20

1.35

1.5

1.4

2.86

2.96

g/l

0.36

108

843

Calcific tendinitis of shoulder

175

1.55

1.34

1.1

1.4

3.49

2.88

g/l

0.76

119

Adenomyosis (Endometriosis of uterus)

478

1.32

1.34

1.2

1.4

2.70

2.75

g/l

0.10

331

Primary coxarthrosis, bilateral

123

1013

1.22

1.33

1.4

2.70

2.91

g/l

0.61

100

686

Use of interferon beta-1a

1.79

1.33

1.4

2.81

2.84

g/l

—

Benign neoplasm: Kidney

1.79

1.33

1.3

1.4

2.58

2.83

g/l

0.21

Fitting and adjustment of other devices

155

1177

1.19

1.33

1.4

2.73

2.98

g/l

1.06

132

813

Pediculosis, acariasis and other infestations

726

1.26

1.33

1.5

1.4

3.04

2.91

g/l

0.30

512

Anorexia (incl.atypical)

216

1.49

1.32

1.1

1.4

2.92

2.78

g/l

0.20

141

Carcinoma in situ of breast, intraductal

308

0.61

1.32

1.2

1.4

3.09

2.74

g/l

—

211

Other vitreous opacities

113

1.69

1.32

1.4

1.3

2.58

2.76

g/l

0.23

Malignant neoplasm of bronchus and lung

462

1.30

1.31

1.2

1.4

2.70

3.01

g/l

0.79

328

Cicatricial alopecia [scarring hair loss]

2.53

1.31

1.7

1.4

2.50

2.89

g/l

—

Malignant neoplasm of oral cavity, including Hilmo

121

1.66

1.30

1.2

1.3

2.78

2.94

g/l

0.15

Recurrent dislocation and subluxation of joint

250

1.44

1.30

1.2

1.4

2.58

3.07

g/l

1.43

166

Benign mammary dysplasia

516

1.30

1.29

1.5

1.4

2.54

2.76

g/l

0.52

348

Amblyopia ex anopsia

145

1.59

1.29

1.2

1.3

3.42

2.40

g/l

1.38

110

Granulomatous disorders of skin and subcutaneous tissue

1.90

1.29

1.6

1.2

3.82

2.78

g/l

—

Delivery

158

987

0.84

1.28

1.4

2.86

2.70

g/l

0.49

729

L02BB Anti-androgens

231

0.56

1.28

2.2

1.2

3.12

3.05

g/l

—

167

Delivery, wide proxy

123

790

0.83

1.27

1.4

2.87

2.75

g/l

0.29

570

Eating disorder

378

1.35

1.27

1.2

1.4

2.85

g/l

0.01

265

Diabetic retinopathy

171

905

1.18

1.27

1.4

3.04

2.93

g/l

0.26

101

602

Conduct disorder

1.83

1.26

1.3

2.64

2.74

g/l

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

154

1.56

1.26

1.1

1.4

2.83

2.95

g/l

0.14

114

Pedestrian injured in transport accident

219

1.47

1.25

1.2

1.3

3.11

2.95

g/l

0.11

151

False labour

174

924

1.18

1.25

1.3

1.4

3.15

3.01

g/l

0.42

118

660

Infectious mononucleosis

346

1.36

1.24

2.1

1.4

2.84

2.96

g/l

0.23

237

Congenital cataract

2.68

1.22

1.0

1.4

2.33

2.22

g/l

—

Other and unspecified disorders of adult personality and behaviour

2.67

1.22

1.2

1.5

1.97

3.06

g/l

—

Exposure to other and unspecified forces of nature

2.67

1.22

2.0

1.1

2.50

3.18

g/l

—

Oral leukoplakia, including avohilmo

1.81

1.21

1.4

1.3

2.04

2.79

g/l

—

Sequelae of injuries of head

180

1.51

1.21

1.5

1.3

2.56

2.99

g/l

0.39

122

Pregnancy with abortive outcome

364

1703

1.12

1.21

1.3

1.4

2.85

2.89

g/l

0.14

251

1204

Left bundle-branch block

180

1.50

1.20

1.4

1.3

3.11

3.08

g/l

0.02

124

Lichen sclerosus et atrophicus

348

1.35

1.20

1.6

1.4

2.92

2.80

g/l

0.17

240

Acute alcohol intoxication

124

1035

1.20

1.4

2.97

2.98

g/l

0.02

721

Myocardial infarction, with ST-elevation

531

1.28

1.20

1.2

1.4

2.57

3.06

g/l

2.14

373

Vestibular neuronitis

297

1.38

1.20

1.3

1.4

3.18

2.92

g/l

0.39

212

Other disorders of cornea

314

1.37

1.20

1.1

1.4

2.84

g/l

0.00

224

Parkinson's disease, including avohilmo

466

0.71

1.20

1.7

1.3

2.39

2.93

g/l

1.48

331

Hepatocellular carcinoma, including Hilmo

1.84

1.19

1.5

1.2

3.51

3.04

g/l

—

Primary ovarian failure

1.89

1.18

1.3

2.44

2.85

g/l

—

Dementia in Alzheimer disease

344

0.69

1.18

1.1

1.2

2.78

2.86

g/l

0.08

247

Other disorders of breast

515

1.28

1.18

1.4

3.30

2.84

g/l

1.00

355

Other and unspecified vascular occlusions

231

1.43

1.17

1.2

1.4

2.57

2.88

g/l

0.53

169

Long labour

983

0.82

1.16

1.3

1.4

2.95

2.93

g/l

0.05

704

Sequelae of injuries of lower limb

359

1.34

1.16

1.6

1.3

2.88

2.98

g/l

0.12

252

L02BA Anti-estrogens

645

0.76

1.15

1.1

1.4

2.78

2.80

g/l

0.03

447

Macular pucker

474

1.29

1.14

1.7

1.4

2.95

2.92

g/l

0.05

338

Other renal tubulo-interstitial diseases

1.86

1.13

1.1

1.3

3.18

2.75

g/l

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

309

1.36

1.13

1.0

1.4

2.54

2.99

g/l

0.70

223

Postmenopausal atrophic vaginitis

122

561

1.20

1.12

1.4

2.71

2.73

g/l

0.04

386

Coronary artery bypass grafting

551

1.23

1.12

1.6

1.3

2.85

3.15

g/l

1.06

359

Retinoschisis and retinal cysts

1.91

1.12

2.8

1.3

2.91

2.69

g/l

—

Foreign body on external eye

582

1.26

1.11

1.2

1.3

2.78

3.03

g/l

0.67

393

Presbyopia

259

1.40

1.11

1.4

3.57

2.97

g/l

0.90

181

Injury of muscle and tendon at hip and thigh level

371

1.32

1.11

1.1

1.4

2.94

2.92

g/l

0.04

255

Vertical strabismus

104

1.64

1.09

1.4

3.98

2.76

g/l

0.79

Impacted maxillary canine

1.97

1.09

1.3

1.2

2.36

2.77

g/l

—

Thyrotoxicosis with toxic single thyroid nodule

2.40

1.09

1.8

1.5

4.17

2.75

g/l

—

Colitis due to radiation

2.40

1.09

1.4

2.94

2.98

g/l

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

346

1.33

1.09

1.1

1.4

3.57

2.77

g/l

1.39

235

256

0.62

1.09

1.1

1.3

3.80

2.92

g/l

—

181

Dementia in other diseases classified elsewhere

112

1.61

1.09

1.2

2.77

2.73

g/l

—

Scabies

611

1.25

1.09

1.5

1.4

3.05

2.89

g/l

0.37

429

In situ neoplasms

178

1548

1.15

1.08

1.4

2.64

2.93

g/l

1.75

116

1080

Other spirochaetal diseases

154

1326

1.16

1.07

1.4

2.87

2.91

g/l

0.12

123

926

Congenital musculoskeletal deformities of head, face, spine and chest

1.94

1.07

1.6

1.3

2.73

2.22

g/l

—

Polyp of the female genital tract

147

721

1.17

1.06

1.3

1.4

2.82

2.83

g/l

0.03

107

497

Obstructed labour due to maternal pelvic abnormality

623

1.24

1.05

1.3

1.4

2.87

2.79

g/l

0.20

438

Other spirochaetal diseases

152

1310

1.16

1.05

1.4

2.85

2.91

g/l

0.17

122

913

LSIL lesion of the cervix uteri

507

1.27

1.05

1.3

1.4

2.69

2.92

g/l

0.69

350

Other congenital malformations of the digestive system

210

1.42

1.04

1.6

1.3

2.53

2.37

g/l

0.28

162

Diabetic nephropathy

580

1.24

1.04

1.4

1.5

2.86

2.93

g/l

0.11

377

Hereditary corneal dystrophies

1.67

1.04

1.1

1.5

2.54

2.76

g/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

154

1310

1.16

1.04

1.3

1.4

2.74

3.00

g/l

1.34

111

924

Gilbert syndrome

2.29

1.04

2.2

1.3

2.91

2.54

g/l

—

Benign neoplasm: Brain, supratentorial

1.93

1.02

1.4

1.3

2.88

2.66

g/l

—

Malignant neoplasm of prostate

587

0.81

1.02

1.3

1.4

3.43

3.17

g/l

0.56

406

Non-small cell lung cancer

270

1.36

1.02

1.2

1.4

2.76

3.01

g/l

0.43

196

Non-small cell lung cancer, including Hilmo

429

1.28

1.01

1.1

1.4

3.00

3.01

g/l

0.01

301

Early lumbar disc prolapse operation

483

1.27

1.01

1.2

1.3

3.13

3.04

g/l

0.14

324

Varicella [chickenpox]

230

1.40

1.01

1.2

1.3

2.76

2.78

g/l

0.03

168

Fall on and from stairs and steps

126

1074

1.17

1.01

1.5

1.3

2.95

2.87

g/l

0.19

749

Sequelae of other and unspecified infectious and parasitic diseases

205

1.42

1.01

1.6

1.4

2.64

2.96

g/l

0.45

141

Migraine with aura, drug-induced

2.02

1.00

2.4

1.4

3.33

2.65

g/l

—

Contact with heat and hot substances

197

1.43

1.00

1.4

1.3

2.75

2.82

g/l

0.07

138

Malignant neoplasm of rectum, including Hilmo

402

0.72

0.99

1.3

1.4

2.36

2.99

g/l

1.38

284

Maternal care for other known or suspected fetal problems

136

737

1.17

0.98

1.3

1.4

3.10

3.04

g/l

0.15

531

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

0.00

0.98

0.0

1.2

—

2.91

—

Other congenital malformations of heart

1.97

0.97

1.4

1.2

1.23

2.54

g/l

—

Other congenital malformations of the digestive system

180

1.44

0.97

1.7

1.3

2.52

2.36

g/l

0.24

138

Other disorders of breast and lactation associated with childbirth

1.86

0.97

1.3

1.82

2.88

g/l

—

Torticollis

1.81

0.97

1.1

1.3

2.67

2.55

g/l

—

Pathological resorption of teeth

108

1.58

0.96

1.2

2.83

2.78

g/l

0.05

Motorcycle rider injured in other and unspecified transport accidents

224

1.39

0.96

1.5

1.2

2.82

3.08

g/l

0.42

155

Melanocytic naevi of trunk

460

1.26

0.96

1.2

1.4

2.95

2.91

g/l

0.06

328

Perineal laceration during delivery

663

0.81

0.95

1.7

1.4

3.08

2.93

g/l

0.29

463

Contact with machinery

390

1.29

0.94

1.2

1.3

2.78

3.09

g/l

0.53

269

Behavioural disorders

1.66

0.94

1.3

1.2

2.64

2.65

g/l

—

Complications of the puerperium, not elsewhere classified

166

1.45

0.94

1.3

1.4

3.20

2.92

g/l

0.36

115

Fracture of skull and facial bones

106

897

1.18

0.94

1.4

1.3

2.87

2.95

g/l

0.15

614

Malignant neoplasm of skin

230

1406

1.12

0.94

1.5

1.4

2.65

3.00

g/l

2.64

162

994

Acute myeloid leukaemia, helper endpoint

2.24

0.94

1.7

1.1

1.73

2.69

g/l

—

Acute myeloid leukaemia

2.24

0.94

1.7

1.1

1.73

2.69

g/l

—

Acute myeloid leukaemia, including Hilmo

2.24

0.94

1.7

1.1

1.73

2.69

g/l

—

Autism spe

109

1.57

0.94

1.4

1.3

2.34

2.76

g/l

—

Schizophrenia or delusion

125

1452

0.86

0.94

1.2

1.3

2.68

2.96

g/l

1.11

988

Autism

109

1.57

0.94

1.4

2.34

2.85

g/l

—

Overexertion and strenuous or repetitive movements

373

1.29

0.94

1.2

1.4

2.21

2.98

g/l

3.36

260

Juvenile osteochondrosis

109

1.57

0.93

1.8

1.4

2.77

2.59

g/l

0.21

Primary angle-closure glaucoma

101

1.59

0.93

1.8

1.3

2.62

2.92

g/l

0.46

Ovarian dysfunction

286

1.33

0.93

1.4

2.69

3.01

g/l

0.76

196

Male infertility

175

1.43

0.93

1.2

1.3

3.53

3.22

g/l

0.24

113

Other ill-defined and unspecified causes of mortality

175

1.43

0.92

1.2

3.19

2.87

g/l

0.37

125

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

295

1.33

0.92

1.2

1.4

2.68

3.04

g/l

0.94

193

Right hemicolectomy

142

1.48

0.92

1.2

1.3

3.67

2.90

g/l

1.01

Car occupant injured in other and unspecified transport accidents

799

1.19

0.91

1.6

1.4

2.93

2.97

g/l

0.09

554

Erectile dysfunction

235

1.37

0.91

1.5

1.2

3.34

3.02

g/l

0.38

167

Premature rupture of membranes

721

0.83

0.90

1.3

1.4

3.14

3.04

g/l

0.20

510

Carcinoma in situ of skin

227

1.37

0.90

1.3

2.39

2.90

g/l

1.04

162

Schizophrenia, schizotypal and delusional disorders

126

1457

0.86

0.90

1.2

1.3

2.66

2.95

g/l

1.16

991

Bipolar affective disorders

819

1.19

0.90

1.3

2.90

3.01

g/l

0.23

554

Diabetic maculopathy

463

1.24

0.89

1.5

1.4

2.87

2.86

g/l

0.01

303

Malignant neoplasm of kidney, except renal pelvis

245

1.35

0.89

1.0

1.4

2.56

3.02

g/l

0.78

180

Thiazolidinediones

359

1.28

0.88

1.3

1.4

2.37

2.86

g/l

1.65

249

Pregnancy, childbirth and the puerperium

107

654

0.85

1.4

2.88

2.79

g/l

0.17

469

Assault

559

1.22

0.85

1.2

1.3

3.12

2.96

g/l

0.30

378

Mental and behavioural disorders due to cannabinoids

104

1.55

0.84

1.1

1.3

2.78

2.89

g/l

—

1.95

0.84

1.7

1.2

2.41

2.73

g/l

—

Benign neoplasm of thyroid gland

1.57

0.84

2.6

1.3

2.87

2.63

g/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

263

1801

1.10

0.84

1.4

2.83

2.94

g/l

0.54

188

1289

Diabetic neuropathy

404

1.26

0.84

1.5

1.4

2.34

2.96

g/l

2.46

263

Malignant neoplasm of stomach, including Hilmo

137

1.46

0.84

1.5

1.4

3.52

3.07

g/l

0.43

102

Basal cell carcinoma, including avohilmo

202

1243

1.12

0.84

1.6

1.4

2.65

3.02

g/l

2.47

146

871

Intracerebral haemorrhage

345

1.28

0.82

1.2

1.3

3.03

2.93

g/l

0.14

240

Infections of genitourinary tract in pregnancy

381

1.26

0.82

1.3

1.5

3.05

2.82

g/l

0.51

262

Congenital malformations of heart and great arteries

562

1.21

0.81

1.3

1.4

2.49

2.71

g/l

0.53

411

Other and unspecified mononeuropathies, also in other diseases

1.61

0.81

1.4

1.3

2.60

2.83

g/l

0.28

Organic, including symptomatic, mental disorders

176

1406

0.89

0.80

1.3

1.4

2.84

2.94

g/l

0.25

123

957

Other disorders of the genitourinary system

436

1.24

0.80

1.4

2.93

2.69

g/l

0.39

297

Congenital musculoskeletal deformities of head, face, spine and chest

1.74

0.80

1.6

1.3

2.73

2.24

g/l

—

Other chromosome abnormalities, not elsewhere classified

1.85

0.80

1.5

1.3

1.97

2.19

g/l

—

Other specified/unspecified nutritional deficiencies

0.00

0.79

0.0

1.5

—

2.82

—

Malignant melanoma

491

1.22

0.79

1.3

1.4

2.78

2.95

g/l

0.27

344

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.79

0.0

1.2

—

2.83

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

0.00

0.79

0.0

1.3

—

2.63

—

Graves disease, strict definition

392

1.25

0.79

1.4

2.85

2.92

g/l

0.10

278

Femoral hernia

106

1.51

0.79

1.4

1.2

3.15

2.78

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

339

1.27

0.78

1.2

1.5

3.24

2.89

g/l

0.66

238

Kela-code for behavioural disturbances in mental retardation

0.00

0.78

0.0

1.3

—

2.55

—

Pre-eclampsia or poor fetal growth

158

1400

1.13

0.76

1.4

3.12

2.96

g/l

0.51

108

990

Injury of muscle and tendon at lower leg level

585

1.20

0.76

2.0

1.3

3.07

3.08

g/l

0.01

404

Emotional disorders starting during childhood or adolescence

207

1.34

0.76

1.4

2.06

2.70

g/l

2.05

159

Other and unspecified corneal deformities and disorders

1.52

0.75

1.2

1.4

2.72

2.98

g/l

—

Basal cell carcinoma

189

1173

1.12

0.75

1.6

1.4

2.61

3.00

g/l

2.56

135

820

Solid cancers, helper endpoint

455

2506

1.07

0.74

1.3

1.4

2.86

3.04

g/l

1.17

304

1768

Benign neoplasm: Skin of other and unspecified parts of face

333

1.26

0.74

1.5

1.4

2.82

2.86

g/l

0.05

236

Lyme disease

146

1296

1.13

0.73

1.4

2.84

2.92

g/l

0.23

119

900

Spontaneous abortion

243

1492

1.10

0.73

1.3

1.4

2.93

2.91

g/l

0.05

172

1064

Other fall from one level to another

111

968

1.15

0.72

1.3

1.4

2.80

2.89

g/l

0.23

686

Alcohol dependence

123

1081

1.14

0.72

1.2

1.4

2.93

3.02

g/l

0.21

759

Supervision of normal pregnancy

611

0.86

0.72

1.2

1.4

2.82

2.97

g/l

0.38

446

Intermittent heterotropia

237

1.31

0.72

1.4

2.73

2.64

g/l

0.07

171

Parkinson's disease, strict definition, excluding more controls

317

0.75

0.71

1.3

1.4

2.27

2.93

g/l

1.38

210

Foreign body entering into or through eye or natural orifice

300

1.27

0.70

1.3

2.58

2.89

g/l

0.55

215

Spirochaetal infections, other/unspecified

147

1310

1.12

0.70

1.4

2.84

2.92

g/l

0.24

120

914

Malignant neoplasm of brain

101

1.49

0.70

1.4

1.2

2.69

2.92

g/l

—

Toxic effect of contact with venomous animals

143

1.40

0.70

1.2

1.3

3.08

2.70

g/l

0.31

Unspecified maternal hypertension

1.72

0.70

1.1

1.4

3.39

2.71

g/l

—

Hydrocele

372

1.24

0.70

1.4

2.56

3.16

g/l

1.60

264

Other osteochondropathies

265

1.29

0.70

1.4

1.3

2.41

2.91

g/l

0.67

180

Unspecified abortion

195

1.34

0.69

1.5

1.4

2.88

2.83

g/l

0.05

134

Open wound of head

271

2403

1.09

0.69

1.5

1.3

2.65

2.95

g/l

1.96

176

1642

Aneurysms, operations, SAH

583

1.19

0.68

1.3

1.4

2.92

2.84

g/l

0.13

398

Varicose veins of other sites

213

1.32

0.68

1.2

1.3

3.33

3.06

g/l

0.28

149

Melanocytic naevi of other and unspecified parts of face

196

1.33

0.67

1.3

1.4

3.12

2.93

g/l

0.20

132

Alzheimer’s disease (Late onset), excluding more controls

261

0.78

0.67

1.1

1.4

2.96

2.83

g/l

0.16

167

Traumatic subdural haemorrhage

342

1.24

0.66

1.5

1.4

3.17

2.98

g/l

0.26

240

Chronic periodontitis, including avohilmo

528

3336

1.06

0.66

1.4

2.93

2.98

g/l

0.28

373

2296

Tibial collateral bursitis [Pellegrini-Stieda]

1.79

0.66

1.0

1.5

3.09

2.70

g/l

—

Inguinal hernia

290

1790

1.08

0.66

1.3

1.4

3.01

2.99

g/l

0.06

203

1209

Inflammatory disorders of breast

232

1.30

0.66

1.7

1.4

2.72

2.79

g/l

0.09

159

Nontoxic goitre/thyroid nodule

131

1166

1.12

0.65

1.9

1.4

2.78

g/l

0.01

811

Short Achilles tendon (acquired)

1.62

0.65

1.4

3.40

2.85

g/l

—

Malignant neoplasm of breast, HER-negative

709

0.84

0.65

1.2

1.5

2.60

2.90

g/l

0.78

501

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

349

1.23

0.65

1.2

1.4

3.24

2.98

g/l

0.46

238

Toxic effects of substances chiefly nonmedicinal as to source

449

1.20

0.65

1.3

3.01

2.89

g/l

0.12

315

Follow-up examination after treatment for malignant neoplasms

224

1.30

0.64

1.1

1.3

2.67

2.90

g/l

0.24

130

Malignant melanoma, including Hilmo

588

1.18

0.63

1.3

1.4

2.63

2.96

g/l

0.73

418

Crushed, pushed or stepped on by crowd or human stampede

305

1.25

0.63

1.2

1.3

2.45

2.93

g/l

1.36

216

Inguinal or femoral hernia, bilateral

341

1.23

0.63

1.2

1.3

3.27

2.99

g/l

0.42

239

Superficial injury of shoulder and upper arm

414

1.21

0.63

1.7

1.4

3.06

3.01

g/l

0.08

292

Pervasive developmental disorders excl. Autism + Asperger

1.61

0.63

1.0

1.3

1.90

2.27

g/l

—

Parkinson's disease, excluding more controls

338

0.78

0.62

1.3

1.4

2.33

2.99

g/l

1.53

227

Mandibular retrognathia

269

1.26

0.62

1.4

2.73

2.85

g/l

0.18

190

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

291

0.75

0.62

1.4

2.30

2.97

g/l

1.79

211

Inguinal hernia, bilateral

333

1.23

0.62

1.2

1.3

3.19

3.00

g/l

0.25

235

Redundant prepuce, phimosis and paraphimosis

852

1.14

0.61

1.2

1.3

2.96

3.04

g/l

0.17

575

All dysplastic lesions of the cervix uteri

133

1181

1.12

0.61

1.3

1.4

2.72

3.02

g/l

1.69

838

Maternal care for known or suspected malpresentation of fetus

638

0.86

0.61

1.4

2.80

3.06

g/l

0.73

456

Foreign body or object entering through skin

226

1.29

0.61

1.4

1.3

3.10

2.85

g/l

0.28

160

Malignant neoplasm of ovary

152

0.66

0.61

1.4

1.6

2.31

2.72

g/l

—

104

Malignant neoplasm of bladder, including Hilmo

314

1.24

0.60

1.6

1.4

2.96

3.12

g/l

0.15

231

Malignant neoplasm of breast, ER-negative, including Hilmo

795

0.86

0.60

1.2

1.5

2.63

2.88

g/l

0.72

563

Injury of muscle and tendon at wrist and hand level

536

1.18

0.60

1.3

1.4

2.75

3.02

g/l

0.63

376

Focal brain injury

165

1.34

0.60

1.6

1.3

3.45

2.95

g/l

0.47

113

Epidural haemorrhage

0.00

0.60

0.0

1.4

—

3.04

—

Injury of eye and orbit

601

1.17

0.60

1.2

1.3

3.13

2.95

g/l

0.28

410

Diabetic retinopathy, strict definition

604

1.16

0.60

1.5

1.4

3.08

2.89

g/l

0.31

393

0.00

0.60

0.0

1.1

—

2.90

—

Nontoxic single thyroid nodule

236

1.27

0.59

2.1

1.3

2.98

2.84

g/l

0.17

171

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

326

1.23

0.59

1.4

2.63

2.89

g/l

0.74

226

Intrahepatic Cholestasis of Pregnancy (ICP)

290

1.24

0.59

1.1

1.4

3.41

2.90

g/l

0.98

205

Malignant neoplasm of urinary organs

272

1.25

0.59

1.0

1.4

2.82

3.02

g/l

0.21

197

Hyperplasia of prostate

150

767

1.11

0.59

1.3

1.4

3.07

3.19

g/l

0.30

106

528

Malignant neoplasm of stomach

114

1.41

0.58

1.5

1.2

3.91

2.98

g/l

0.91

Traction detachment of retina

0.00

0.58

0.0

1.2

—

2.66

—

Vascular dementia

160

1.33

0.58

1.4

1.2

2.68

2.86

g/l

0.15

119

Other mental disorders due to brain damage and dysfunction and to physical disease

327

1.23

0.58

1.4

2.98

2.88

g/l

0.08

229

HSIL lesion of the cervix uteri

852

0.87

0.58

1.4

2.78

3.02

g/l

0.80

598

Pedal cyclist injured in noncollision transport accidents

474

0.82

0.57

1.4

1.3

2.87

2.97

g/l

0.12

332

Periodontitis

527

3343

1.05

0.57

1.4

2.93

2.98

g/l

0.23

374

2298

Pedal cyclist injured in transport accident

978

0.88

0.56

1.5

1.3

3.16

2.90

g/l

0.66

680

Puerperal sepsis

503

1.17

0.56

1.7

1.4

2.82

2.81

g/l

0.01

346

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

293

1.23

0.55

1.1

1.4

3.41

3.01

g/l

0.71

203

Leiomyoma of uterus

323

1712

1.07

0.55

1.4

2.83

2.88

g/l

0.22

220

1225

Postpartum haemorrhage due to retained placenta

547

0.84

0.54

1.2

1.3

3.21

3.07

g/l

0.19

381

Malignant neoplasm of bladder

151

1.33

0.53

1.5

1.2

2.93

3.03

g/l

0.05

115

Maternal care for known or suspected fetal abnormality and damage

645

0.87

0.53

1.3

1.4

2.95

3.07

g/l

0.23

456

Calculus of lower urinary tract

134

1.35

0.53

1.7

1.3

2.97

3.00

g/l

—

Left ventricular outflow tract obstruction, narrow definition

187

1.29

0.52

1.4

1.3

2.12

2.72

g/l

1.10

132

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

0.61

0.52

1.3

1.4

1.44

2.08

g/l

—

Viral hepatitis

277

1.23

0.52

1.1

1.3

3.26

3.06

g/l

0.20

191

Transitory endocrine and metabolic disorders specific to fetus and newborn

0.60

0.52

1.3

1.4

1.44

2.09

g/l

—

Transient global amnesia

293

0.78

0.52

2.4

1.4

2.49

2.84

g/l

0.58

203

Pedestrian injured in collision with pedal cycle

1.45

0.52

1.2

1.3

2.81

2.83

g/l

—

Wide developmental disorders

161

1.31

0.51

1.3

1.4

2.10

2.50

g/l

0.61

124

Malignant neoplasm of rectum

280

0.78

0.50

1.4

2.23

3.01

g/l

1.92

201

Other blood glucose lowering drugs, excl. Insulins

547

1.15

0.50

1.2

1.4

2.98

2.83

g/l

0.21

378

Slow fetal growth and fetal malnutrition

1.56

0.49

2.1

1.3

1.56

2.28

g/l

—

Pregnancy examination and test

473

1.13

0.49

1.6

1.4

2.93

2.94

g/l

0.02

345

Other and unspecified nonorganic psychotic disorders

880

0.89

0.48

1.2

1.4

2.69

2.99

g/l

0.80

594

Foreign body in alimentary tract

172

1.28

0.48

1.2

1.3

3.05

2.89

g/l

0.18

124

Ill-defined and unknown causes of mortality

199

1.26

0.47

1.2

3.19

2.89

g/l

0.35

138

Obstructed labour due to malposition and malpresentation of fetus

997

0.90

0.47

1.3

1.4

3.20

2.95

g/l

0.74

712

Generalized epilepsy, mode (most common among epilepsy diagnosis)

111

1.36

0.46

1.4

1.3

2.46

2.60

g/l

—

Malignant neoplasm of head and neck

236

1.23

0.46

1.2

1.3

2.47

3.03

g/l

1.12

169

Other disorders of iris and ciliary body

1.43

0.45

1.2

1.3

2.79

g/l

—

Scissor bite

140

0.70

0.45

1.4

1.5

2.42

2.44

g/l

—

113

Other abnormal products of conception

171

1045

1.08

0.45

1.4

1.3

3.09

2.99

g/l

0.31

117

751

Generalized epilepsy

156

1.29

0.45

1.4

1.3

2.83

2.75

g/l

0.09

111

Polyhydramnios

183

1.26

0.45

1.4

3.12

2.93

g/l

0.17

125

HSIL lesion of the cervix uteri, vagina or vulva

927

0.89

0.44

1.4

2.68

3.01

g/l

1.32

654

Type 1 diabetes, strict (exclude DM2)

449

1.16

0.44

1.2

1.4

3.00

2.91

g/l

0.12

330

Carcinoma in situ of cervix uteri

384

0.83

0.44

1.5

1.4

2.56

2.87

g/l

0.89

265

Antenatal screening

101

628

0.90

0.44

1.2

1.4

3.08

2.96

g/l

0.33

457

Type 1 diabetes, definitions combined

450

1.15

0.43

1.2

1.3

3.00

2.90

g/l

0.13

332

Benign leiomyoma with endometriosis

583

1.13

0.43

1.2

1.4

2.66

2.77

g/l

0.21

396

Medical treatment for female infertility

108

976

1.10

0.43

1.3

1.4

2.99

3.04

g/l

0.11

683

Macular hole

151

0.73

0.42

1.1

1.5

2.03

2.83

g/l

—

114

Complications following abortion and ectopic and molar pregnancy

113

1.33

0.42

1.1

1.6

3.03

2.78

g/l

—

Clear cell adenocarcinoma of kidney

122

1.31

0.42

1.0

1.4

3.06

3.14

g/l

—

Polycystic ovarian syndrome, broad definition

462

1.15

0.42

1.5

1.4

3.02

3.03

g/l

0.02

331

Focal epilepsy, mode (most common among epilepsy diagnosis)

745

1.11

0.42

1.3

2.92

2.90

g/l

0.03

528

Postpartum haemorrhage due to anatomy

446

0.85

0.42

1.1

1.3

3.08

g/l

0.00

309

Malignant neoplasm of hypopharynx

0.00

0.41

0.0

1.1

—

2.03

—

Alcoholic cardiomyopathy

0.00

0.41

0.0

1.4

—

2.18

—

Open bite

240

1.21

0.41

1.2

1.4

3.41

2.66

g/l

1.09

172

Manic episode

1.40

0.40

1.4

1.3

2.42

2.72

g/l

—

Prominent ears

1.48

0.40

1.4

1.2

2.77

2.87

g/l

—

Frostbite

1.48

0.40

1.4

2.68

2.63

g/l

—

Focal epilepsy

871

1.10

0.40

1.3

2.81

2.86

g/l

0.07

616

Assault by bodily force

324

1.17

0.40

1.2

1.3

3.13

3.01

g/l

0.16

222

Malignant neoplasm of brain, including Hilmo

150

1.27

0.40

1.3

1.4

2.53

2.91

g/l

0.38

109

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.40

0.0

1.4

—

2.60

—

Deep bite

456

1.14

0.40

1.3

1.4

2.84

2.73

g/l

0.26

335

Malignant neoplasm of other and ill-defined digestive organs

0.00

0.40

0.0

1.2

—

2.87

—

Other viral hepatitis

241

1.21

0.40

1.1

1.3

3.03

3.08

g/l

0.06

166

Non-small cell lung cancer, squamous

1.37

0.40

1.4

1.2

2.62

3.03

g/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

270

0.81

0.39

1.4

2.30

2.98

g/l

1.83

194

Malignant neoplasm of hypopharynx, including Hilmo

0.00

0.39

0.0

1.1

—

2.14

—

Other and unspecified disorders of pigmentation

0.00

0.39

0.0

1.2

—

2.95

—

Colorectal adenocarcinoma

600

0.88

0.38

1.3

1.4

2.70

2.99

g/l

0.59

422

Malignant melanoma of skin

366

0.85

0.38

1.4

2.44

2.93

g/l

1.07

258

Single delivery by forceps and vacuum extractor

458

0.89

0.37

1.3

1.4

3.18

2.87

g/l

0.70

345

Pre-eclampsia

886

1.10

0.37

1.5

1.4

3.09

2.89

g/l

0.52

610

Malignant neoplasm of corpus uteri, including Hilmo

271

1.18

0.37

1.1

1.5

2.76

2.72

g/l

0.04

181

Bulimia nervosa (incl. atypical)

125

1.28

0.37

1.3

1.4

2.94

2.77

g/l

0.17

Other disorders of amniotic fluid and membranes

615

0.89

0.36

1.8

1.4

2.73

3.09

g/l

0.79

433

Lesion of plantar nerve

189

1.22

0.36

2.1

1.4

3.29

2.92

g/l

0.44

132

Congenital malformations of aortic and mitral valves

153

1.24

0.35

1.4

1.3

2.02

2.73

g/l

1.18

109

Noise effects on inner ear

126

1.27

0.35

1.2

1.3

2.42

3.10

g/l

0.97

Unspecified lump in breast

603

1.11

0.35

1.6

1.4

2.46

2.83

g/l

1.16

414

Postpartum care and examination

418

0.89

0.34

1.3

1.4

2.90

2.99

g/l

0.19

299

Otosclerosis

246

1.18

0.34

1.0

1.5

2.96

2.81

g/l

0.25

172

Nontraumatic intracranial haemmorrhage

652

1.10

0.33

1.3

1.4

3.08

2.86

g/l

0.52

453

Tooth agenesis EXCLUDE clefts and syndromes

166

0.78

0.33

1.5

1.4

1.96

2.64

g/l

—

124

Postpartum haemorrhage

112

1016

0.93

0.32

1.2

1.4

3.15

2.95

g/l

0.61

726

Non-small cell lung cancer, squamous, helper endpoint

1.31

0.31

1.4

1.2

2.62

2.77

g/l

—

Polycystic ovarian syndrome

202

1.19

0.31

1.4

2.63

2.95

g/l

0.63

132

Postpartum hemorraghe, all women as controls

112

1184

0.93

0.30

1.2

1.4

3.15

3.00

g/l

0.42

838

Malignant melanoma of skin, including Hilmo

495

0.89

0.30

1.4

2.32

2.95

g/l

2.02

352

Contact with other sharp object(s)

272

0.84

0.30

1.3

2.26

2.99

g/l

1.91

191

Kela-code for severe mental illness

160

1695

0.94

0.29

1.2

1.4

2.85

2.96

g/l

0.33

108

1156

Retinal breaks without detachment

620

1.10

0.29

1.7

1.4

3.03

2.94

g/l

0.16

442

Convergent concomitant strabismus

242

1.16

0.28

1.5

1.4

2.49

2.81

g/l

0.46

174

Focal epilepsy, strict definition

797

1.08

0.27

1.3

2.80

2.86

g/l

0.09

565

Burn and corrosion of head and neck

1.21

0.26

1.3

2.61

2.85

g/l

—

Multiple gestation

404

1.12

0.26

1.4

3.23

3.03

g/l

0.37

281

Other sexually transmitted chlamydial diseases

416

0.89

0.26

1.3

1.4

2.73

3.03

g/l

0.55

276

Abnormal spermatozoa

395

1.11

0.26

1.2

1.3

3.38

3.08

g/l

0.40

280

Maternal care related to the fetus and amniotic cavity and possible delivery problems

233

1307

1.05

0.26

1.4

2.92

2.94

g/l

0.04

173

937

Benign neoplasm of breast

457

0.90

0.26

1.3

1.4

2.50

2.82

g/l

0.55

319

Malignant neoplasm of ovary, including Hilmo

203

0.84

0.25

1.2

1.5

2.34

2.78

g/l

—

140

Labour and delivery complicated by fetal stress [distress]

124

764

1.06

0.25

1.3

1.4

3.31

2.98

g/l

1.27

547

Poor fetal growth

579

1.09

0.25

1.2

1.4

3.27

2.96

g/l

0.56

413

Other and/or unspecified nontoxic goitre

266

0.86

0.24

3.3

1.3

2.85

2.76

g/l

0.12

186

malignant neoplasm of female genital organs

494

0.90

0.24

1.2

1.4

2.75

2.84

g/l

0.10

342

Twin gestation

388

1.11

0.24

1.4

3.23

3.00

g/l

0.42

268

Fracture of forearm

276

2435

1.04

0.24

1.3

1.4

2.96

2.87

g/l

0.33

194

1702

Pre-eclampsia or eclampsia

102

959

1.06

0.23

1.5

1.4

3.10

2.88

g/l

0.58

665

Hydrocephalus

190

1.16

0.23

2.0

1.3

2.56

2.72

g/l

0.15

140

Type 1 diabetes, strict definition, subgroup 1

341

1.11

0.23

1.3

2.80

2.82

g/l

0.03

259

Sulfonylureas

110

928

0.94

0.23

1.1

1.4

2.67

2.92

g/l

0.72

627

Chronic viral hepatitis

200

0.85

0.22

1.1

1.3

3.10

3.07

g/l

0.02

135

Undescended testis, unilateral

1.25

0.22

1.0

1.4

1.99

2.20

g/l

—

Gestational diabetes (for exclusion)

176

1280

0.96

0.22

1.2

1.4

3.19

2.97

g/l

0.94

130

914

Ependymoma

0.00

0.21

0.0

1.2

—

2.46

—

Other and unspecified injuries of head

229

1.14

0.21

1.2

1.3

2.86

2.88

g/l

0.02

156

Malignant neoplasm of larynx, including Hilmo

1.19

0.21

1.0

1.2

3.09

2.87

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

536

1.08

0.21

1.2

1.3

2.97

2.94

g/l

0.05

381

Syndactyly

0.00

0.21

0.0

1.2

—

3.16

—

Benign neoplasm of other and unspecified female genital organs

126

1.19

0.21

1.5

1.6

2.72

2.96

g/l

—

Ectopic pregnancy

760

1.07

0.20

1.4

2.90

2.87

g/l

0.05

534

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.20

0.0

1.1

—

3.09

—

Helminthiases

1.25

0.20

1.5

1.2

2.36

2.56

g/l

—

Supervision of high-risk pregnancy

106

603

1.06

0.20

1.4

3.21

2.97

g/l

0.64

439

Malignant neoplasm of testis, including Hilmo

1.23

0.20

1.2

1.3

2.79

3.17

g/l

—

Malignant neoplasm of corpus uteri

221

1.13

0.20

1.1

1.5

3.01

2.67

g/l

0.33

152

Acute and transient psychotic disorders

489

0.92

0.19

1.1

1.4

2.77

2.98

g/l

0.32

335

Burn and corrosion of trunk

1.22

0.19

1.3

3.15

2.78

g/l

—

Colorectal cancer

730

0.94

0.19

1.2

1.4

2.78

3.00

g/l

0.51

502

Use of disulfiram, acamprosate or naltrexone

356

1.10

0.19

1.4

1.3

2.66

3.10

g/l

0.83

240

424

1.09

0.18

1.2

1.4

2.80

3.09

g/l

0.55

288

Placenta praevia

194

1.14

0.18

1.3

1.4

3.38

3.01

g/l

0.33

131

Periapical abscess

223

2157

1.03

0.18

1.4

2.74

2.98

g/l

1.43

155

1522

Abnormal findings on antenatal screening of mother

363

0.91

0.18

1.5

3.00

2.95

g/l

0.04

259

Abnormalities of forces of labour

466

0.92

0.18

1.3

1.4

2.73

2.91

g/l

0.34

328

Bicuspidal aortic valve syndrome

119

1.18

0.17

1.4

1.3

2.29

2.79

g/l

—

Complications of labour and delivery

319

1725

1.03

0.17

1.3

1.4

3.05

2.84

g/l

1.31

220

1217

Alcohol withdrawal state with delirium

233

1.12

0.17

1.1

1.3

2.65

3.14

g/l

0.97

164

Use of levodopa decarboxylase inhibitor

372

0.91

0.17

1.3

1.94

2.96

g/l

3.43

260

Renal cell carcinoma of kidney

0.73

0.17

1.0

1.2

2.92

2.74

g/l

—

Struck by thrown, projected or falling objec

178

1.12

0.15

1.3

2.79

3.03

g/l

0.20

120

Burns and corrosions

594

0.94

0.14

1.5

1.3

2.64

2.93

g/l

0.68

413

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.82

0.14

1.4

1.3

2.25

2.00

g/l

—

Memory loss

247

1.09

0.13

1.2

1.4

2.69

2.88

g/l

0.25

171

Diabetes mellitus in pregnancy

163

1012

1.03

0.13

1.2

1.4

3.19

3.04

g/l

0.48

118

727

Antepartum haemorrhage, not elsewhere classified

396

0.93

0.12

1.3

1.4

2.60

3.01

g/l

0.94

283

Colon adenocarcinoma

334

0.93

0.12

1.2

1.4

3.01

2.97

g/l

0.03

237

Contact with sharp glass

133

1.13

0.12

1.2

1.3

2.82

2.86

g/l

—

Uterine polyps

346

1.07

0.12

1.4

2.36

2.76

g/l

1.17

250

Malignant neoplasm of colon, including Hilmo

590

1.05

0.12

1.5

1.4

3.13

2.96

g/l

0.33

412

Unspecified mental disorder

198

1931

1.03

0.11

1.2

1.4

2.91

2.98

g/l

0.19

138

1328

Other disorders of penis

356

1.07

0.11

1.6

1.3

2.93

3.03

g/l

0.15

261

Schizophrenia or delusion, excluding more controls

125

1200

1.03

0.11

1.2

1.4

2.68

3.05

g/l

1.64

811

Acute appendicitis, with complications

780

0.96

0.10

1.4

1.3

2.78

3.00

g/l

0.55

553

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.14

0.10

1.0

1.4

2.43

2.63

g/l

—

Malignant neoplasm of testis

1.11

0.10

1.2

1.4

3.17

3.15

g/l

—

Type1 diabetes, definitions combined, early onset

309

1.06

0.09

1.3

2.89

2.68

g/l

0.32

227

Chronic periodontitis, complicated

252

2454

1.02

0.09

1.4

2.80

2.95

g/l

0.73

173

1704

Gonococcal infection

1.14

0.09

1.5

2.57

2.97

g/l

—

Combinations of oral blood glucose lowering drugs

107

1099

0.97

0.08

1.3

1.4

3.17

3.00

g/l

0.35

756

Injury of nerves at wrist and hand level

117

1.11

0.08

1.3

1.93

3.07

g/l

—

severe traumatic brain injury, does not include concussion

766

1.03

0.08

1.5

1.3

3.07

2.99

g/l

0.16

536

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.03

0.08

1.1

1.2

2.48

2.62

g/l

—

Other disorders of prostate

1.03

0.08

1.6

1.3

3.27

3.22

g/l

—

Postpartum hemorraghe, parous women as controls

112

977

0.98

0.07

1.2

1.3

3.15

3.02

g/l

0.33

684

Maternal care for known or suspected abnormality of pelvic organs

122

811

1.02

0.07

1.2

1.4

2.87

3.02

g/l

0.32

578

Gonococcal infection

108

1.11

0.07

1.4

1.5

2.57

2.95

g/l

—

Myocardial infarction, unclassifiable

563

0.97

0.07

1.3

2.87

2.99

g/l

0.21

396

Pedal cyclist injured in collision with motor vehicle

1.12

0.07

2.0

1.3

2.76

2.82

g/l

—

Pedal cyclist injured in other and unspecified transport accidents

437

0.96

0.06

1.4

3.46

2.94

g/l

1.14

305

Other obstructed labour

305

1.05

0.06

1.2

1.4

2.81

2.80

g/l

0.02

210

Other complications of labour and delivery, not elsewhere classified

489

1.03

0.05

1.1

1.4

3.01

2.94

g/l

0.15

347

Subarachnoid haemorrhage

304

0.95

0.05

1.4

3.16

2.89

g/l

0.38

211

Use of rivastigmine

325

1.04

0.05

1.4

1.3

2.52

2.87

g/l

0.75

232

Dislocation, sprain and strain of joints and ligaments of elbow

248

1.05

0.05

1.9

1.4

3.24

2.87

g/l

0.48

175

Family history of certain disabilities and chronic diseases leading to disablement

181

0.94

0.05

1.1

1.3

2.99

2.98

g/l

0.01

130

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

201

0.94

0.04

1.5

1.4

3.23

2.95

g/l

—

138

Multiple delivery

368

1.03

0.04

1.4

1.3

3.64

2.67

g/l

1.51

283

Orchitis and epididymitis

310

1.03

0.03

1.3

1.4

3.17

g/l

0.00

218

Retinal detachment with retinal break

431

1.02

0.02

1.6

1.3

2.93

2.96

g/l

0.04

308

Fall on and from ladder

242

1.03

0.02

1.4

1.2

3.11

2.99

g/l

0.11

171

Burn and corrosion of wrist and hand

117

0.94

0.01

2.1

1.3

2.81

2.69

g/l

0.08

Thyrotoxicosis with toxic multinodular goitre

177

0.96

0.01

1.8

1.6

3.14

2.84

g/l

—

126

Failed induction of labour

243

1.03

0.01

1.3

1.4

2.69

2.90

g/l

0.34

169

Retained placenta and membranes, without haemorrhage

503

1.01

0.01

1.3

2.57

2.80

g/l

0.42

345

Single delivery by caesarean section

552

1.01

0.01

1.4

1.5

3.29

2.83

g/l

1.72

421

Divergent concomitant strabismus

284

1.02

0.00

1.7

1.4

3.05

2.90

g/l

0.12

197

Family history of malignant neoplasm

444

1.01

0.00

1.2

1.4

2.36

2.84

g/l

1.38

324

Spermatocele

235

1.02

0.00

1.5

1.3

2.82

3.16

g/l

0.44

161

Type 1 diabetes, strict definition

388

1.00

0.00

1.3

2.78

2.86

g/l

0.12

288

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

828

1.00

0.00

1.2

1.4

2.55

3.02

g/l

2.11

577

Rubella [German measles]

122

0.98

0.00

2.5

1.4

3.22

2.83

g/l

—

Burns and corrosions of external body surface, specified by site

443

0.99

0.00

1.6

1.3

2.82

2.87

g/l

0.07

312

Other sexually transmitted chlamydial diseases

258

1.01

0.00

1.3

1.4

2.84

3.05

g/l

0.26

169

Maternal care for cervical incompetence

121

0.99

0.00

1.3

1.5

2.59

2.93

g/l

—

Malignant neoplasm of colon

435

1.01

0.00

1.1

1.4

3.19

2.96

g/l

0.35

304

Crowding of teeth, including avohilmo

354

1.00

0.00

1.3

1.4

2.74

2.64

g/l

0.14

257

Traumatic amputation of wrist and hand

123

0.98

0.00

1.4

1.3

2.14

3.22

g/l

—

Respiratory and cardiovascular disorders specific to the perinatal period

141

1.01

0.00

1.8

1.3

1.91

2.20

g/l

0.52

123

Respiratory distress of newborn

108

1.03

0.00

2.0

1.3

1.75

2.03

g/l

0.52

Acne varioliformis

0.00

0.0

1.0

—

4.03

—

Congenital malposition of the kidney

0.00

0.0

1.0

—

2.62

—

Staphylococcal scalded skin syndrome

0.00

-0.00

0.0

1.2

—

2.21

—

Exposure to other and unspecified man-made environmental factors

0.96

-0.00

1.0

1.3

2.63

2.64

g/l

—

Chondrosarcoma

0.00

-0.00

0.0

1.1

—

1.95

—

Accidental poisoning by and exposure to pesticides

0.00

-0.00

0.0

1.3

—

3.16

—

Hirsprung

0.00

-0.00

0.0

1.0

—

2.00

—

Microtia (small ears)

0.00

-0.00

0.0

1.1

—

2.70

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

-0.00

0.0

1.4

—

2.05

—

Intracranial nontraumatic haemorrhage of fetus and newborn

0.00

-0.00

0.0

1.4

—

2.45

—

Congenital malformation of optic disc

0.00

-0.00

0.0

1.0

—

3.06

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

-0.00

0.0

1.2

—

2.26

—

Cholera

0.00

-0.00

0.0

1.2

—

2.19

—

Other perinatal haematological disorders

0.00

-0.00

0.0

1.1

—

2.33

—

Birth injury to skeleton

0.00

-0.00

0.0

1.5

—

2.40

—

Other inherited muscular atrophy

0.00

-0.00

0.0

1.0

—

2.28

—

Liveborn infants according to place of birth

0.91

-0.00

1.0

1.2

2.04

2.23

g/l

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgG subclass 2 [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS